SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'GLU'


List of Similar Pattern of Amino Acids


Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A29_A_TFPA154_1
(CALMODULIN)
4gow CALMODULIN
(Homo
sapiens)
5 / 10 LEU D  18
MET D 109
GLU D 114
LEU D 116
MET D 124
LEU  D  18 ( 0.6A)
MET  D 109 ( 0.0A)
GLU  D 114 ( 0.6A)
LEU  D 116 ( 0.6A)
MET  D 124 ( 0.0A)
1.27A 1a29A-4gowD:
14.6
1a29A-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1A29_A_TFPA154_1
(CALMODULIN)
4gow CALMODULIN
(Homo
sapiens)
5 / 10 MET D 109
LEU D 116
GLU D 120
GLU D 123
MET D 124
MET  D 109 ( 0.0A)
LEU  D 116 ( 0.6A)
GLU  D 120 ( 0.6A)
GLU  D 123 ( 0.6A)
MET  D 124 ( 0.0A)
1.12A 1a29A-4gowD:
14.6
1a29A-4gowD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMA_A_SAMA105_0
(PROTEIN (MET
REPRESSOR))
5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE

(Bacillus
subtilis)
4 / 8 GLU A 297
ARG A 293
LEU A 273
GLU A 270
GLU  A 297 ( 0.6A)
ARG  A 293 ( 0.6A)
LEU  A 273 ( 0.6A)
GLU  A 270 ( 0.6A)
1.06A 1cmaA-5ep8A:
undetectable
1cmaB-5ep8A:
undetectable
1cmaA-5ep8A:
17.07
1cmaB-5ep8A:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMA_B_SAMB105_0
(PROTEIN (MET
REPRESSOR))
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
5 / 11 GLU A  36
GLU A  43
LEU A  40
ALA A 155
GLY A 153
GLU  A  36 ( 0.6A)
GLU  A  43 ( 0.5A)
LEU  A  40 ( 0.6A)
ALA  A 155 ( 0.0A)
GLY  A 153 ( 0.0A)
1.31A 1cmaA-2ogsA:
undetectable
1cmaB-2ogsA:
undetectable
1cmaA-2ogsA:
11.99
1cmaB-2ogsA:
11.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMA_B_SAMB105_0
(PROTEIN (MET
REPRESSOR))
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 11 GLU A 376
GLU A 378
LEU A 381
ALA A 501
GLY A 499
GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
1.23A 1cmaA-4flxA:
undetectable
1cmaB-4flxA:
undetectable
1cmaA-4flxA:
10.19
1cmaB-4flxA:
10.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMC_A_SAMA105_0
(MET REPRESSOR)
3g9k CAPSULE BIOSYNTHESIS
PROTEIN CAPD
CAPSULE BIOSYNTHESIS
PROTEIN CAPD

(Bacillus
anthracis;
Bacillus
anthracis)
5 / 10 ALA L  58
GLY L  62
ARG S 520
GLU L  87
LEU L  83
None
None
GLU  S   2 (-4.2A)
None
None
1.29A 1cmcA-3g9kL:
undetectable
1cmcB-3g9kL:
undetectable
1cmcA-3g9kL:
15.48
1cmcB-3g9kL:
15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)
4gow CALMODULIN
(Homo
sapiens)
6 / 9 ILE D 100
GLU D 123
GLU D 127
ALA D 128
VAL D 136
MET D 144
ILE  D 100 ( 0.7A)
GLU  D 123 ( 0.6A)
GLU  D 127 ( 0.6A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
MET  D 144 ( 0.0A)
1.27A 1ctrA-4gowD:
17.2
1ctrA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)
4gow CALMODULIN
(Homo
sapiens)
6 / 9 ILE D 100
LEU D 105
GLU D 127
ALA D 128
VAL D 136
MET D 144
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
GLU  D 127 ( 0.6A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
MET  D 144 ( 0.0A)
1.00A 1ctrA-4gowD:
17.2
1ctrA-4gowD:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CTR_A_TFPA153_1
(CALMODULIN)
4gow CALMODULIN
(Homo
sapiens)
6 / 9 ILE D 100
LEU D 105
MET D 124
GLU D 127
ALA D 128
VAL D 136
ILE  D 100 ( 0.7A)
LEU  D 105 ( 0.6A)
MET  D 124 ( 0.0A)
GLU  D 127 ( 0.6A)
ALA  D 128 ( 0.0A)
VAL  D 136 ( 0.6A)
0.71A 1ctrA-4gowD:
17.2
1ctrA-4gowD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1D4F_B_ADNB602_2
(S-ADENOSYLHOMOCYSTEI
NE HYDROLASE)
4hpp PROBABLE GLUTAMINE
SYNTHETASE

(Pseudomonas
aeruginosa)
4 / 5 THR A 281
THR A 340
THR A 232
HIS A 236
None
None
GLU  A 503 (-4.2A)
GLU  A 503 (-4.1A)
1.23A 1d4fB-4hppA:
undetectable
1d4fB-4hppA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DMA_A_NCAA700_0
(EXOTOXIN A)
4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN

(Mycolicibacteriu
m
fortuitum)
4 / 7 GLY A 149
TYR A 170
ALA A 150
GLU A 168
GLY  A 149 ( 0.0A)
TYR  A 170 ( 1.3A)
ALA  A 150 ( 0.0A)
GLU  A 168 (-0.5A)
0.90A 1dmaA-4w65A:
undetectable
1dmaA-4w65A:
22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DMA_A_NCAA700_0
(EXOTOXIN A)
5nh2 UNCHARACTERIZED
PROTEIN

(Bartonella
henselae)
4 / 7 GLY B  49
ALA B  51
TYR B  50
GLU B  17
GLY  B  49 ( 0.0A)
ALA  B  51 ( 0.0A)
TYR  B  50 ( 1.3A)
GLU  B  17 ( 0.5A)
0.85A 1dmaA-5nh2B:
undetectable
1dmaA-5nh2B:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DTL_A_BEPA204_1
(CARDIAC TROPONIN C)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo
sapiens)
5 / 11 LEU A  96
VAL A 106
GLU A 150
LEU A 149
LEU A 146
LEU  A  96 ( 0.5A)
VAL  A 106 ( 0.6A)
GLU  A 150 ( 0.5A)
LEU  A 149 ( 0.6A)
LEU  A 146 ( 0.5A)
1.04A 1dtlA-3sl5A:
undetectable
1dtlA-3sl5A:
19.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1DTL_A_BEPA206_1
(CARDIAC TROPONIN C)
4gow CALMODULIN
(Homo
sapiens)
4 / 8 MET D  36
GLN D  41
PRO D  43
GLU D  47
MET  D  36 ( 0.0A)
GLN  D  41 ( 0.6A)
PRO  D  43 ( 1.1A)
GLU  D  47 ( 0.5A)
1.06A 1dtlA-4gowD:
12.2
1dtlA-4gowD:
53.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DY4_A_SNPA437_1
(EXOGLUCANASE 1)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
5 / 12 ALA A 307
SER A  31
GLU A  47
THR A  51
ARG A  24
None
None
None
None
GLU  A2471 (-3.8A)
1.48A 1dy4A-1tkkA:
undetectable
1dy4A-1tkkA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DY4_A_SNPA437_1
(EXOGLUCANASE 1)
5w0a GLUCANASE
(Trichoderma
harzianum)
8 / 12 ALA A 144
TYR A 146
TYR A 170
ASP A 172
GLN A 174
GLU A 196
ASP A 198
GLU A 201
ALA  A 144 ( 0.0A)
TYR  A 146 ( 1.3A)
TYR  A 170 ( 1.3A)
ASP  A 172 ( 0.5A)
GLN  A 174 ( 0.5A)
GLU  A 196 ( 0.6A)
ASP  A 198 (-0.6A)
GLU  A 201 (-0.5A)
0.36A 1dy4A-5w0aA:
48.5
1dy4A-5w0aA:
11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DY4_A_SNPA437_1
(EXOGLUCANASE 1)
5w0a GLUCANASE
(Trichoderma
harzianum)
6 / 12 ALA A 144
TYR A 146
TYR A 170
ASP A 198
GLU A 201
ASP A 322
ALA  A 144 ( 0.0A)
TYR  A 146 ( 1.3A)
TYR  A 170 ( 1.3A)
ASP  A 198 (-0.6A)
GLU  A 201 (-0.5A)
ASP  A 322 ( 0.6A)
0.76A 1dy4A-5w0aA:
48.5
1dy4A-5w0aA:
11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7B_A_HLTA4002_1
(SERUM ALBUMIN)
4non FERROUS IRON UPTAKE
TRANSPORTER PROTEIN
B

(Streptococcus
thermophilus)
4 / 4 ARG A 197
ALA A 200
ALA A 179
GLU A 177
ARG  A 197 ( 0.6A)
ALA  A 200 ( 0.0A)
ALA  A 179 ( 0.0A)
GLU  A 177 ( 0.6A)
0.96A 1e7bA-4nonA:
undetectable
1e7bA-4nonA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7B_B_HLTB4002_1
(SERUM ALBUMIN)
4non FERROUS IRON UPTAKE
TRANSPORTER PROTEIN
B

(Streptococcus
thermophilus)
4 / 4 ARG A 197
ALA A 200
ALA A 179
GLU A 177
ARG  A 197 ( 0.6A)
ALA  A 200 ( 0.0A)
ALA  A 179 ( 0.0A)
GLU  A 177 ( 0.6A)
0.97A 1e7bB-4nonA:
undetectable
1e7bB-4nonA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7C_A_HLTA4002_1
(SERUM ALBUMIN)
3ig0 DNA GYRASE SUBUNIT B
(Mycobacterium
tuberculosis)
4 / 5 ARG A 631
ALA A 564
LYS A 526
GLU A 454
ARG  A 631 ( 0.6A)
ALA  A 564 ( 0.0A)
LYS  A 526 ( 0.0A)
GLU  A 454 ( 0.6A)
1.09A 1e7cA-3ig0A:
undetectable
1e7cA-3ig0A:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7C_A_HLTA4002_1
(SERUM ALBUMIN)
4non FERROUS IRON UPTAKE
TRANSPORTER PROTEIN
B

(Streptococcus
thermophilus)
4 / 5 ARG A 197
ALA A 200
ALA A 179
GLU A 177
ARG  A 197 ( 0.6A)
ALA  A 200 ( 0.0A)
ALA  A 179 ( 0.0A)
GLU  A 177 ( 0.6A)
0.95A 1e7cA-4nonA:
undetectable
1e7cA-4nonA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_A_FFOA1293_1
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima)
3 / 3 GLU A 170
TYR A 166
PHE A 124
GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
0.92A 1eqbB-4ursA:
undetectable
1eqbB-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_B_FFOB2293_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima)
3 / 3 GLU A 170
TYR A 166
PHE A 124
GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
0.92A 1eqbA-4ursA:
undetectable
1eqbA-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_C_FFOC3293_2
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima)
3 / 3 GLU A 170
TYR A 166
PHE A 124
GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
0.92A 1eqbD-4ursA:
undetectable
1eqbD-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1EQB_D_FFOD4293_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
4urs DIGUANYLATE CYCLASE
(Thermotoga
maritima)
3 / 3 GLU A 170
TYR A 166
PHE A 124
GLU  A 170 ( 0.6A)
TYR  A 166 ( 1.3A)
PHE  A 124 ( 1.3A)
0.93A 1eqbC-4ursA:
undetectable
1eqbC-4ursA:
16.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ERR_A_CCSA381_0
(ESTROGEN RECEPTOR)
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
4 / 5 HIS A  35
GLU A  99
ALA A 102
SER A 109
HIS  A  35 ( 1.0A)
GLU  A  99 ( 0.5A)
ALA  A 102 ( 0.0A)
SER  A 109 ( 0.0A)
1.11A 1errA-4mwtA:
undetectable
1errB-4mwtA:
undetectable
1errA-4mwtA:
20.65
1errB-4mwtA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ERR_B_CCSB381_0
(ESTROGEN RECEPTOR)
1t2w SORTASE
(Staphylococcus
aureus)
3 / 3 GLU A 105
ALA A  92
SER A 102
GLU  A 333 (-3.2A)
GLY  A 335 (-3.0A)
None
0.53A 1errB-1t2wA:
undetectable
1errB-1t2wA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ERR_B_CCSB381_0
(ESTROGEN RECEPTOR)
5x5l ADER
(Acinetobacter
baumannii)
3 / 3 GLU A 204
ALA A 202
SER A 200
GLU  A 204 ( 0.6A)
ALA  A 202 ( 0.0A)
SER  A 200 ( 0.0A)
0.68A 1errB-5x5lA:
undetectable
1errB-5x5lA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FDU_D_ESTD352_1
(17-BETA-HYDROXYSTERO
ID DEHYDROGENASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 6 GLY A  44
LEU A  67
TYR A  65
GLU A  74
GLY  A  44 (-0.0A)
LEU  A  67 ( 0.6A)
TYR  A  65 ( 1.3A)
GLU  A  74 (-0.6A)
1.04A 1fduD-3ulkA:
6.5
1fduD-3ulkA:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FO4_B_SALB4005_1
(XANTHINE
DEHYDROGENASE)
1wsv AMINOMETHYLTRANSFERA
SE

(Homo
sapiens)
5 / 7 GLU A  71
SER A  89
THR A  87
VAL A 104
ALA A  79
GLU  A  71 ( 0.6A)
SER  A  89 ( 0.0A)
THR  A  87 ( 0.8A)
VAL  A 104 ( 0.6A)
ALA  A  79 ( 0.0A)
1.23A 1fo4B-1wsvA:
undetectable
1fo4B-1wsvA:
15.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1G50_A_ESTA600_1
(ESTROGEN RECEPTOR)
3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE

(Citrus
x
microcarpa)
5 / 11 LEU A 222
ALA A 113
GLU A 116
ARG A 234
LEU A 187
LEU  A 222 ( 0.6A)
ALA  A 113 ( 0.0A)
GLU  A 116 ( 0.5A)
ARG  A 234 ( 0.6A)
LEU  A 187 ( 0.5A)
1.21A 1g50A-3wd7A:
undetectable
1g50A-3wd7A:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GHM_A_CEDA1_1
(BETA-LACTAMASE)
3iha SALT-TOLERANT
GLUTAMINASE

(Micrococcus
luteus)
6 / 12 SER A  64
LYS A  67
ASN A 114
LYS A 258
SER A 259
GLY A 260
GLU  A 500 (-2.6A)
GLU  A 500 ( 4.6A)
GLU  A 500 (-3.7A)
GLU  A 500 ( 4.7A)
None
GLU  A 500 ( 3.8A)
0.81A 1ghmA-3ihaA:
12.5
1ghmA-3ihaA:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GSE_B_EAAB224_1
(GLUTATHIONE
TRANSFERASE)
5yge AMINO-ACID
ACETYLTRANSFERASE

(Mycobacterium
tuberculosis)
6 / 12 GLY A  76
LEU A 109
LEU A 107
VAL A 103
LEU A 100
ALA A  67
None
None
None
None
None
GLU  A 202 ( 3.7A)
1.37A 1gseB-5ygeA:
undetectable
1gseB-5ygeA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HK3_A_T44A3004_1
(SERUM ALBUMIN)
3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo
sapiens)
4 / 7 GLU A 256
VAL A 338
MET A 339
LEU A 239
GLU  A 256 ( 0.6A)
VAL  A 338 ( 0.6A)
MET  A 339 ( 0.0A)
LEU  A 239 ( 0.6A)
0.83A 1hk3A-3o96A:
1.6
1hk3A-3o96A:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HMY_A_SAMA328_0
(HAEIII
METHYLTRANSFERASE)
3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea)
4 / 8 GLU A 112
ILE A  21
THR A  20
LEU A  17
GLU  A 112 ( 0.6A)
ILE  A  21 ( 0.7A)
THR  A  20 ( 0.8A)
LEU  A  17 ( 0.5A)
0.79A 1hmyA-3eqzA:
5.7
1hmyA-3eqzA:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IOL_A_ESTA400_1
(ESTROGENIC 17-BETA
HYDROXYSTEROID
DEHYDROGENASE)
3i4k MUCONATE LACTONIZING
ENZYME

(Corynebacterium
glutamicum)
5 / 11 SER A  31
GLY A  57
LEU A 305
GLY A  25
GLU A 329
SER  A  31 ( 0.0A)
GLY  A  57 ( 0.0A)
LEU  A 305 ( 0.6A)
GLY  A  25 ( 0.0A)
GLU  A 329 ( 0.6A)
1.45A 1iolA-3i4kA:
3.3
1iolA-3i4kA:
23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JDV_E_ADNE4260_1
(5'-METHYLTHIOADENOSI
NE PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 12 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.69A 1jdvE-4g41A:
23.8
1jdvF-4g41A:
23.7
1jdvE-4g41A:
24.70
1jdvF-4g41A:
24.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JDV_E_ADNE4260_1
(5'-METHYLTHIOADENOSI
NE PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 12 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.81A 1jdvE-4g41A:
23.8
1jdvF-4g41A:
23.7
1jdvE-4g41A:
24.70
1jdvF-4g41A:
24.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JG4_A_SAMA500_1
(PROTEIN-L-ISOASPARTA
TE
O-METHYLTRANSFERASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 8 GLU A 393
SER A 216
GLU A 221
LEU A 218
GLU  A 393 (-0.6A)
SER  A 216 ( 0.0A)
GLU  A 221 (-0.6A)
LEU  A 218 ( 0.6A)
0.86A 1jg4A-3ulkA:
3.6
1jg4A-3ulkA:
19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JHO_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
5 / 9 GLY A 350
GLY A 358
LEU A 253
GLU A 353
GLY A 257
GLY  A 350 ( 0.0A)
GLY  A 358 ( 0.0A)
LEU  A 253 ( 0.6A)
GLU  A 353 ( 0.5A)
GLY  A 257 ( 0.0A)
1.31A 1jhoA-3ulkA:
undetectable
1jhoA-3ulkA:
23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JHR_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
5 / 9 GLY A 350
GLY A 358
LEU A 253
GLU A 353
GLY A 257
GLY  A 350 ( 0.0A)
GLY  A 358 ( 0.0A)
LEU  A 253 ( 0.6A)
GLU  A 353 ( 0.5A)
GLY  A 257 ( 0.0A)
1.32A 1jhrA-3ulkA:
undetectable
1jhrA-3ulkA:
23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JHY_A_NIOA991_1
(NICOTINATE
MONONUCLEOTIDE:5,6-D
IMETHYLBENZIMIDAZOLE
PHOSPHORIBOSYLTRANSF
ERASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
5 / 9 GLY A 350
GLY A 358
LEU A 253
GLU A 353
GLY A 257
GLY  A 350 ( 0.0A)
GLY  A 358 ( 0.0A)
LEU  A 253 ( 0.6A)
GLU  A 353 ( 0.5A)
GLY  A 257 ( 0.0A)
1.27A 1jhyA-3ulkA:
undetectable
1jhyA-3ulkA:
23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2T_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 1k2tA-5bs1A:
undetectable
1k2tB-5bs1A:
undetectable
1k2tA-5bs1A:
14.56
1k2tB-5bs1A:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KQB_D_BEZD523_0
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F)
4 / 6 PHE A 718
GLU A 721
GLY A 720
SER A 700
PHE  A 718 ( 1.3A)
GLU  A 721 ( 0.6A)
GLY  A 720 ( 0.0A)
SER  A 700 ( 0.0A)
1.16A 1kqbC-1v0fA:
undetectable
1kqbD-1v0fA:
undetectable
1kqbC-1v0fA:
14.61
1kqbD-1v0fA:
14.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KW0_A_H4BA429_1
(PHENYLALANINE-4-HYDR
OXYLASE)
1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii)
5 / 12 LEU A 310
LEU A 338
GLU A 123
TYR A 317
GLU A 318
LEU  A 310 ( 0.6A)
LEU  A 338 ( 0.6A)
GLU  A 123 ( 0.6A)
TYR  A 317 ( 1.3A)
GLU  A 318 ( 0.6A)
1.08A 1kw0A-1wqaA:
undetectable
1kw0A-1wqaA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1L4N_A_NIOA991_1
(NICOTINATE-NUCLEOTID
E--DIMETHYLBENZIMIDA
ZOLE
PHOSPHORIBOSYLTRANSF
ERASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
5 / 9 GLY A 350
GLY A 358
LEU A 253
GLU A 353
GLY A 257
GLY  A 350 ( 0.0A)
GLY  A 358 ( 0.0A)
LEU  A 253 ( 0.6A)
GLU  A 353 ( 0.5A)
GLY  A 257 ( 0.0A)
1.33A 1l4nA-3ulkA:
undetectable
1l4nA-3ulkA:
23.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIK_A_ADNA699_1
(ADENOSINE KINASE)
2qm6 GAMMA-GLUTAMYLTRANSP
EPTIDASE

(Helicobacter
pylori)
5 / 12 ILE B 476
GLY B 473
GLY B 472
THR B 396
ASN B 400
None
GLU  B   1 (-3.6A)
GLU  B   1 (-3.6A)
None
GLU  B   1 (-3.5A)
1.04A 1likA-2qm6B:
undetectable
1likA-2qm6B:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIN_A_TFPA154_1
(CALMODULIN)
2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1

(Homo
sapiens)
4 / 7 GLU A 147
LEU A 146
GLU A 148
GLU A 153
GLU  A 147 ( 0.6A)
LEU  A 146 ( 0.6A)
GLU  A 148 ( 0.6A)
GLU  A 153 ( 0.5A)
0.89A 1linA-2qv2A:
undetectable
1linA-2qv2A:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIN_A_TFPA155_1
(CALMODULIN)
4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA

(Homo
sapiens)
4 / 7 GLN A 261
GLU A 193
PHE A 364
ALA A 343
GLN  A 261 (-0.6A)
GLU  A 193 ( 0.5A)
PHE  A 364 ( 1.3A)
ALA  A 343 ( 0.0A)
1.36A 1linA-4hneA:
undetectable
1linA-4hneA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIN_A_TFPA156_1
(CALMODULIN)
1vho ENDOGLUCANASE
(Thermotoga
maritima)
5 / 8 ILE A 299
LEU A 324
ILE A 260
GLU A 262
ILE A 246
ILE  A 299 ( 0.7A)
LEU  A 324 ( 0.6A)
ILE  A 260 ( 0.7A)
GLU  A 262 ( 0.6A)
ILE  A 246 ( 0.7A)
1.45A 1linA-1vhoA:
undetectable
1linA-1vhoA:
16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIN_A_TFPA156_1
(CALMODULIN)
2j5b TYROSYL-TRNA
SYNTHETASE

(Acanthamoeba
polyphaga
mimivirus)
5 / 8 ILE A  45
ILE A 307
GLU A 238
VAL A 241
ILE A 232
ILE  A  45 ( 0.7A)
ILE  A 307 ( 0.7A)
GLU  A 238 ( 0.6A)
VAL  A 241 ( 0.6A)
ILE  A 232 ( 0.7A)
1.45A 1linA-2j5bA:
undetectable
1linA-2j5bA:
18.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1LXF_C_BEPC92_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)
4gow CALMODULIN
(Homo
sapiens)
6 / 12 PHE D  92
LEU D 105
MET D 124
ILE D 125
GLU D 127
VAL D 136
PHE  D  92 ( 1.3A)
LEU  D 105 ( 0.6A)
MET  D 124 ( 0.0A)
ILE  D 125 ( 0.4A)
GLU  D 127 ( 0.6A)
VAL  D 136 ( 0.6A)
0.94A 1lxfC-4gowD:
9.8
1lxfC-4gowD:
67.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1M00_B_H4BB1760_1
(NITRIC-OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 1m00A-5bs1A:
undetectable
1m00B-5bs1A:
undetectable
1m00A-5bs1A:
14.56
1m00B-5bs1A:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1M4I_A_KANA500_1
(AMINOGLYCOSIDE
2'-N-ACETYLTRANSFERA
SE)
1tza APAG PROTEIN
(Shewanella
oneidensis)
4 / 8 ASP A   5
GLU A  41
GLY A  40
SER A 104
ASP  A   5 ( 0.6A)
GLU  A  41 ( 0.6A)
GLY  A  40 ( 0.0A)
SER  A 104 ( 0.0A)
0.89A 1m4iA-1tzaA:
undetectable
1m4iA-1tzaA:
19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MAA_A_DMEA998_1
(ACETYLCHOLINESTERASE)
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
5 / 12 ASP A 300
GLY A  57
GLU A 149
SER A 150
HIS A 429
ASP  A 300 ( 0.6A)
GLY  A  57 ( 0.0A)
GLU  A 149 ( 0.5A)
SER  A 150 ( 0.0A)
HIS  A 429 ( 1.0A)
1.23A 1maaA-4mwtA:
11.4
1maaA-4mwtA:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MAA_B_DMEB996_1
(ACETYLCHOLINESTERASE)
1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F)
4 / 6 GLU A 309
ILE A 714
TYR A 713
GLY A 755
GLU  A 309 ( 0.6A)
ILE  A 714 ( 0.7A)
TYR  A 713 ( 1.3A)
GLY  A 755 ( 0.0A)
1.05A 1maaB-1v0fA:
undetectable
1maaD-1v0fA:
undetectable
1maaB-1v0fA:
22.78
1maaD-1v0fA:
22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MAA_D_DMED999_1
(ACETYLCHOLINESTERASE)
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
4 / 8 GLY A  57
GLU A 149
SER A 150
HIS A 429
GLY  A  57 ( 0.0A)
GLU  A 149 ( 0.5A)
SER  A 150 ( 0.0A)
HIS  A 429 ( 1.0A)
0.79A 1maaD-4mwtA:
11.4
1maaD-4mwtA:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_A_SAMA2200_0
(PROTEIN (METHIONINE
REPRESSOR))
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 12 ALA A 501
GLY A 499
GLU A 376
GLU A 378
LEU A 381
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
1.22A 1mj2A-4flxA:
undetectable
1mj2B-4flxA:
undetectable
1mj2A-4flxA:
10.36
1mj2B-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_C_SAMC200_0
(METHIONINE REPRESSOR)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 12 ALA A 501
GLY A 499
GLU A 376
GLU A 378
LEU A 381
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
1.27A 1mjoC-4flxA:
undetectable
1mjoD-4flxA:
undetectable
1mjoC-4flxA:
10.36
1mjoD-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_C_SAMC199_0
(METHIONINE REPRESSOR)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 10 GLU A 376
GLU A 378
LEU A 381
ALA A 501
GLY A 499
GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
1.22A 1mjqC-4flxA:
undetectable
1mjqD-4flxA:
undetectable
1mjqC-4flxA:
10.36
1mjqD-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJQ_I_SAMI199_0
(METHIONINE REPRESSOR)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 11 GLU A 376
GLU A 378
LEU A 381
ALA A 501
GLY A 499
GLU  A 376 ( 0.6A)
GLU  A 378 ( 0.6A)
LEU  A 381 ( 0.6A)
ALA  A 501 ( 0.0A)
GLY  A 499 ( 0.0A)
1.21A 1mjqI-4flxA:
undetectable
1mjqJ-4flxA:
undetectable
1mjqI-4flxA:
10.36
1mjqJ-4flxA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMK_A_H4BA1427_1
(PHENYLALANINE-4-HYDR
OXYLASE)
1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii)
5 / 12 LEU A 310
LEU A 338
GLU A 123
TYR A 317
GLU A 318
LEU  A 310 ( 0.6A)
LEU  A 338 ( 0.6A)
GLU  A 123 ( 0.6A)
TYR  A 317 ( 1.3A)
GLU  A 318 ( 0.6A)
1.17A 1mmkA-1wqaA:
undetectable
1mmkA-1wqaA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMT_A_H4BA1426_1
(PHENYLALANINE-4-HYDR
OXYLASE)
1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii)
5 / 11 LEU A 310
LEU A 338
GLU A 123
TYR A 317
GLU A 318
LEU  A 310 ( 0.6A)
LEU  A 338 ( 0.6A)
GLU  A 123 ( 0.6A)
TYR  A 317 ( 1.3A)
GLU  A 318 ( 0.6A)
1.20A 1mmtA-1wqaA:
undetectable
1mmtA-1wqaA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMV_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 1mmvA-5bs1A:
undetectable
1mmvB-5bs1A:
undetectable
1mmvA-5bs1A:
14.56
1mmvB-5bs1A:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MMV_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 1mmvA-5bs1A:
undetectable
1mmvB-5bs1A:
undetectable
1mmvA-5bs1A:
14.56
1mmvB-5bs1A:
14.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MRG_A_ADNA300_1
(ALPHA-MOMORCHARIN)
4wxj GLUTAMATE RECEPTOR
IIB,GLUTAMATE
RECEPTOR IIB

(Drosophila
melanogaster)
5 / 9 PHE A 109
GLY A 227
TYR A 226
ALA A 149
GLU A 200
None
None
GLU  A 301 ( 4.6A)
GLU  A 301 (-3.0A)
GLU  A 301 (-2.1A)
1.34A 1mrgA-4wxjA:
undetectable
1mrgA-4wxjA:
23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MT1_C_AG2C7004_1
(PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE BETA
CHAIN
PYRUVOYL-DEPENDENT
ARGININE
DECARBOXYLASE ALPHA
CHAIN)
5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE

(Thymus
vulgaris)
4 / 6 LEU A 195
GLU A 223
LEU A 243
LEU A 236
LEU  A 195 ( 0.6A)
GLU  A 223 ( 0.5A)
LEU  A 243 ( 0.5A)
LEU  A 236 ( 0.6A)
1.00A 1mt1D-5c05A:
undetectable
1mt1E-5c05A:
undetectable
1mt1D-5c05A:
11.27
1mt1E-5c05A:
6.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MXG_A_ACRA443_1
(ALPHA AMYLASE)
2qc5 STREPTOGRAMIN B
LACTONASE

(Staphylococcus
cohnii)
4 / 8 SER A  99
LEU A 136
ASP A 120
GLU A 175
SER  A  99 ( 0.0A)
LEU  A 136 ( 0.6A)
ASP  A 120 ( 0.5A)
GLU  A 175 ( 0.6A)
1.21A 1mxgA-2qc5A:
undetectable
1mxgA-2qc5A:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N6C_A_SAMA402_0
(SET
DOMAIN-CONTAINING
PROTEIN 7)
5nqf APICAL MEMBRANE
ANTIGEN 1

(Plasmodium
falciparum)
5 / 11 ILE A 127
ALA A 346
GLY A 394
GLU A 120
ASN A 398
ILE  A 127 ( 0.7A)
ALA  A 346 ( 0.0A)
GLY  A 394 ( 0.0A)
GLU  A 120 ( 0.5A)
ASN  A 398 ( 0.6A)
1.15A 1n6cA-5nqfA:
undetectable
1n6cA-5nqfA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NT2_A_SAMA301_1
(FIBRILLARIN-LIKE
PRE-RRNA PROCESSING
PROTEIN)
1dtd CARBOXYPEPTIDASE A2
(Homo
sapiens)
3 / 3 THR A 433
GLU A 427
ASP A 498
None
ZN  A 301 (-2.6A)
GLU  A 300 ( 4.5A)
0.84A 1nt2A-1dtdA:
undetectable
1nt2A-1dtdA:
23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_A_AICA5001_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
1rrv GLYCOSYLTRANSFERASE
GTFD

(Amycolatopsis
orientalis)
4 / 8 GLU A 293
GLN A 297
HIS A 241
SER A 273
GLU  A 293 (-0.6A)
GLN  A 297 ( 0.6A)
HIS  A 241 ( 1.0A)
SER  A 273 ( 0.0A)
1.22A 1nx9A-1rrvA:
3.4
1nx9A-1rrvA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_A_AICA5001_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 ARG A 369
TYR A 348
GLU A 373
SER A 224
ARG  A 369 ( 0.6A)
TYR  A 348 ( 1.3A)
GLU  A 373 ( 0.5A)
SER  A 224 ( 0.0A)
1.19A 1nx9A-2ogsA:
10.2
1nx9A-2ogsA:
23.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_B_AICB5002_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
1rrv GLYCOSYLTRANSFERASE
GTFD

(Amycolatopsis
orientalis)
4 / 8 GLU A 293
GLN A 297
HIS A 241
SER A 273
GLU  A 293 (-0.6A)
GLN  A 297 ( 0.6A)
HIS  A 241 ( 1.0A)
SER  A 273 ( 0.0A)
1.24A 1nx9B-1rrvA:
3.3
1nx9B-1rrvA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_B_AICB5002_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 ARG A 369
TYR A 348
GLU A 373
SER A 224
ARG  A 369 ( 0.6A)
TYR  A 348 ( 1.3A)
GLU  A 373 ( 0.5A)
SER  A 224 ( 0.0A)
1.19A 1nx9B-2ogsA:
16.6
1nx9B-2ogsA:
23.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_C_AICC5003_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
1rrv GLYCOSYLTRANSFERASE
GTFD

(Amycolatopsis
orientalis)
4 / 8 GLU A 293
GLN A 297
HIS A 241
SER A 273
GLU  A 293 (-0.6A)
GLN  A 297 ( 0.6A)
HIS  A 241 ( 1.0A)
SER  A 273 ( 0.0A)
1.23A 1nx9C-1rrvA:
3.4
1nx9C-1rrvA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_C_AICC5003_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 ARG A 369
TYR A 348
GLU A 373
SER A 224
ARG  A 369 ( 0.6A)
TYR  A 348 ( 1.3A)
GLU  A 373 ( 0.5A)
SER  A 224 ( 0.0A)
1.18A 1nx9C-2ogsA:
10.2
1nx9C-2ogsA:
23.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_D_AICD5004_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
1rrv GLYCOSYLTRANSFERASE
GTFD

(Amycolatopsis
orientalis)
4 / 8 GLU A 293
GLN A 297
HIS A 241
SER A 273
GLU  A 293 (-0.6A)
GLN  A 297 ( 0.6A)
HIS  A 241 ( 1.0A)
SER  A 273 ( 0.0A)
1.23A 1nx9D-1rrvA:
3.8
1nx9D-1rrvA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NX9_D_AICD5004_1
(ALPHA-AMINO ACID
ESTER HYDROLASE)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 ARG A 369
TYR A 348
GLU A 373
SER A 224
ARG  A 369 ( 0.6A)
TYR  A 348 ( 1.3A)
GLU  A 373 ( 0.5A)
SER  A 224 ( 0.0A)
1.18A 1nx9D-2ogsA:
16.5
1nx9D-2ogsA:
23.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
5 / 12 GLU A 262
HIS A 239
HIS A 208
HIS A 183
TYR A 155
GLU  A 262 ( 0.6A)
HIS  A 239 (-1.0A)
HIS  A 208 ( 1.0A)
HIS  A 183 (-1.0A)
TYR  A 155 ( 1.3A)
1.46A 1o86A-4kqnA:
undetectable
1o86A-4kqnA:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
5 / 12 GLU A 262
HIS A 239
PHE A  65
HIS A 183
TYR A 155
GLU  A 262 ( 0.6A)
HIS  A 239 (-1.0A)
PHE  A  65 ( 1.3A)
HIS  A 183 (-1.0A)
TYR  A 155 ( 1.3A)
1.42A 1o86A-4kqnA:
undetectable
1o86A-4kqnA:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ODI_C_ADNC1238_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.92A 1odiC-4g41A:
23.2
1odiC-4g41A:
27.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OE2_A_CUA502_0
(DISSIMILATORY
COPPER-CONTAINING
NITRITE REDUCTASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
3 / 3 GLU A 351
HIS A 377
HIS A 179
GLU  A 351 ( 0.6A)
HIS  A 377 ( 1.0A)
HIS  A 179 ( 1.0A)
0.70A 1oe2A-5gprA:
2.8
1oe2A-5gprA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM4_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 1om4A-5bs1A:
undetectable
1om4B-5bs1A:
undetectable
1om4A-5bs1A:
14.45
1om4B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM4_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 1om4A-5bs1A:
undetectable
1om4B-5bs1A:
undetectable
1om4A-5bs1A:
14.45
1om4B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM5_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 1om5A-5bs1A:
undetectable
1om5B-5bs1A:
undetectable
1om5A-5bs1A:
14.49
1om5B-5bs1A:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_B_BEZB503_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)
1gc7 RADIXIN
(Mus
musculus)
4 / 6 ALA A 148
TYR A 146
ILE A 172
GLU A 169
ALA  A 148 ( 0.0A)
TYR  A 146 ( 1.3A)
ILE  A 172 ( 0.7A)
GLU  A 169 ( 0.6A)
1.29A 1oniB-1gc7A:
undetectable
1oniC-1gc7A:
undetectable
1oniB-1gc7A:
17.03
1oniC-1gc7A:
17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OS2_A_HAEA874_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.28A 1os2A-5d7wA:
14.6
1os2A-5d7wA:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OS2_D_HAED574_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.30A 1os2D-5d7wA:
14.7
1os2D-5d7wA:
17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6J_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 1p6jA-5bs1A:
undetectable
1p6jB-5bs1A:
undetectable
1p6jA-5bs1A:
14.49
1p6jB-5bs1A:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6K_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 1p6kA-5bs1A:
undetectable
1p6kB-5bs1A:
undetectable
1p6kA-5bs1A:
14.49
1p6kB-5bs1A:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P91_A_SAMA1401_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE A)
3h6t GLUTAMATE RECEPTOR 2
(Rattus
norvegicus)
5 / 11 LEU A 138
GLY A  62
ILE A  11
TYR A  16
PRO A  15
GLU  A 264 (-4.6A)
None
None
None
None
1.17A 1p91A-3h6tA:
undetectable
1p91A-3h6tA:
21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PB9_A_4AXA901_1
(N-METHYL-D-ASPARTATE
RECEPTOR SUBUNIT 1)
4pe5 GLUTAMATE RECEPTOR
IONOTROPIC, NMDA 2B

(Rattus
norvegicus)
5 / 9 LEU B 513
THR B 514
ARG B 519
SER B 690
ASP B 732
GLU  B 921 (-4.5A)
GLU  B 921 (-3.7A)
GLU  B 921 (-2.4A)
GLU  B 921 (-3.2A)
GLU  B 921 (-4.2A)
0.74A 1pb9A-4pe5B:
29.3
1pb9A-4pe5B:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_A_ADNA1245_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 9 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.64A 1pk7A-4g41A:
25.1
1pk7A-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_B_ADNB1246_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
2qvs CAMP-DEPENDENT
PROTEIN KINASE TYPE
II-ALPHA REGULATORY
SUBUNIT

(Mus
musculus)
4 / 8 GLY B 349
VAL B 302
GLU B 301
ILE B 284
GLY  B 349 ( 0.0A)
VAL  B 302 ( 0.6A)
GLU  B 301 ( 0.6A)
ILE  B 284 ( 0.7A)
0.76A 1pk7B-2qvsB:
undetectable
1pk7B-2qvsB:
22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_B_ADNB1246_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
3r6y ASPARTASE
(Bacillus
sp.
YM55-1)
4 / 8 GLY A  84
VAL A  81
GLU A  80
ILE A  46
GLY  A  84 ( 0.0A)
VAL  A  81 ( 0.6A)
GLU  A  80 ( 0.6A)
ILE  A  46 ( 0.7A)
0.85A 1pk7B-3r6yA:
undetectable
1pk7B-3r6yA:
20.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_C_ADNC1247_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.90A 1pk7C-4g41A:
24.6
1pk7C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_C_ADNC1247_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.80A 1pk7C-4g41A:
24.6
1pk7C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.74A 1pk9A-4g41A:
25.0
1pk9A-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_A_2FAA306_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.66A 1pk9A-4g41A:
25.0
1pk9A-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_B_2FAB307_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 9 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.72A 1pk9B-4g41A:
24.6
1pk9B-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.91A 1pk9C-4g41A:
24.8
1pk9C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.72A 1pk9C-4g41A:
24.8
1pk9C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK9_C_2FAC308_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.74A 1pk9C-4g41A:
24.8
1pk9C-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_A_RABA645_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.68A 1pw7A-4g41A:
25.1
1pw7A-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_B_RABB646_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.71A 1pw7B-4g41A:
24.6
1pw7B-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_C_RABC647_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.75A 1pw7C-4g41A:
24.7
1pw7C-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PW7_C_RABC647_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.69A 1pw7C-4g41A:
24.7
1pw7C-4g41A:
24.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q8J_B_C2FB802_0
(5-METHYLTETRAHYDROFO
LATE S-HOMOCYSTEINE
METHYLTRANSFERASE)
5d7w SERRALYSIN
(Serratia
marcescens)
5 / 12 GLU A 329
ASN A 347
GLY A 363
SER A 311
ILE A 328
GLU  A 329 (-0.6A)
ASN  A 347 (-0.6A)
GLY  A 363 (-0.0A)
SER  A 311 ( 0.0A)
ILE  A 328 ( 0.7A)
1.12A 1q8jB-5d7wA:
undetectable
1q8jB-5d7wA:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QTI_A_GNTA600_1
(ACETYLCHOLINESTERASE)
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
6 / 12 ASP A 300
GLY A  56
GLY A  57
GLU A 149
SER A 150
HIS A 429
ASP  A 300 ( 0.6A)
GLY  A  56 ( 0.0A)
GLY  A  57 ( 0.0A)
GLU  A 149 ( 0.5A)
SER  A 150 ( 0.0A)
HIS  A 429 ( 1.0A)
1.14A 1qtiA-4mwtA:
9.6
1qtiA-4mwtA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QVU_A_PRLA196_0
(TRANSCRIPTIONAL
REGULATOR QACR)
5l5n PLEXIN-A4
(Mus
musculus)
4 / 6 LEU A 279
GLU A 294
TRP A 384
THR A 197
LEU  A 279 ( 0.5A)
GLU  A 294 ( 0.5A)
TRP  A 384 ( 0.5A)
THR  A 197 ( 0.8A)
1.29A 1qvuA-5l5nA:
undetectable
1qvuA-5l5nA:
10.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R15_D_NCAD349_0
(ADP-RIBOSYL CYCLASE)
5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE

(Thymus
vulgaris)
3 / 3 GLU A 427
ASN A 445
TRP A 430
GLU  A 427 ( 0.6A)
ASN  A 445 ( 0.6A)
TRP  A 430 ( 0.5A)
1.19A 1r15D-5c05A:
undetectable
1r15D-5c05A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R15_F_NCAF369_0
(ADP-RIBOSYL CYCLASE)
5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE

(Thymus
vulgaris)
3 / 3 GLU A 427
ASN A 445
TRP A 430
GLU  A 427 ( 0.6A)
ASN  A 445 ( 0.6A)
TRP  A 430 ( 0.5A)
1.16A 1r15F-5c05A:
undetectable
1r15F-5c05A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R30_A_SAMA501_0
(BIOTIN SYNTHASE)
1dtd CARBOXYPEPTIDASE A2
METALLOCARBOXYPEPTID
ASE INHIBITOR

(Homo
sapiens;
Hirudo
medicinalis)
5 / 12 PRO B  64
GLY A 422
ASN A 500
ASP A 498
VAL B  17
None
None
GLU  A 300 (-3.4A)
GLU  A 300 ( 4.5A)
None
1.17A 1r30A-1dtdB:
undetectable
1r30A-1dtdB:
9.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R55_A_097A518_1
(ADAM 33)
5d7w SERRALYSIN
(Serratia
marcescens)
5 / 10 THR A 173
HIS A 176
GLU A 177
HIS A 180
HIS A 186
THR  A 173 ( 0.8A)
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.49A 1r55A-5d7wA:
6.8
1r55A-5d7wA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_A_SAMA801_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 6 TYR A 390
ASP A 454
ASN A 456
GLU A 412
TYR  A 390 ( 1.3A)
ASP  A 454 ( 0.6A)
ASN  A 456 ( 0.6A)
GLU  A 412 ( 0.6A)
1.03A 1rjdA-2ogsA:
2.7
1rjdA-2ogsA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_A_SAMA801_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo
sapiens)
4 / 6 ASP A 331
TYR A 272
ASN A 279
GLU A 319
ASP  A 331 ( 0.6A)
TYR  A 272 (-1.3A)
ASN  A 279 ( 0.6A)
GLU  A 319 ( 0.5A)
1.28A 1rjdA-3o96A:
undetectable
1rjdA-3o96A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_B_SAMB802_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 6 TYR A 390
ASP A 454
ASN A 456
GLU A 412
TYR  A 390 ( 1.3A)
ASP  A 454 ( 0.6A)
ASN  A 456 ( 0.6A)
GLU  A 412 ( 0.6A)
1.02A 1rjdB-2ogsA:
2.4
1rjdB-2ogsA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_B_SAMB802_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo
sapiens)
4 / 6 ASP A 331
TYR A 272
ASN A 279
GLU A 319
ASP  A 331 ( 0.6A)
TYR  A 272 (-1.3A)
ASN  A 279 ( 0.6A)
GLU  A 319 ( 0.5A)
1.28A 1rjdB-3o96A:
undetectable
1rjdB-3o96A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_C_SAMC803_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 6 TYR A 390
ASP A 454
ASN A 456
GLU A 412
TYR  A 390 ( 1.3A)
ASP  A 454 ( 0.6A)
ASN  A 456 ( 0.6A)
GLU  A 412 ( 0.6A)
1.05A 1rjdC-2ogsA:
3.0
1rjdC-2ogsA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_C_SAMC803_1
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)
3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo
sapiens)
4 / 6 ASP A 331
TYR A 272
ASN A 279
GLU A 319
ASP  A 331 ( 0.6A)
TYR  A 272 (-1.3A)
ASN  A 279 ( 0.6A)
GLU  A 319 ( 0.5A)
1.28A 1rjdC-3o96A:
undetectable
1rjdC-3o96A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RKW_A_PNTA225_0
(TRANSCRIPTIONAL
REGULATOR QACR)
6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB

(Yersinia
pseudotuberculos
is)
5 / 12 GLU A  24
LYS A  28
TYR A  17
GLU A  22
ASN A  67
GLU  A  24 ( 0.6A)
LYS  A  28 ( 0.0A)
TYR  A  17 ( 1.3A)
GLU  A  22 ( 0.5A)
ASN  A  67 ( 0.6A)
1.31A 1rkwA-6gefA:
0.0
1rkwA-6gefA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RMT_B_ADNB1502_1
(CLASS B ACID
PHOSPHATASE)
3gle PILIN
(Streptococcus
pyogenes)
4 / 7 GLU A 117
TYR A 128
THR A  50
TYR A  83
GLU  A 117 ( 0.6A)
TYR  A 128 ( 1.3A)
THR  A  50 ( 0.8A)
TYR  A  83 ( 1.3A)
1.24A 1rmtB-3gleA:
undetectable
1rmtB-3gleA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS6_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN

(Mycolicibacteriu
m
fortuitum)
4 / 8 TRP A 151
GLU A 168
VAL A 197
TRP A 169
TRP  A 151 (-0.5A)
GLU  A 168 (-0.5A)
VAL  A 197 ( 0.6A)
TRP  A 169 ( 0.5A)
1.05A 1rs6A-4w65A:
undetectable
1rs6B-4w65A:
undetectable
1rs6A-4w65A:
20.65
1rs6B-4w65A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1S3Z_B_RIOB501_0
(AMINOGLYCOSIDE
6'-N-ACETYLTRANSFERA
SE)
3i4k MUCONATE LACTONIZING
ENZYME

(Corynebacterium
glutamicum)
4 / 8 GLU A 329
HIS A 279
GLU A 252
ASP A 200
GLU  A 329 ( 0.6A)
HIS  A 279 ( 1.0A)
GLU  A 252 ( 0.6A)
ASP  A 200 ( 0.6A)
1.22A 1s3zA-3i4kA:
1.9
1s3zB-3i4kA:
1.9
1s3zA-3i4kA:
17.51
1s3zB-3i4kA:
17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1S3Z_B_RIOB501_0
(AMINOGLYCOSIDE
6'-N-ACETYLTRANSFERA
SE)
4pas GAMMA-AMINOBUTYRIC
ACID TYPE B RECEPTOR
SUBUNIT 1
GAMMA-AMINOBUTYRIC
ACID TYPE B RECEPTOR
SUBUNIT 2

(Homo
sapiens;
Homo
sapiens)
4 / 8 GLU A 789
VAL A 792
HIS B 797
ASP B 808
GLU  A 789 ( 0.6A)
VAL  A 792 ( 0.6A)
HIS  B 797 ( 1.0A)
ASP  B 808 ( 0.6A)
1.10A 1s3zA-4pasA:
undetectable
1s3zB-4pasA:
undetectable
1s3zA-4pasA:
11.04
1s3zB-4pasA:
11.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SN5_C_T3C601_1
(TRANSTHYRETIN)
5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus)
4 / 6 LEU A 459
GLU A 462
LEU A 455
VAL A 469
LEU  A 459 ( 0.6A)
GLU  A 462 ( 0.6A)
LEU  A 455 ( 0.6A)
VAL  A 469 ( 0.6A)
1.19A 1sn5A-5cdnA:
undetectable
1sn5A-5cdnA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SN5_D_T3D602_1
(TRANSTHYRETIN)
4rhy HYPOXANTHINE-GUANINE
PHOSPHORIBOSYLTRANSF
ERASE

(Mycobacterium
tuberculosis)
5 / 12 LEU A 119
VAL A 125
LEU A 131
GLU A 163
LEU A 134
LEU  A 119 ( 0.6A)
VAL  A 125 (-0.6A)
LEU  A 131 ( 0.6A)
GLU  A 163 ( 0.6A)
LEU  A 134 ( 0.6A)
1.09A 1sn5B-4rhyA:
undetectable
1sn5D-4rhyA:
undetectable
1sn5B-4rhyA:
21.05
1sn5D-4rhyA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SN5_D_T3D602_1
(TRANSTHYRETIN)
4rhy HYPOXANTHINE-GUANINE
PHOSPHORIBOSYLTRANSF
ERASE

(Mycobacterium
tuberculosis)
5 / 12 LEU A 131
GLU A 163
LEU A 134
LEU A 119
VAL A 125
LEU  A 131 ( 0.6A)
GLU  A 163 ( 0.6A)
LEU  A 134 ( 0.6A)
LEU  A 119 ( 0.6A)
VAL  A 125 (-0.6A)
1.10A 1sn5B-4rhyA:
undetectable
1sn5D-4rhyA:
undetectable
1sn5B-4rhyA:
21.05
1sn5D-4rhyA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T6Z_A_RBFA296_1
(RIBOFLAVIN
KINASE/FMN
ADENYLYLTRANSFERASE)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
5 / 11 THR A 311
VAL A  90
GLU A 262
ARG A 455
LEU A 179
THR  A 311 ( 0.8A)
VAL  A  90 ( 0.6A)
GLU  A 262 ( 0.6A)
ARG  A 455 ( 0.6A)
LEU  A 179 ( 0.5A)
1.11A 1t6zA-4kqnA:
undetectable
1t6zA-4kqnA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T87_B_CAMB2422_0
(CYTOCHROME P450-CAM)
3s6h N-ACETYLGLUTAMATE
KINASE /
N-ACETYLGLUTAMATE
SYNTHASE

(Maricaulis
maris)
5 / 7 TYR A 324
THR A 436
LEU A 437
VAL A 312
ILE A 344
None
GLU  A 501 (-3.8A)
GLU  A 501 ( 4.1A)
None
None
1.27A 1t87B-3s6hA:
undetectable
1t87B-3s6hA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TUF_A_AZ1A502_1
(DIAMINOPIMELATE
DECARBOXYLASE)
2vha PERIPLASMIC BINDING
TRANSPORT PROTEIN

(Shigella
flexneri)
5 / 9 GLY A 138
SER A  72
ARG A  24
TYR A 211
SER A 141
None
GLU  A1280 (-2.7A)
GLU  A1280 (-3.0A)
GLU  A1280 (-4.7A)
None
1.30A 1tufA-2vhaA:
undetectable
1tufB-2vhaA:
undetectable
1tufA-2vhaA:
21.58
1tufB-2vhaA:
21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTT_A_HAEA1265_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.37A 1uttA-5d7wA:
14.4
1uttA-5d7wA:
19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTZ_A_HAEA1267_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.29A 1utzA-5d7wA:
14.3
1utzA-5d7wA:
19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTZ_B_HAEB1266_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.31A 1utzB-5d7wA:
14.3
1utzB-5d7wA:
19.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_A_ADNA252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.76A 1vhwA-4g41A:
24.5
1vhwD-4g41A:
24.6
1vhwA-4g41A:
24.82
1vhwD-4g41A:
24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_C_ADNC252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.77A 1vhwC-4g41A:
24.6
1vhwE-4g41A:
24.6
1vhwC-4g41A:
24.82
1vhwE-4g41A:
24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_D_ADND252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.76A 1vhwA-4g41A:
24.5
1vhwD-4g41A:
24.6
1vhwA-4g41A:
24.82
1vhwD-4g41A:
24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VHW_E_ADNE252_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.77A 1vhwC-4g41A:
24.6
1vhwE-4g41A:
24.6
1vhwC-4g41A:
24.82
1vhwE-4g41A:
24.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W76_A_GNTA1538_1
(ACETYLCHOLINESTERASE)
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
5 / 11 ASP A 300
GLY A  57
GLU A 149
SER A 150
HIS A 429
ASP  A 300 ( 0.6A)
GLY  A  57 ( 0.0A)
GLU  A 149 ( 0.5A)
SER  A 150 ( 0.0A)
HIS  A 429 ( 1.0A)
1.03A 1w76A-4mwtA:
13.1
1w76A-4mwtA:
21.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WRL_F_TFPF209_1
(TROPONIN C, SLOW
SKELETAL AND CARDIAC
MUSCLES)
4gow CALMODULIN
(Homo
sapiens)
5 / 10 LEU D  18
GLU D 120
MET D 124
MET D 144
MET D 145
LEU  D  18 ( 0.6A)
GLU  D 120 ( 0.6A)
MET  D 124 ( 0.0A)
MET  D 144 ( 0.0A)
MET  D 145 ( 0.0A)
1.03A 1wrlE-4gowD:
11.4
1wrlF-4gowD:
11.3
1wrlE-4gowD:
67.09
1wrlF-4gowD:
67.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_A_THHA3001_1
(AMINOMETHYLTRANSFERA
SE)
1wsv AMINOMETHYLTRANSFERA
SE

(Homo
sapiens)
3 / 3 ASP A 101
GLU A 204
TYR A 371
ASP  A 101 (-0.6A)
GLU  A 204 (-0.5A)
TYR  A 371 (-1.3A)
0.02A 1wsvA-1wsvA:
66.6
1wsvA-1wsvA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1WSV_B_THHB4001_1
(AMINOMETHYLTRANSFERA
SE)
1wsv AMINOMETHYLTRANSFERA
SE

(Homo
sapiens)
4 / 4 ASP A 101
GLU A 204
ARG A 233
TYR A 371
ASP  A 101 (-0.6A)
GLU  A 204 (-0.5A)
ARG  A 233 (-0.6A)
TYR  A 371 (-1.3A)
0.23A 1wsvB-1wsvA:
62.3
1wsvB-1wsvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1X70_A_715A801_1
(DIPEPTIDYL PEPTIDASE
IV)
1szb MANNOSE BINDING
LECTIN-ASSOCIATED
SERINE PROTEASE-2
RELATED PROTEIN,
MAP19 (19KDA)

(Homo
sapiens)
5 / 12 GLU A  52
SER A  54
PHE A  61
TYR A  24
ASN A 108
GLU  A  52 (-0.6A)
SER  A  54 ( 0.0A)
PHE  A  61 ( 1.3A)
TYR  A  24 ( 1.3A)
ASN  A 108 (-0.6A)
1.05A 1x70A-1szbA:
undetectable
1x70A-1szbA:
11.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XVA_A_ACTA294_0
(GLYCINE
N-METHYLTRANSFERASE)
4dlk PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE, ATPASE
SUBUNIT

(Bacillus
anthracis)
4 / 5 ILE A 266
LEU A 246
ALA A 113
GLU A 110
ILE  A 266 ( 0.7A)
LEU  A 246 ( 0.6A)
ALA  A 113 ( 0.0A)
GLU  A 110 ( 0.6A)
1.29A 1xvaA-4dlkA:
2.8
1xvaB-4dlkA:
2.6
1xvaA-4dlkA:
20.90
1xvaB-4dlkA:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XVA_B_ACTB294_0
(GLYCINE
N-METHYLTRANSFERASE)
3pu5 EXTRACELLULAR
SOLUTE-BINDING
PROTEIN

(Bordetella
parapertussis)
4 / 6 ALA A  53
GLU A  57
ILE A  35
LEU A  66
ALA  A  53 ( 0.0A)
GLU  A  57 ( 0.6A)
ILE  A  35 ( 0.7A)
LEU  A  66 ( 0.6A)
0.70A 1xvaA-3pu5A:
undetectable
1xvaB-3pu5A:
undetectable
1xvaA-3pu5A:
22.00
1xvaB-3pu5A:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Y93_A_HAEA301_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 6 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.30A 1y93A-5d7wA:
14.1
1y93A-5d7wA:
26.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YKI_D_NFZD4219_1
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
4 / 8 TYR A 367
PHE A 377
GLU A 149
GLY A 177
TYR  A 367 ( 1.3A)
PHE  A 377 ( 1.3A)
GLU  A 149 ( 0.5A)
GLY  A 177 ( 0.0A)
0.98A 1ykiC-4mwtA:
undetectable
1ykiD-4mwtA:
undetectable
1ykiC-4mwtA:
16.78
1ykiD-4mwtA:
16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z35_A_2FAA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.69A 1z35A-4g41A:
23.2
1z35A-4g41A:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z37_A_ADNA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 9 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.80A 1z37A-4g41A:
23.1
1z37A-4g41A:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z37_A_ADNA300_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 9 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.81A 1z37A-4g41A:
23.1
1z37A-4g41A:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZLQ_B_EDTB1511_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
4 / 8 TYR A  74
ARG A  71
TYR A 236
THR A 188
GLU  A 701 (-4.6A)
None
GLU  A 701 (-3.4A)
GLU  A 701 (-3.1A)
1.45A 1zlqB-1ewkA:
0.8
1zlqB-1ewkA:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZLQ_B_EDTB1511_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
4 / 8 TYR A  64
ARG A  61
TYR A 223
THR A 175
GLU  A 506 (-4.6A)
None
GLU  A 506 (-3.4A)
GLU  A 506 (-3.0A)
1.46A 1zlqB-3lmkA:
1.3
1zlqB-3lmkA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZQ9_A_SAMA4000_1
(PROBABLE
DIMETHYLADENOSINE
TRANSFERASE)
5w0a GLUCANASE
(Trichoderma
harzianum)
3 / 3 GLY A 140
GLU A 141
ASN A 326
GLY  A 140 ( 0.0A)
GLU  A 141 ( 0.6A)
ASN  A 326 ( 0.6A)
0.72A 1zq9A-5w0aA:
undetectable
1zq9A-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZQ_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 1zzqA-5bs1A:
undetectable
1zzqB-5bs1A:
undetectable
1zzqA-5bs1A:
14.52
1zzqB-5bs1A:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_B_ACTB861_0
(NITRIC-OXIDE
SYNTHASE, BRAIN)
3iha SALT-TOLERANT
GLUTAMINASE

(Micrococcus
luteus)
4 / 5 GLY A 260
GLN A  63
VAL A 199
SER A  66
GLU  A 500 ( 3.8A)
GLU  A 500 (-3.4A)
None
None
1.06A 1zzuB-3ihaA:
undetectable
1zzuB-3ihaA:
20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZU_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.27A 1zzuA-5bs1A:
undetectable
1zzuB-5bs1A:
undetectable
1zzuA-5bs1A:
14.52
1zzuB-5bs1A:
14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A1O_B_CAMB2422_0
(CYTOCHROME P450-CAM)
3s6h N-ACETYLGLUTAMATE
KINASE /
N-ACETYLGLUTAMATE
SYNTHASE

(Maricaulis
maris)
5 / 9 TYR A 324
THR A 436
LEU A 437
VAL A 312
ILE A 344
None
GLU  A 501 (-3.8A)
GLU  A 501 ( 4.1A)
None
None
1.27A 2a1oB-3s6hA:
undetectable
2a1oB-3s6hA:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1433_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
10 / 11 TYR A 156
PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
0.39A 2a3aA-5gprA:
12.4
2a3aA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1433_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
8 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TRP A 532
TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TRP  A 532 ( 0.5A)
0.65A 2a3aA-5gprA:
12.4
2a3aA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_B_TEPB2433_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
8 / 9 PHE A 184
GLY A 267
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
0.47A 2a3aB-5gprA:
43.1
2a3aB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_A_CFFA1435_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
9 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TYR A 383
TRP A 532
TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
0.78A 2a3bA-5gprA:
43.0
2a3bA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3B_B_CFFB2435_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
9 / 10 PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
0.67A 2a3bB-5gprA:
43.1
2a3bB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_A_PNXA1434_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
9 / 12 TYR A 156
TRP A 160
PHE A 184
GLY A 267
ASP A 306
GLU A 308
MET A 381
TYR A 383
TRP A 532
TYR  A 156 ( 1.3A)
TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
0.72A 2a3cA-5gprA:
12.4
2a3cA-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3C_B_PNXB2433_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
11 / 12 TRP A 160
PHE A 184
GLY A 267
THR A 269
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
TRP  A 160 ( 0.5A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
THR  A 269 ( 0.8A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
0.71A 2a3cB-5gprA:
43.1
2a3cB-5gprA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AZQ_A_PCFA954_0
(CATECHOL
1,2-DIOXYGENASE)
5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN

(Vibrio
vulnificus)
5 / 9 LEU A4016
ALA A4024
TYR A4026
LEU A3897
GLU A3930
LEU  A4016 ( 0.6A)
ALA  A4024 ( 0.0A)
TYR  A4026 ( 1.3A)
LEU  A3897 ( 0.6A)
GLU  A3930 ( 0.6A)
1.30A 2azqA-5w6lA:
undetectable
2azqA-5w6lA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C8A_A_NCAA1252_0
(MONO-ADP-RIBOSYLTRAN
SFERASE C3)
1dtd CARBOXYPEPTIDASE A2
(Homo
sapiens)
4 / 7 SER A 555
SER A 553
PHE A 635
GLU A 626
None
None
None
GLU  A 300 (-4.2A)
1.17A 2c8aA-1dtdA:
undetectable
2c8aA-1dtdA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C8A_B_NCAB1246_0
(MONO-ADP-RIBOSYLTRAN
SFERASE C3)
1dtd CARBOXYPEPTIDASE A2
(Homo
sapiens)
5 / 7 GLY A 634
SER A 555
SER A 553
PHE A 635
GLU A 626
None
None
None
None
GLU  A 300 (-4.2A)
1.27A 2c8aB-1dtdA:
undetectable
2c8aB-1dtdA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C8A_B_NCAB1246_0
(MONO-ADP-RIBOSYLTRAN
SFERASE C3)
4c9g ADP, ATP CARRIER
PROTEIN 2

(Saccharomyces
cerevisiae)
4 / 7 GLY A  89
SER A  85
ARG A 152
GLU A  81
GLY  A  89 (-0.0A)
SER  A  85 ( 0.0A)
ARG  A 152 ( 0.6A)
GLU  A  81 ( 0.6A)
0.93A 2c8aB-4c9gA:
undetectable
2c8aB-4c9gA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C8A_C_NCAC1252_0
(MONO-ADP-RIBOSYLTRAN
SFERASE C3)
1dtd CARBOXYPEPTIDASE A2
(Homo
sapiens)
4 / 6 SER A 555
SER A 553
PHE A 635
GLU A 626
None
None
None
GLU  A 300 (-4.2A)
1.23A 2c8aC-1dtdA:
undetectable
2c8aC-1dtdA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C8A_D_NCAD1247_0
(MONO-ADP-RIBOSYLTRAN
SFERASE C3)
1dtd CARBOXYPEPTIDASE A2
(Homo
sapiens)
5 / 7 GLY A 634
SER A 555
SER A 553
PHE A 635
GLU A 626
None
None
None
None
GLU  A 300 (-4.2A)
1.30A 2c8aD-1dtdA:
undetectable
2c8aD-1dtdA:
22.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C8A_D_NCAD1247_0
(MONO-ADP-RIBOSYLTRAN
SFERASE C3)
4c9g ADP, ATP CARRIER
PROTEIN 2

(Saccharomyces
cerevisiae)
4 / 7 GLY A  89
SER A  85
ARG A 152
GLU A  81
GLY  A  89 (-0.0A)
SER  A  85 ( 0.0A)
ARG  A 152 ( 0.6A)
GLU  A  81 ( 0.6A)
0.99A 2c8aD-4c9gA:
undetectable
2c8aD-4c9gA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CDQ_A_SAMA1500_0
(ASPARTOKINASE)
6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB

(Yersinia
pseudotuberculos
is)
4 / 8 SER A  62
ARG A  64
LEU A  66
GLU A  70
SER  A  62 ( 0.0A)
ARG  A  64 ( 0.6A)
LEU  A  66 ( 0.5A)
GLU  A  70 ( 0.6A)
0.99A 2cdqA-6gefA:
1.3
2cdqA-6gefA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CDQ_B_SAMB1500_0
(ASPARTOKINASE)
2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN

(Porphyromonas
gingivalis)
4 / 7 ASP A 102
SER A  62
LEU A 105
GLU A 284
ASP  A 102 ( 0.6A)
SER  A  62 ( 0.0A)
LEU  A 105 ( 0.6A)
GLU  A 284 ( 0.5A)
1.10A 2cdqB-2nvvA:
undetectable
2cdqB-2nvvA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2CDQ_B_SAMB1500_0
(ASPARTOKINASE)
6gef TYPE IV SECRETION
SYSTEM PROTEIN DOTB

(Yersinia
pseudotuberculos
is)
4 / 7 SER A  62
ARG A  64
LEU A  66
GLU A  70
SER  A  62 ( 0.0A)
ARG  A  64 ( 0.6A)
LEU  A  66 ( 0.5A)
GLU  A  70 ( 0.6A)
1.10A 2cdqB-6gefA:
undetectable
2cdqB-6gefA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DM6_A_IMNA1401_1
(NADP-DEPENDENT
LEUKOTRIENE B4
12-HYDROXYDEHYDROGEN
ASE)
2j5b TYROSYL-TRNA
SYNTHETASE

(Acanthamoeba
polyphaga
mimivirus)
5 / 10 ILE A 194
ALA A 193
ILE A 179
GLU A  16
ILE A 206
ILE  A 194 ( 0.7A)
ALA  A 193 ( 0.0A)
ILE  A 179 ( 0.7A)
GLU  A  16 ( 0.6A)
ILE  A 206 ( 0.6A)
1.35A 2dm6A-2j5bA:
2.1
2dm6B-2j5bA:
2.2
2dm6A-2j5bA:
22.45
2dm6B-2j5bA:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DM6_A_IMNA1401_1
(NADP-DEPENDENT
LEUKOTRIENE B4
12-HYDROXYDEHYDROGEN
ASE)
3k5s CADHERIN-13
(Gallus
gallus)
5 / 10 TYR A 112
ALA A 209
ILE A 170
GLU A 190
ILE A 213
TYR  A 112 ( 1.3A)
ALA  A 209 ( 0.0A)
ILE  A 170 ( 0.7A)
GLU  A 190 ( 0.5A)
ILE  A 213 ( 0.7A)
1.34A 2dm6A-3k5sA:
undetectable
2dm6B-3k5sA:
undetectable
2dm6A-3k5sA:
19.02
2dm6B-3k5sA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DRD_A_MIYA2001_1
(ACRB)
3gwm HOLO-[ACYL-CARRIER-P
ROTEIN] SYNTHASE

(Mycolicibacteriu
m
smegmatis)
5 / 9 GLY A   5
GLU A 129
ILE A 126
ALA A 125
VAL A 124
GLY  A   5 ( 0.0A)
GLU  A 129 ( 0.6A)
ILE  A 126 ( 0.7A)
ALA  A 125 ( 0.0A)
VAL  A 124 ( 0.6A)
1.41A 2drdA-3gwmA:
undetectable
2drdA-3gwmA:
8.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DTJ_A_THRA401_0
(ASPARTOKINASE)
4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB

(Caldanaerobacter
subterraneus)
4 / 8 GLY A  19
GLU A  18
ALA A  17
ILE A 139
GLY  A  19 ( 0.0A)
GLU  A  18 ( 0.6A)
ALA  A  17 ( 0.0A)
ILE  A 139 ( 0.5A)
0.75A 2dtjA-4egsA:
undetectable
2dtjB-4egsA:
undetectable
2dtjA-4egsA:
23.21
2dtjB-4egsA:
23.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2DTT_A_H4BA1003_1
(HYPOTHETICAL PROTEIN
PH0634)
2dj6 HYPOTHETICAL PROTEIN
PH0634

(Pyrococcus
horikoshii)
6 / 10 HIS A  15
HIS A  29
THR A  76
THR A  77
GLU A  78
GLU A 105
HIS  A  15 ( 1.0A)
HIS  A  29 ( 1.0A)
THR  A  76 ( 0.8A)
THR  A  77 ( 0.8A)
GLU  A  78 ( 0.5A)
GLU  A 105 ( 0.6A)
0.32A 2dttA-2dj6A:
22.2
2dttC-2dj6A:
21.8
2dttA-2dj6A:
100.00
2dttC-2dj6A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DTT_C_H4BC1002_1
(HYPOTHETICAL PROTEIN
PH0634)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 6 ASP A 356
PHE A 355
THR A 260
GLU A 351
ASP  A 356 ( 0.6A)
PHE  A 355 ( 1.3A)
THR  A 260 ( 0.8A)
GLU  A 351 ( 0.5A)
1.48A 2dttB-3ulkA:
undetectable
2dttC-3ulkA:
undetectable
2dttB-3ulkA:
14.26
2dttC-3ulkA:
14.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2DTT_D_H4BD1006_1
(HYPOTHETICAL PROTEIN
PH0634)
2dj6 HYPOTHETICAL PROTEIN
PH0634

(Pyrococcus
horikoshii)
6 / 10 HIS A  15
HIS A  29
THR A  76
THR A  77
GLU A  78
GLU A 105
HIS  A  15 ( 1.0A)
HIS  A  29 ( 1.0A)
THR  A  76 ( 0.8A)
THR  A  77 ( 0.8A)
GLU  A  78 ( 0.5A)
GLU  A 105 ( 0.6A)
0.56A 2dttD-2dj6A:
21.5
2dttF-2dj6A:
21.7
2dttD-2dj6A:
100.00
2dttF-2dj6A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2DTT_E_H4BE1004_1
(HYPOTHETICAL PROTEIN
PH0634)
2dj6 HYPOTHETICAL PROTEIN
PH0634

(Pyrococcus
horikoshii)
6 / 11 HIS A  15
HIS A  29
THR A  76
THR A  77
GLU A  78
GLU A 105
HIS  A  15 ( 1.0A)
HIS  A  29 ( 1.0A)
THR  A  76 ( 0.8A)
THR  A  77 ( 0.8A)
GLU  A  78 ( 0.5A)
GLU  A 105 ( 0.6A)
0.46A 2dttD-2dj6A:
21.5
2dttE-2dj6A:
20.6
2dttD-2dj6A:
100.00
2dttE-2dj6A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2DTT_F_H4BF1005_1
(HYPOTHETICAL PROTEIN
PH0634)
2dj6 HYPOTHETICAL PROTEIN
PH0634

(Pyrococcus
horikoshii)
5 / 9 HIS A  29
THR A  76
THR A  77
GLU A  78
GLU A 105
HIS  A  29 ( 1.0A)
THR  A  76 ( 0.8A)
THR  A  77 ( 0.8A)
GLU  A  78 ( 0.5A)
GLU  A 105 ( 0.6A)
0.52A 2dttE-2dj6A:
20.6
2dttF-2dj6A:
21.7
2dttE-2dj6A:
100.00
2dttF-2dj6A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FN1_B_SALB503_1
(SALICYLATE
SYNTHETASE, IRP9)
1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE

(Escherichia
coli)
5 / 11 ILE A 202
GLU A 154
GLY A 171
THR A 170
THR A 199
ILE  A 202 ( 0.7A)
GLU  A 154 ( 0.6A)
GLY  A 171 ( 0.0A)
THR  A 170 ( 0.8A)
THR  A 199 ( 0.8A)
1.23A 2fn1B-1fxjA:
undetectable
2fn1B-1fxjA:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6H_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN

(Mycolicibacteriu
m
fortuitum)
4 / 8 VAL A 197
TRP A 169
TRP A 151
GLU A 168
VAL  A 197 ( 0.6A)
TRP  A 169 ( 0.5A)
TRP  A 151 (-0.5A)
GLU  A 168 (-0.5A)
1.14A 2g6hA-4w65A:
undetectable
2g6hB-4w65A:
undetectable
2g6hA-4w65A:
20.70
2g6hB-4w65A:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2GJ5_A_VD3A163_1
(BETA-LACTOGLOBULIN)
1ted PKS18
(Mycobacterium
tuberculosis)
5 / 12 LEU A 352
VAL A 199
LEU A 231
GLU A 357
ILE A  35
LEU  A 352 ( 0.6A)
VAL  A 199 ( 0.6A)
LEU  A 231 ( 0.6A)
GLU  A 357 ( 0.6A)
ILE  A  35 ( 0.6A)
1.14A 2gj5A-1tedA:
undetectable
2gj5A-1tedA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HRC_A_CHDA703_0
(FERROCHELATASE)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
4 / 4 LEU A 303
PRO A 300
LEU A 302
ARG A  25
None
None
None
GLU  A 403 (-3.5A)
1.14A 2hrcA-4gfiA:
undetectable
2hrcA-4gfiA:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HU6_A_HAEA269_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.31A 2hu6A-5d7wA:
14.2
2hu6A-5d7wA:
26.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
6 / 12 VAL A  39
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
0.75A 2hyyB-5d7aA:
24.2
2hyyB-5d7aA:
23.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2INE_A_PACA317_0
(ALDOSE REDUCTASE)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
4 / 5 TRP A  24
TYR A  53
HIS A 111
TRP A 112
GLU  A 301 (-3.5A)
GLU  A 301 (-4.4A)
GLU  A 301 (-3.8A)
GLU  A 301 (-4.1A)
0.45A 2ineA-4fziA:
37.3
2ineA-4fziA:
38.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ISF_A_PACA317_0
(ALDOSE REDUCTASE)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
4 / 5 TRP A  24
TYR A  53
HIS A 111
TRP A 112
GLU  A 301 (-3.5A)
GLU  A 301 (-4.4A)
GLU  A 301 (-3.8A)
GLU  A 301 (-4.1A)
0.50A 2isfA-4fziA:
37.0
2isfA-4fziA:
38.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J9C_A_ACTA1121_0
(HYPOTHETICAL
NITROGEN REGULATORY
PII-LIKE PROTEIN
MJ0059)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
4 / 5 SER A 200
VAL A 118
SER A 178
VAL A 182
None
None
GLU  A1055 (-3.8A)
None
1.40A 2j9cA-2dvzA:
1.9
2j9cB-2dvzA:
1.7
2j9cC-2dvzA:
1.5
2j9cA-2dvzA:
15.71
2j9cB-2dvzA:
15.71
2j9cC-2dvzA:
15.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2J9D_J_ACTJ1116_0
(HYPOTHETICAL
NITROGEN REGULATORY
PII-LIKE PROTEIN
MJ0059)
4yba REGULATORY PROTEIN C
(Klebsiella
pneumoniae)
4 / 8 GLU A  62
ILE A  58
LYS A   5
ILE A   6
GLU  A  62 ( 0.6A)
ILE  A  58 ( 0.6A)
HIS  A   5 ( 0.0A)
ILE  A   6 ( 0.6A)
0.85A 2j9dJ-4ybaA:
undetectable
2j9dK-4ybaA:
undetectable
2j9dL-4ybaA:
undetectable
2j9dJ-4ybaA:
23.53
2j9dK-4ybaA:
23.53
2j9dL-4ybaA:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JIH_A_097A1001_1
(ADAMTS-1)
5d7w SERRALYSIN
(Serratia
marcescens)
5 / 9 THR A 173
HIS A 176
GLU A 177
HIS A 180
HIS A 186
THR  A 173 ( 0.8A)
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.40A 2jihA-5d7wA:
7.0
2jihA-5d7wA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JIH_B_097B1001_1
(ADAMTS-1)
5d7w SERRALYSIN
(Serratia
marcescens)
5 / 8 THR A 173
HIS A 176
GLU A 177
HIS A 180
HIS A 186
THR  A 173 ( 0.8A)
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.37A 2jihB-5d7wA:
6.8
2jihB-5d7wA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_A_SNLA1001_1
(MINERALOCORTICOID
RECEPTOR)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
5 / 12 MET A 282
LEU A 247
LEU A 297
THR A 125
PHE A  18
None
None
None
ALA  A 402 (-3.5A)
GLU  A 403 (-4.6A)
1.32A 2oaxA-4gfiA:
undetectable
2oaxA-4gfiA:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_B_SNLB2001_1
(MINERALOCORTICOID
RECEPTOR)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
5 / 12 MET A 282
LEU A 247
LEU A 297
THR A 125
PHE A  18
None
None
None
ALA  A 402 (-3.5A)
GLU  A 403 (-4.6A)
1.34A 2oaxB-4gfiA:
undetectable
2oaxB-4gfiA:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_C_SNLC3001_1
(MINERALOCORTICOID
RECEPTOR)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
5 / 12 MET A 282
LEU A 247
LEU A 297
THR A 125
PHE A  18
None
None
None
ALA  A 402 (-3.5A)
GLU  A 403 (-4.6A)
1.33A 2oaxC-4gfiA:
undetectable
2oaxC-4gfiA:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OAX_F_SNLF6001_1
(MINERALOCORTICOID
RECEPTOR)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
5 / 12 MET A 282
LEU A 247
LEU A 297
THR A 125
PHE A  18
None
None
None
ALA  A 402 (-3.5A)
GLU  A 403 (-4.6A)
1.37A 2oaxF-4gfiA:
undetectable
2oaxF-4gfiA:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OCF_A_ESTA596_1
(ESTROGEN RECEPTOR)
3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE

(Citrus
x
microcarpa)
5 / 10 LEU A 222
ALA A 113
GLU A 116
ARG A 234
LEU A 187
LEU  A 222 ( 0.6A)
ALA  A 113 ( 0.0A)
GLU  A 116 ( 0.5A)
ARG  A 234 ( 0.6A)
LEU  A 187 ( 0.5A)
1.25A 2ocfA-3wd7A:
undetectable
2ocfA-3wd7A:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OW9_A_HAEA502_1
(COLLAGENASE 3)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 6 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.18A 2ow9A-5d7wA:
14.6
2ow9A-5d7wA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OW9_B_HAEB502_1
(COLLAGENASE 3)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.25A 2ow9B-5d7wA:
14.4
2ow9B-5d7wA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OZR_C_HAEC3001_1
(COLLAGENASE 3)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.23A 2ozrC-5d7wA:
14.6
2ozrC-5d7wA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OZR_D_HAED3002_1
(COLLAGENASE 3)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.26A 2ozrD-5d7wA:
14.7
2ozrD-5d7wA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OZR_E_HAEE3003_1
(COLLAGENASE 3)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.39A 2ozrE-5d7wA:
14.4
2ozrE-5d7wA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2P16_A_GG2A298_2
(COAGULATION FACTOR X
(EC 3.4.21.6)
(STUART FACTOR)
(STUART-PROWER
FACTOR))
5l5n PLEXIN-A4
(Mus
musculus)
3 / 3 ARG A 365
GLU A 416
GLN A 361
ARG  A 365 ( 0.6A)
GLU  A 416 ( 0.5A)
GLN  A 361 ( 0.6A)
0.82A 2p16A-5l5nA:
undetectable
2p16A-5l5nA:
11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PLW_A_SAMA203_0
(RIBOSOMAL RNA
METHYLTRANSFERASE,
PUTATIVE)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 12 GLY A 400
TYR A 583
GLY A 586
TRP A 398
GLU A 554
GLY  A 400 ( 0.0A)
TYR  A 583 ( 1.3A)
GLY  A 586 ( 0.0A)
TRP  A 398 ( 0.5A)
GLU  A 554 ( 0.5A)
1.02A 2plwA-4flxA:
undetectable
2plwA-4flxA:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2UVN_A_ECNA1409_1
(CYTOCHROME P450 130)
4otu GAMMA-GLUTAMYLTRANSP
EPTIDASE

(Bacillus
licheniformis)
5 / 12 LEU B 459
THR B 483
GLY B 482
GLY B 481
THR B 399
None
None
GLU  B 602 (-3.1A)
GLU  B 602 ( 4.2A)
GLU  B 602 (-2.7A)
1.16A 2uvnA-4otuB:
undetectable
2uvnA-4otuB:
17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2UY4_A_AZMA1311_1
(ENDOCHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
6 / 9 TYR A 156
PHE A 184
GLY A 267
GLU A 308
TYR A 383
TRP A 532
TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
0.52A 2uy4A-5gprA:
18.4
2uy4A-5gprA:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)
5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE

(Bacillus
licheniformis)
5 / 9 ILE A 387
ALA A 332
GLU A 356
GLY A 347
LEU A 348
ILE  A 387 ( 0.7A)
ALA  A 332 ( 0.0A)
GLU  A 356 ( 0.5A)
GLY  A 347 ( 0.0A)
LEU  A 348 ( 0.5A)
1.18A 2v0mB-5xluA:
undetectable
2v0mB-5xluA:
10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VUF_A_FUAA2002_1
(SERUM ALBUMIN)
1zx3 HYPOTHETICAL PROTEIN
NE0241

(Nitrosomonas
europaea)
4 / 9 PHE A  53
ALA A  54
VAL A  57
GLU A  58
PHE  A  53 ( 1.4A)
ALA  A  54 ( 0.0A)
VAL  A  57 ( 0.6A)
GLU  A  58 ( 0.5A)
0.49A 2vufA-1zx3A:
undetectable
2vufA-1zx3A:
9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VUF_A_FUAA2002_1
(SERUM ALBUMIN)
5wm9 RV0078
(Mycobacterium
tuberculosis)
4 / 9 ILE A 113
PHE A  62
VAL A  66
GLU A  67
ILE  A 113 ( 0.7A)
PHE  A  62 ( 1.3A)
VAL  A  66 ( 0.6A)
GLU  A  67 ( 0.6A)
0.82A 2vufA-5wm9A:
4.0
2vufA-5wm9A:
8.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_B_FOLB401_1
(DIHYDROFOLATE
REDUCTASE)
5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6

(Rattus
norvegicus)
3 / 3 GLU A 249
GLN A 305
ARG A 304
GLU  A 249 ( 0.6A)
GLN  A 305 ( 0.6A)
ARG  A 304 ( 0.6A)
0.79A 2w3bB-5wo6A:
undetectable
2w3bB-5wo6A:
13.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_A_EV1A1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo
sapiens)
8 / 12 TYR A 159
HIS A 160
LEU A 319
ILE A 336
GLU A 339
MET A 357
GLN A 369
PHE A 372
TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
GLU  A 339 ( 0.5A)
MET  A 357 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
1.01A 2weyA-3sl5A:
37.9
2weyA-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WEY_A_EV1A1771_1
(CAMP AND
CAMP-INHIBITED CGMP
3', 5'-CYCLIC
PHOSPHODIESTERASE)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo
sapiens)
8 / 12 TYR A 159
HIS A 160
LEU A 319
ILE A 336
GLU A 339
PHE A 340
GLN A 369
PHE A 372
TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
LEU  A 319 ( 0.6A)
ILE  A 336 ( 0.4A)
GLU  A 339 ( 0.5A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
0.83A 2weyA-3sl5A:
37.9
2weyA-3sl5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X0P_A_ADNA1607_1
(ALCALIGIN
BIOSYNTHESIS PROTEIN)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 8 GLY A 227
ASN A 410
MET A 409
GLU A 221
GLY  A 227 ( 0.0A)
ASN  A 410 ( 0.6A)
MET  A 409 ( 0.0A)
GLU  A 221 (-0.6A)
0.80A 2x0pA-3ulkA:
0.5
2x0pA-3ulkA:
22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X45_A_HSMA1160_1
(ALLERGEN ARG R 1)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
4 / 6 SER A 199
VAL A 241
TYR A 243
ASP A 195
None
None
GLU  A1055 (-4.2A)
None
1.11A 2x45A-2dvzA:
undetectable
2x45A-2dvzA:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X45_B_HSMB1160_1
(ALLERGEN ARG R 1)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
4 / 7 SER A 199
VAL A 241
TYR A 243
ASP A 195
None
None
GLU  A1055 (-4.2A)
None
1.13A 2x45B-2dvzA:
undetectable
2x45B-2dvzA:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X45_B_HSMB1162_1
(ALLERGEN ARG R 1)
1dtd CARBOXYPEPTIDASE A2
(Homo
sapiens)
3 / 3 GLU A 626
HIS A 424
GLU A 427
GLU  A 300 (-4.2A)
ZN  A 301 ( 3.4A)
ZN  A 301 (-2.6A)
0.82A 2x45B-1dtdA:
0.0
2x45B-1dtdA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X45_C_HSMC1160_1
(ALLERGEN ARG R 1)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
4 / 7 SER A 199
VAL A 241
TYR A 243
ASP A 195
None
None
GLU  A1055 (-4.2A)
None
1.11A 2x45C-2dvzA:
undetectable
2x45C-2dvzA:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X45_C_HSMC1162_1
(ALLERGEN ARG R 1)
1dtd CARBOXYPEPTIDASE A2
(Homo
sapiens)
3 / 3 GLU A 626
HIS A 424
GLU A 427
GLU  A 300 (-4.2A)
ZN  A 301 ( 3.4A)
ZN  A 301 (-2.6A)
0.84A 2x45C-1dtdA:
0.0
2x45C-1dtdA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XCT_H_CPFH1020_1
(DNA GYRASE SUBUNIT
B, DNA GYRASE
SUBUNIT A)
3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE

(Corynebacterium
glutamicum)
3 / 3 ARG A 197
GLU A 200
SER A  44
ARG  A 197 ( 0.6A)
GLU  A 200 ( 0.6A)
SER  A  44 ( 0.0A)
0.73A 2xctD-3r64A:
undetectable
2xctD-3r64A:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XCT_X_CPFX1020_1
(DNA GYRASE SUBUNIT
B, DNA GYRASE
SUBUNIT A)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
4 / 4 ARG A 223
GLY A 222
GLU A 219
SER A 233
ARG  A 223 ( 0.6A)
GLY  A 222 ( 0.0A)
GLU  A 219 ( 0.6A)
SER  A 233 ( 0.0A)
1.41A 2xctS-4kqnA:
undetectable
2xctU-4kqnA:
undetectable
2xctS-4kqnA:
20.86
2xctU-4kqnA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKW_A_P1BA1478_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA

(Homo
sapiens)
4 / 7 LEU A 282
GLU A 280
ILE A 340
ILE A 345
LEU  A 282 ( 0.6A)
GLU  A 280 ( 0.6A)
ILE  A 340 ( 0.6A)
ILE  A 345 (-0.5A)
0.85A 2xkwA-4hneA:
undetectable
2xkwA-4hneA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKW_B_P1BB1475_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
5e37 EF-HAND
DOMAIN-CONTAINING
THIOREDOXIN

(Chlamydomonas
reinhardtii)
5 / 12 GLU A 216
ALA A 116
LEU A 178
ILE A 164
MET A 153
GLU  A 216 ( 0.5A)
ALA  A 116 ( 0.0A)
LEU  A 178 ( 0.6A)
ILE  A 164 ( 0.7A)
MET  A 153 ( 0.0A)
1.31A 2xkwB-5e37A:
undetectable
2xkwB-5e37A:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XRZ_A_ACTA1467_0
(DEOXYRIBODIPYRIMIDIN
E PHOTOLYASE)
1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE

(Escherichia
coli)
4 / 5 ARG A 237
ASP A 261
ILE A 279
GLU A 236
ARG  A 237 ( 0.6A)
ASP  A 261 ( 0.6A)
ILE  A 279 ( 0.7A)
GLU  A 236 ( 0.6A)
1.40A 2xrzA-1fxjA:
0.4
2xrzB-1fxjA:
0.3
2xrzA-1fxjA:
20.79
2xrzB-1fxjA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XTK_A_AZMA1339_1
(CLASS III CHITINASE
CHIA1)
5gpr CHITINASE
(Ostrinia
furnacalis)
6 / 11 TYR A 156
PHE A 184
GLY A 267
GLU A 308
TYR A 383
TRP A 532
TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
0.74A 2xtkA-5gprA:
19.8
2xtkA-5gprA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XTK_B_AZMB1339_1
(CLASS III CHITINASE
CHIA1)
5gpr CHITINASE
(Ostrinia
furnacalis)
6 / 10 TYR A 156
PHE A 184
GLY A 267
GLU A 308
TYR A 383
TRP A 532
TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
TRP  A 532 ( 0.5A)
0.56A 2xtkB-5gprA:
19.7
2xtkB-5gprA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XZ5_A_ACHA1211_0
(SOLUBLE
ACETYLCHOLINE
RECEPTOR)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
4 / 7 TYR A  47
SER A  49
ILE A  69
SER A  55
None
None
GLU  A1620 (-4.9A)
None
1.08A 2xz5A-2pyyA:
undetectable
2xz5B-2pyyA:
undetectable
2xz5A-2pyyA:
20.88
2xz5B-2pyyA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XZ5_B_ACHB1211_0
(SOLUBLE
ACETYLCHOLINE
RECEPTOR)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
4 / 8 TYR A  47
SER A  49
ILE A  69
SER A  55
None
None
GLU  A1620 (-4.9A)
None
1.07A 2xz5B-2pyyA:
undetectable
2xz5E-2pyyA:
undetectable
2xz5B-2pyyA:
20.88
2xz5E-2pyyA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7H_B_SAMB530_1
(TYPE I RESTRICTION
ENZYME ECOKI M
PROTEIN)
2cfo GLUTAMYL-TRNA
SYNTHETASE

(Synechococcus
elongatus)
3 / 3 TYR A 192
GLU A  42
THR A  19
GLU  A1486 (-4.9A)
GLU  A1486 ( 4.9A)
None
0.86A 2y7hB-2cfoA:
undetectable
2y7hB-2cfoA:
23.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YA7_C_ZMRC1776_2
(NEURAMINIDASE A)
1l4a S-SNAP25 FUSION
PROTEIN
S-SYNTAXIN
SYNAPTOBREVIN

(Doryteuthis
pealeii)
4 / 6 ASP A  73
ILE A  69
GLN C  56
GLU B 231
ASP  A  73 ( 0.6A)
ILE  A  69 ( 0.7A)
GLN  C  56 ( 0.6A)
GLU  B 231 ( 0.5A)
1.42A 2ya7C-1l4aA:
undetectable
2ya7C-1l4aA:
9.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YS6_A_GLYA431_0
(PHOSPHORIBOSYLGLYCIN
AMIDE SYNTHETASE)
2qm6 GAMMA-GLUTAMYLTRANSP
EPTIDASE

(Helicobacter
pylori)
4 / 8 TYR B 433
ARG B 475
GLY B 473
PRO B 471
GLU  B   1 (-4.3A)
None
GLU  B   1 (-3.6A)
GLU  B   1 ( 4.8A)
1.07A 2ys6A-2qm6B:
undetectable
2ys6A-2qm6B:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YZQ_A_SAMA6075_0
(PUTATIVE
UNCHARACTERIZED
PROTEIN PH1780)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 12 ILE A 256
ASP A   4
VAL A 205
ILE A 206
GLU A 251
ILE  A 256 ( 0.7A)
ASP  A   4 ( 0.6A)
VAL  A 205 ( 0.5A)
ILE  A 206 ( 0.7A)
GLU  A 251 ( 0.6A)
1.16A 2yzqA-4flxA:
undetectable
2yzqA-4flxA:
18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZIF_B_SAMB298_1
(PUTATIVE
MODIFICATION
METHYLASE)
3eqz RESPONSE REGULATOR
(Colwellia
psychrerythraea)
3 / 3 ASP A  57
THR A  40
GLU A  62
ASP  A  57 ( 0.5A)
THR  A  40 ( 0.8A)
GLU  A  62 ( 0.6A)
0.81A 2zifB-3eqzA:
2.5
2zifB-3eqzA:
16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_B_2FAB500_1
(ADENOSYLHOMOCYSTEINA
SE)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
5 / 12 ASP A 244
GLU A 219
LYS A 160
LEU A  23
GLY A 195
MG  A1601 ( 3.2A)
MG  A1601 (-2.9A)
GLU  A2471 (-2.6A)
None
None
1.36A 2zj0B-1tkkA:
undetectable
2zj0B-1tkkA:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
5 / 12 ASP A 244
GLU A 219
LYS A 160
LEU A  23
GLY A 195
MG  A1601 ( 3.2A)
MG  A1601 (-2.9A)
GLU  A2471 (-2.6A)
None
None
1.41A 2zj0C-1tkkA:
undetectable
2zj0C-1tkkA:
24.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZMB_A_PXBA692_1
(LACTOTRANSFERRIN)
5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4

(Homo
sapiens)
3 / 3 PRO A 306
GLU A 221
TYR A 290
PRO  A 306 ( 1.1A)
GLU  A 221 ( 0.6A)
TYR  A 290 ( 1.3A)
0.79A 2zmbA-5nksA:
undetectable
2zmbA-5nksA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZUL_A_SAMA376_1
(PROBABLE RIBOSOMAL
RNA SMALL SUBUNIT
METHYLTRANSFERASE)
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
3 / 3 SER A 186
GLU A 249
ASP A 219
SER  A 186 ( 0.0A)
GLU  A 249 (-0.6A)
ASP  A 219 (-0.5A)
0.65A 2zulA-1omoA:
5.0
2zulA-1omoA:
24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZUL_A_SAMA376_1
(PROBABLE RIBOSOMAL
RNA SMALL SUBUNIT
METHYLTRANSFERASE)
1vho ENDOGLUCANASE
(Thermotoga
maritima)
3 / 3 SER A 174
GLU A 274
ASP A 236
SER  A 174 ( 0.0A)
GLU  A 274 ( 0.6A)
ASP  A 236 ( 0.6A)
0.80A 2zulA-1vhoA:
undetectable
2zulA-1vhoA:
24.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZUL_A_SAMA376_1
(PROBABLE RIBOSOMAL
RNA SMALL SUBUNIT
METHYLTRANSFERASE)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
3 / 3 SER A 493
GLU A 330
ASP A 259
SER  A 493 ( 0.0A)
GLU  A 330 ( 0.5A)
ASP  A 259 ( 0.6A)
0.71A 2zulA-4flxA:
undetectable
2zulA-4flxA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AF3_A_PAUA314_0
(PANTOTHENATE KINASE)
2vha PERIPLASMIC BINDING
TRANSPORT PROTEIN

(Shigella
flexneri)
4 / 6 TYR A 211
PHE A 108
PHE A 247
PHE A 260
GLU  A1280 (-4.7A)
None
None
None
1.06A 3af3A-2vhaA:
undetectable
3af3A-2vhaA:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AIA_B_SAMB206_0
(UPF0217 PROTEIN
MJ1640)
2v9u MSPA
(Mycolicibacteriu
m
smegmatis)
4 / 5 SER A 132
LEU A 166
GLY A  60
GLU A  63
SER  A 132 ( 0.0A)
LEU  A 166 ( 0.5A)
GLY  A  60 ( 0.0A)
GLU  A  63 ( 0.6A)
0.96A 3aiaA-2v9uA:
undetectable
3aiaB-2v9uA:
undetectable
3aiaA-2v9uA:
16.51
3aiaB-2v9uA:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AMU_A_AG2A422_1
(PUTATIVE
UNCHARACTERIZED
PROTEIN)
4g6z GLUTAMATE-TRNA
LIGASE

(Burkholderia
thailandensis)
4 / 5 GLU A  44
VAL A 193
CYH A 190
ARG A  42
GLU  A 501 (-3.7A)
None
None
None
1.10A 3amuA-4g6zA:
undetectable
3amuA-4g6zA:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APV_A_TP0A190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)
3gnr OS03G0212800 PROTEIN
(Oryza
sativa)
5 / 12 PHE A 301
LEU A 223
GLU A 305
ARG A 149
TYR A 286
PHE  A 301 ( 1.3A)
LEU  A 223 ( 0.5A)
GLU  A 305 ( 0.6A)
ARG  A 149 ( 0.6A)
TYR  A 286 ( 1.3A)
1.44A 3apvA-3gnrA:
undetectable
3apvA-3gnrA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APV_B_TP0B190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)
3gnr OS03G0212800 PROTEIN
(Oryza
sativa)
5 / 12 PHE A 301
LEU A 223
GLU A 305
ARG A 149
TYR A 286
PHE  A 301 ( 1.3A)
LEU  A 223 ( 0.5A)
GLU  A 305 ( 0.6A)
ARG  A 149 ( 0.6A)
TYR  A 286 ( 1.3A)
1.36A 3apvB-3gnrA:
undetectable
3apvB-3gnrA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3APW_B_DP0B190_1
(ALPHA-1-ACID
GLYCOPROTEIN 2)
3gnr OS03G0212800 PROTEIN
(Oryza
sativa)
5 / 12 PHE A 301
LEU A 223
GLU A 305
ARG A 149
TYR A 286
PHE  A 301 ( 1.3A)
LEU  A 223 ( 0.5A)
GLU  A 305 ( 0.6A)
ARG  A 149 ( 0.6A)
TYR  A 286 ( 1.3A)
1.43A 3apwB-3gnrA:
undetectable
3apwB-3gnrA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AX7_B_SALB1336_1
(XANTHINE
DEHYDROGENASE/OXIDAS
E)
1wsv AMINOMETHYLTRANSFERA
SE

(Homo
sapiens)
5 / 9 GLU A  71
SER A  89
THR A  87
VAL A 104
ALA A  79
GLU  A  71 ( 0.6A)
SER  A  89 ( 0.0A)
THR  A  87 ( 0.8A)
VAL  A 104 ( 0.6A)
ALA  A  79 ( 0.0A)
1.23A 3ax7B-1wsvA:
0.0
3ax7B-1wsvA:
15.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3AX9_B_SALB1340_1
(XANTHINE
DEHYDROGENASE/OXIDAS
E)
2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE

(Lactococcus
lactis)
4 / 8 GLU A 156
ARG A 148
ALA A 132
ALA A 133
GLU  A 156 ( 0.6A)
ARG  A 148 ( 0.6A)
ALA  A 132 ( 0.0A)
ALA  A 133 ( 0.0A)
1.03A 3ax9B-2vbfA:
undetectable
3ax9B-2vbfA:
18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3N_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3b3nA-5bs1A:
undetectable
3b3nB-5bs1A:
undetectable
3b3nA-5bs1A:
14.45
3b3nB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3O_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3b3oA-5bs1A:
undetectable
3b3oB-5bs1A:
undetectable
3b3oA-5bs1A:
14.45
3b3oB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3P_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)
4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN

(Mycolicibacteriu
m
fortuitum)
4 / 8 TRP A 151
GLU A 168
VAL A 197
TRP A 169
TRP  A 151 (-0.5A)
GLU  A 168 (-0.5A)
VAL  A 197 ( 0.6A)
TRP  A 169 ( 0.5A)
0.98A 3b3pA-4w65A:
undetectable
3b3pB-4w65A:
undetectable
3b3pA-4w65A:
20.60
3b3pB-4w65A:
20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3P_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 8 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3b3pA-5bs1A:
undetectable
3b3pB-5bs1A:
undetectable
3b3pA-5bs1A:
14.45
3b3pB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BU1_A_HSMA301_1
(LIPOCALIN)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
4 / 7 SER A 199
VAL A 241
TYR A 243
ASP A 195
None
None
GLU  A1055 (-4.2A)
None
1.07A 3bu1A-2dvzA:
undetectable
3bu1A-2dvzA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CB8_A_SAMA501_0
(PYRUVATE
FORMATE-LYASE
1-ACTIVATING ENZYME)
1ng0 COAT PROTEIN
(Cocksfoot
mottle
virus)
5 / 12 TYR A 213
ASN A 206
GLU A 203
ARG A 217
VAL A 214
TYR  A 213 ( 1.3A)
ASN  A 206 ( 0.6A)
GLU  A 203 ( 0.5A)
ARG  A 217 ( 0.6A)
VAL  A 214 ( 0.6A)
1.13A 3cb8A-1ng0A:
undetectable
3cb8A-1ng0A:
20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CE6_B_ADNB500_1
(ADENOSYLHOMOCYSTEINA
SE)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
5 / 12 ASP A 244
GLU A 219
LYS A 160
LEU A  23
GLY A 195
MG  A1601 ( 3.2A)
MG  A1601 (-2.9A)
GLU  A2471 (-2.6A)
None
None
1.39A 3ce6B-1tkkA:
undetectable
3ce6B-1tkkA:
24.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CLD_A_GW6A1_1
(GLUCOCORTICOID
RECEPTOR)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
5 / 12 MET A 282
LEU A 247
LEU A 297
THR A 125
PHE A  18
None
None
None
ALA  A 402 (-3.5A)
GLU  A 403 (-4.6A)
1.43A 3cldA-4gfiA:
undetectable
3cldA-4gfiA:
18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D91_A_REMA350_1
(RENIN)
2jfn GLUTAMATE RACEMASE
(Escherichia
coli)
5 / 12 ASP A  28
GLY A  32
THR A 135
LEU A 209
ALA A 169
GLU  A1287 (-2.8A)
GLU  A1287 ( 4.2A)
GLU  A1287 ( 4.2A)
None
None
1.09A 3d91A-2jfnA:
undetectable
3d91A-2jfnA:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DH0_A_SAMA220_1
(SAM DEPENDENT
METHYLTRANSFERASE)
5c6d UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 7
E3 UBIQUITIN-PROTEIN
LIGASE UHRF1

(Homo
sapiens;
Homo
sapiens)
4 / 8 LYS C 657
ASP A 764
MET A 761
GLU A 744
LYS  C 657 ( 0.0A)
ASP  A 764 ( 0.6A)
MET  A 761 ( 0.0A)
GLU  A 744 ( 0.6A)
1.42A 3dh0A-5c6dC:
undetectable
3dh0A-5c6dC:
8.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DMH_A_SAMA384_1
(PROBABLE RIBOSOMAL
RNA SMALL SUBUNIT
METHYLTRANSFERASE)
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
3 / 3 SER A 186
GLU A 249
ASP A 219
SER  A 186 ( 0.0A)
GLU  A 249 (-0.6A)
ASP  A 219 (-0.5A)
0.63A 3dmhA-1omoA:
5.2
3dmhA-1omoA:
24.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DMH_A_SAMA384_1
(PROBABLE RIBOSOMAL
RNA SMALL SUBUNIT
METHYLTRANSFERASE)
1vho ENDOGLUCANASE
(Thermotoga
maritima)
3 / 3 SER A 174
GLU A 274
ASP A 236
SER  A 174 ( 0.0A)
GLU  A 274 ( 0.6A)
ASP  A 236 ( 0.6A)
0.79A 3dmhA-1vhoA:
undetectable
3dmhA-1vhoA:
25.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DMH_A_SAMA384_1
(PROBABLE RIBOSOMAL
RNA SMALL SUBUNIT
METHYLTRANSFERASE)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
3 / 3 SER A 493
GLU A 330
ASP A 259
SER  A 493 ( 0.0A)
GLU  A 330 ( 0.5A)
ASP  A 259 ( 0.6A)
0.72A 3dmhA-4flxA:
undetectable
3dmhA-4flxA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DZG_B_NCAB302_0
(ADP-RIBOSYL CYCLASE
1)
2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1

(Homo
sapiens)
4 / 7 LEU A  67
GLU A 251
SER A  52
THR A  75
LEU  A  67 (-0.6A)
GLU  A 251 ( 0.6A)
SER  A  52 ( 0.0A)
THR  A  75 ( 0.8A)
1.32A 3dzgB-2b92A:
undetectable
3dzgB-2b92A:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9R_A_ACTA700_0
(PURINE-NUCLEOSIDE
PHOSPHORYLASE)
2zns GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 1

(Homo
sapiens)
4 / 6 GLY A 475
GLY A 673
MET A 676
ASN A 484
None
GLU  A 301 (-3.2A)
None
None
1.00A 3e9rA-2znsA:
undetectable
3e9rA-2znsA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9R_C_ACTC700_0
(PURINE-NUCLEOSIDE
PHOSPHORYLASE)
2zns GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 1

(Homo
sapiens)
4 / 6 GLY A 475
GLY A 673
MET A 676
ASN A 484
None
GLU  A 301 (-3.2A)
None
None
0.99A 3e9rC-2znsA:
undetectable
3e9rC-2znsA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9X_A_NIMA1_1
(LACTOTRANSFERRIN')
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 4 GLU A 332
GLY A 335
THR A 334
GLU A 340
GLU  A 332 ( 0.6A)
GLY  A 335 ( 0.0A)
THR  A 334 ( 0.8A)
GLU  A 340 ( 0.6A)
1.01A 3e9xA-3ulkA:
undetectable
3e9xA-3ulkA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E9X_A_NIMA1_1
(LACTOTRANSFERRIN')
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 4 GLU A 333
GLY A 335
THR A 337
GLU A 340
GLU  A 333 ( 0.6A)
GLY  A 335 ( 0.0A)
THR  A 337 ( 0.8A)
GLU  A 340 ( 0.6A)
1.08A 3e9xA-3ulkA:
undetectable
3e9xA-3ulkA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EIG_A_MTXA200_2
(DIHYDROFOLATE
REDUCTASE)
4wxj GLUTAMATE RECEPTOR
IIB,GLUTAMATE
RECEPTOR IIB

(Drosophila
melanogaster)
4 / 5 ASP A  79
ARG A  16
ILE A  81
THR A 150
None
None
None
GLU  A 301 (-3.5A)
1.19A 3eigA-4wxjA:
undetectable
3eigA-4wxjA:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3F78_A_ICFA1_1
(INTEGRIN ALPHA-L)
2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE

(Lactococcus
lactis)
5 / 9 ILE A 450
TYR A 520
ILE A 522
LYS A 497
GLU A 511
ILE  A 450 ( 0.7A)
TYR  A 520 ( 1.3A)
ILE  A 522 ( 0.6A)
LYS  A 497 ( 0.0A)
GLU  A 511 ( 0.6A)
1.04A 3f78A-2vbfA:
3.8
3f78A-2vbfA:
16.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FHJ_A_TRPA1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 10 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.34A 3fhjA-1i7qB:
2.3
3fhjA-1i7qB:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FHJ_B_TRPB1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 10 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.30A 3fhjB-1i7qB:
undetectable
3fhjB-1i7qB:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FHJ_C_TRPC1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 10 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.29A 3fhjC-1i7qB:
undetectable
3fhjC-1i7qB:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FHJ_E_TRPE1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 10 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.33A 3fhjE-1i7qB:
undetectable
3fhjE-1i7qB:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_A_TRPA1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 9 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.37A 3fi0A-1i7qB:
undetectable
3fi0A-1i7qB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_C_TRPC1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 9 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.34A 3fi0C-1i7qB:
2.2
3fi0C-1i7qB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_H_TRPH1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 9 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.34A 3fi0H-1i7qB:
2.3
3fi0H-1i7qB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_K_TRPK1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 9 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.40A 3fi0K-1i7qB:
undetectable
3fi0K-1i7qB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_L_TRPL1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 9 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.41A 3fi0L-1i7qB:
undetectable
3fi0L-1i7qB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_N_TRPN1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 9 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.34A 3fi0N-1i7qB:
2.4
3fi0N-1i7qB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_O_TRPO1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
1i7q TRPG
(Serratia
marcescens)
5 / 9 GLY B 138
GLN B  89
HIS B 134
VAL B 148
VAL B 159
None
GLU  B1401 (-3.1A)
None
None
None
1.36A 3fi0O-1i7qB:
undetectable
3fi0O-1i7qB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FPJ_B_SAMB301_1
(PUTATIVE
UNCHARACTERIZED
PROTEIN)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
4 / 7 GLY A  49
GLY A  51
GLU A 174
GLU A  10
GLY  A  49 ( 0.0A)
GLY  A  51 ( 0.0A)
GLU  A 174 ( 0.6A)
GLU  A  10 ( 0.6A)
0.87A 3fpjB-4g41A:
undetectable
3fpjB-4g41A:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G6M_A_CFFA1_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
11 / 11 TYR A 156
PHE A 184
GLY A 267
TRP A 268
ASP A 306
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
TRP A 532
TYR  A 156 ( 1.3A)
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
ASP  A 306 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
TRP  A 532 ( 0.5A)
0.49A 3g6mA-5gprA:
7.2
3g6mA-5gprA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GCS_A_BAXA401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
5 / 12 GLU A  99
LEU A 101
ILE A 126
THR A 165
ILE A 146
GLU  A  99 ( 0.6A)
LEU  A 101 ( 0.6A)
ILE  A 126 ( 0.6A)
THR  A 165 ( 0.8A)
ILE  A 146 ( 0.7A)
1.02A 3gcsA-4kqnA:
undetectable
3gcsA-4kqnA:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GWX_B_EPAB3_1
(PROTEIN (PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
(PPAR-DELTA)))
1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE

(Escherichia
coli)
5 / 12 THR A 170
THR A 130
GLU A 167
LEU A 173
ILE A 202
THR  A 170 ( 0.8A)
THR  A 130 ( 0.8A)
GLU  A 167 ( 0.5A)
LEU  A 173 ( 0.6A)
ILE  A 202 ( 0.7A)
1.22A 3gwxB-1fxjA:
undetectable
3gwxB-1fxjA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3H52_A_486A3_1
(GLUCOCORTICOID
RECEPTOR)
5dtb CG3822
(Drosophila
melanogaster)
5 / 12 LEU A 142
ASN A 178
GLY A 181
VAL A 185
ILE A 201
GLU  A 301 ( 3.6A)
GLU  A 301 ( 3.8A)
None
None
None
1.19A 3h52A-5dtbA:
undetectable
3h52A-5dtbA:
24.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEC_A_STIA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
5 / 12 VAL A  31
ALA A  52
LYS A  54
GLU A  69
LEU A  73
VAL  A  31 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A  73 ( 0.6A)
0.48A 3hecA-5d7aA:
17.9
3hecA-5d7aA:
25.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
6 / 12 VAL A  31
VAL A  39
ALA A  52
LYS A  54
GLU A  69
LEU A  73
VAL  A  31 (-0.6A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A  73 ( 0.6A)
0.72A 3hegA-5d7aA:
21.7
3hegA-5d7aA:
25.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HS4_A_AZMA702_1
(CARBONIC ANHYDRASE 2)
4gow CALMODULIN
(Homo
sapiens)
4 / 7 VAL D 142
TYR D 138
LYS D  81
GLU D  83
VAL  D 142 ( 0.6A)
TYR  D 138 ( 1.3A)
SER  D  81 ( 0.0A)
GLU  D  83 ( 0.5A)
1.20A 3hs4A-4gowD:
undetectable
3hs4A-4gowD:
23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 3hsnA-5bs1A:
undetectable
3hsnB-5bs1A:
undetectable
3hsnA-5bs1A:
14.45
3hsnB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSN_B_H4BB1760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.26A 3hsnA-5bs1A:
undetectable
3hsnB-5bs1A:
undetectable
3hsnA-5bs1A:
14.45
3hsnB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HSO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 3hsoA-5bs1A:
undetectable
3hsoB-5bs1A:
undetectable
3hsoA-5bs1A:
14.45
3hsoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HY7_A_097A801_1
(A DISINTEGRIN AND
METALLOPROTEINASE
WITH THROMBOSPONDIN
MOTIFS 5)
5d7w SERRALYSIN
(Serratia
marcescens)
5 / 9 THR A 173
HIS A 176
GLU A 177
HIS A 180
HIS A 186
THR  A 173 ( 0.8A)
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.32A 3hy7A-5d7wA:
7.7
3hy7A-5d7wA:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HY7_B_097B801_1
(A DISINTEGRIN AND
METALLOPROTEINASE
WITH THROMBOSPONDIN
MOTIFS 5)
5d7w SERRALYSIN
(Serratia
marcescens)
5 / 9 THR A 173
HIS A 176
GLU A 177
HIS A 180
HIS A 186
THR  A 173 ( 0.8A)
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.33A 3hy7B-5d7wA:
7.6
3hy7B-5d7wA:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3I9J_B_NCAB302_0
(ADP-RIBOSYL CYCLASE)
2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1

(Homo
sapiens)
4 / 6 LEU A  67
GLU A 251
SER A  52
PHE A  65
LEU  A  67 (-0.6A)
GLU  A 251 ( 0.6A)
SER  A  52 ( 0.0A)
PHE  A  65 ( 1.3A)
1.28A 3i9jB-2b92A:
3.2
3i9jB-2b92A:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3I9J_B_NCAB302_0
(ADP-RIBOSYL CYCLASE)
4hne PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA

(Homo
sapiens)
4 / 6 GLU A 157
ASN A 187
SER A 259
PHE A 151
GLU  A 157 ( 0.5A)
ASN  A 187 ( 0.6A)
SER  A 259 ( 0.0A)
PHE  A 151 ( 1.3A)
1.49A 3i9jB-4hneA:
undetectable
3i9jB-4hneA:
20.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK6_B_HCZB262_1
(GLUTAMATE RECEPTOR 2)
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus
musculus;
Rattus
norvegicus)
6 / 10 ILE A 481
PRO A 494
SER A 497
SER A 729
LYS A 730
GLY A 731
None
CYZ  A1302 (-4.5A)
CYZ  A1302 (-3.2A)
None
GLU  A1301 ( 3.7A)
None
0.60A 3ik6B-5weoA:
25.3
3ik6E-5weoA:
25.2
3ik6B-5weoA:
66.93
3ik6E-5weoA:
66.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IK6_B_HCZB800_1
(GLUTAMATE RECEPTOR 2)
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus
musculus;
Rattus
norvegicus)
6 / 10 ILE A 481
PRO A 494
SER A 497
SER A 729
LYS A 730
GLY A 731
None
CYZ  A1302 (-4.5A)
CYZ  A1302 (-3.2A)
None
GLU  A1301 ( 3.7A)
None
0.69A 3ik6B-5weoA:
25.3
3ik6E-5weoA:
25.2
3ik6B-5weoA:
66.93
3ik6E-5weoA:
66.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ILU_E_HFZE800_1
(GLUTAMATE RECEPTOR 2)
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus
musculus;
Rattus
norvegicus)
6 / 11 ILE A 481
PRO A 494
SER A 497
SER A 729
LYS A 730
GLY A 731
None
CYZ  A1302 (-4.5A)
CYZ  A1302 (-3.2A)
None
GLU  A1301 ( 3.7A)
None
0.68A 3iluB-5weoA:
25.3
3iluE-5weoA:
25.2
3iluB-5weoA:
66.93
3iluE-5weoA:
66.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JB2_A_SAMA1101_0
(STRUCTURAL PROTEIN
VP3)
2qc5 STREPTOGRAMIN B
LACTONASE

(Staphylococcus
cohnii)
5 / 12 ASN A 138
SER A 141
GLU A 175
PRO A 137
GLU A 217
ASN  A 138 ( 0.6A)
SER  A 141 ( 0.0A)
GLU  A 175 ( 0.6A)
PRO  A 137 ( 1.1A)
GLU  A 217 ( 0.6A)
1.46A 3jb2A-2qc5A:
undetectable
3jb2A-2qc5A:
14.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 3jt3A-5bs1A:
undetectable
3jt3B-5bs1A:
undetectable
3jt3A-5bs1A:
14.45
3jt3B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3jt5A-5bs1A:
undetectable
3jt5B-5bs1A:
undetectable
3jt5A-5bs1A:
14.45
3jt5B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT8_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3jt8A-5bs1A:
undetectable
3jt8B-5bs1A:
undetectable
3jt8A-5bs1A:
14.45
3jt8B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT8_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3jt8A-5bs1A:
undetectable
3jt8B-5bs1A:
undetectable
3jt8A-5bs1A:
14.45
3jt8B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWS_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3jwsA-5bs1A:
undetectable
3jwsB-5bs1A:
undetectable
3jwsA-5bs1A:
14.45
3jwsB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWS_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3jwsA-5bs1A:
undetectable
3jwsB-5bs1A:
undetectable
3jwsA-5bs1A:
14.45
3jwsB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3jwtA-5bs1A:
undetectable
3jwtB-5bs1A:
undetectable
3jwtA-5bs1A:
14.45
3jwtB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWU_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3jwuA-5bs1A:
undetectable
3jwuB-5bs1A:
undetectable
3jwuA-5bs1A:
14.45
3jwuB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3jwuA-5bs1A:
undetectable
3jwuB-5bs1A:
undetectable
3jwuA-5bs1A:
14.45
3jwuB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 3jwvA-5bs1A:
undetectable
3jwvB-5bs1A:
undetectable
3jwvA-5bs1A:
14.45
3jwvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JWV_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3jwvA-5bs1A:
undetectable
3jwvB-5bs1A:
undetectable
3jwvA-5bs1A:
14.45
3jwvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 3jx0A-5bs1A:
undetectable
3jx0B-5bs1A:
undetectable
3jx0A-5bs1A:
14.45
3jx0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX1_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5l5n PLEXIN-A4
(Mus
musculus)
4 / 8 GLU A 498
SER A 497
ARG A 430
VAL A 480
GLU  A 498 ( 0.5A)
SER  A 497 ( 0.0A)
ARG  A 430 ( 0.6A)
VAL  A 480 ( 0.6A)
1.33A 3jx1A-5l5nA:
undetectable
3jx1B-5l5nA:
undetectable
3jx1A-5l5nA:
16.53
3jx1B-5l5nA:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_A_THHA642_0
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
5 / 12 GLU A 292
GLY A 293
ASP A 318
VAL A 205
GLY A 163
None
None
GLU  A 701 (-3.0A)
None
None
1.12A 3k13A-1ewkA:
undetectable
3k13A-1ewkA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_A_THHA642_0
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
5 / 12 GLU A 279
GLY A 280
ASP A 305
VAL A 192
GLY A 150
None
None
GLU  A 506 (-2.7A)
None
None
1.11A 3k13A-3lmkA:
undetectable
3k13A-3lmkA:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_A_THHA642_1
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
2qm6 GAMMA-GLUTAMYLTRANSP
EPTIDASE

(Helicobacter
pylori)
3 / 3 ASN B 418
ASP B 422
ARG B 513
None
GLU  B   1 (-2.9A)
None
0.84A 3k13A-2qm6B:
undetectable
3k13A-2qm6B:
22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_B_THHB643_0
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
5 / 12 GLU A 292
GLY A 293
ASP A 318
VAL A 205
GLY A 163
None
None
GLU  A 701 (-3.0A)
None
None
1.14A 3k13B-1ewkA:
undetectable
3k13B-1ewkA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_B_THHB643_0
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
5 / 12 GLU A 279
GLY A 280
ASP A 305
VAL A 192
GLY A 150
None
None
GLU  A 506 (-2.7A)
None
None
1.13A 3k13B-3lmkA:
undetectable
3k13B-3lmkA:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_C_THHC643_0
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
5 / 12 GLU A 292
GLY A 293
ASP A 318
VAL A 205
GLY A 163
None
None
GLU  A 701 (-3.0A)
None
None
1.15A 3k13C-1ewkA:
undetectable
3k13C-1ewkA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K13_C_THHC643_0
(5-METHYLTETRAHYDROFO
LATE-HOMOCYSTEINE
METHYLTRANSFERASE)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
5 / 12 GLU A 279
GLY A 280
ASP A 305
VAL A 192
GLY A 150
None
None
GLU  A 506 (-2.7A)
None
None
1.14A 3k13C-3lmkA:
undetectable
3k13C-3lmkA:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K37_B_BCZB468_1
(NEURAMINIDASE)
5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN

(Vibrio
vulnificus)
3 / 3 ARG A3933
GLU A3821
TYR A3833
ARG  A3933 ( 0.6A)
GLU  A3821 ( 0.6A)
TYR  A3833 ( 1.3A)
0.94A 3k37B-5w6lA:
undetectable
3k37B-5w6lA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)
4bwi PHYTOCHROME-LIKE
PROTEIN CPH2

(Synechocystis
sp.)
4 / 6 LEU A 153
VAL A  30
ILE A  46
MET A  94
GLU  A1427 ( 4.9A)
None
None
None
1.16A 3k5vA-4bwiA:
undetectable
3k5vA-4bwiA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_B_STIB2_1
(TYROSINE-PROTEIN
KINASE ABL1)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
6 / 12 VAL A  39
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
0.78A 3k5vB-5d7aA:
23.7
3k5vB-5d7aA:
25.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K9F_H_LFXH0_1
(DNA TOPOISOMERASE 4
SUBUNIT A
DNA TOPOISOMERASE 4
SUBUNIT B)
3cbt PHOSPHATASE SC4828
(Streptomyces
coelicolor)
4 / 6 ARG A 110
GLY A 112
GLU A 197
GLU A 113
ARG  A 110 (-0.6A)
GLY  A 112 ( 0.0A)
GLU  A 197 ( 0.6A)
GLU  A 113 (-0.5A)
1.12A 3k9fA-3cbtA:
undetectable
3k9fB-3cbtA:
undetectable
3k9fD-3cbtA:
undetectable
3k9fA-3cbtA:
17.64
3k9fB-3cbtA:
17.64
3k9fD-3cbtA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KEC_A_HAEA272_1
(COLLAGENASE 3)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.28A 3kecA-5d7wA:
14.6
3kecA-5d7wA:
16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KKZ_A_SAMA301_0
(UNCHARACTERIZED
PROTEIN Q5LES9)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
5 / 12 GLN A  78
GLY A 140
GLY A 142
ALA A  62
ASN A  65
GLU  A1313 (-3.7A)
None
GLU  A1313 (-3.5A)
None
None
1.07A 3kkzA-1us4A:
undetectable
3kkzA-1us4A:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KKZ_B_SAMB302_0
(UNCHARACTERIZED
PROTEIN Q5LES9)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
5 / 12 GLN A  78
GLY A 140
GLY A 142
ALA A  62
ASN A  65
GLU  A1313 (-3.7A)
None
GLU  A1313 (-3.5A)
None
None
1.07A 3kkzB-1us4A:
undetectable
3kkzB-1us4A:
20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_B_TFPB202_1
(PROTEIN S100-A4)
2j5b TYROSYL-TRNA
SYNTHETASE

(Acanthamoeba
polyphaga
mimivirus)
3 / 3 GLU A 125
LEU A 128
ASP A 129
GLU  A 125 ( 0.6A)
LEU  A 128 ( 0.6A)
ASP  A 129 ( 0.6A)
0.31A 3ko0A-2j5bA:
undetectable
3ko0A-2j5bA:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KO0_S_TFPS202_2
(PROTEIN S100-A4)
2j5b TYROSYL-TRNA
SYNTHETASE

(Acanthamoeba
polyphaga
mimivirus)
3 / 3 GLU A 125
LEU A 128
ASP A 129
GLU  A 125 ( 0.6A)
LEU  A 128 ( 0.6A)
ASP  A 129 ( 0.6A)
0.24A 3ko0T-2j5bA:
undetectable
3ko0T-2j5bA:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KP5_A_KANA2001_1
(TRANSCRIPTIONAL
REGULATOR TCAR)
3gnr OS03G0212800 PROTEIN
(Oryza
sativa)
5 / 11 VAL A 128
ALA A 118
GLU A  73
ASN A 113
ARG A 169
VAL  A 128 ( 0.6A)
ALA  A 118 ( 0.0A)
GLU  A  73 ( 0.5A)
ASN  A 113 ( 0.6A)
ARG  A 169 ( 0.6A)
1.41A 3kp5A-3gnrA:
undetectable
3kp5A-3gnrA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPD_B_SAMB1000_1
(UNCHARACTERIZED
PROTEIN MJ0100)
5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6

(Rattus
norvegicus)
3 / 3 ASN A  57
ASN A  91
GLU A  93
ASN  A  57 ( 0.6A)
ASN  A  91 ( 0.6A)
GLU  A  93 ( 0.6A)
0.88A 3kpdC-5wo6A:
undetectable
3kpdC-5wo6A:
9.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPD_C_SAMC1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)
1l4a S-SNAP25 FUSION
PROTEIN
S-SNAP25 FUSION
PROTEIN

(Doryteuthis
pealeii;
Doryteuthis
pealeii)
3 / 3 ASN C  37
ASN D 156
GLU D 159
ASN  C  37 ( 0.6A)
ASN  D 156 ( 0.6A)
GLU  D 159 ( 0.6A)
0.91A 3kpdB-1l4aC:
undetectable
3kpdB-1l4aC:
18.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KW2_A_ADNA300_1
(PROBABLE R-RNA
METHYLTRANSFERASE)
4pe5 GLUTAMATE RECEPTOR
IONOTROPIC, NMDA 2B

(Rattus
norvegicus)
5 / 11 VAL B 409
ILE B 498
GLY B 499
LEU B 513
ALA B 765
None
None
None
GLU  B 921 (-4.5A)
None
1.22A 3kw2A-4pe5B:
4.7
3kw2A-4pe5B:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KW4_A_TICA600_1
(CYTOCHROME P450 2B4)
1txu RAB5 GDP/GTP
EXCHANGE FACTOR

(Homo
sapiens)
5 / 11 ILE A 175
SER A 174
PHE A 341
ALA A 182
GLU A 180
ILE  A 175 ( 0.3A)
SER  A 174 ( 0.0A)
PHE  A 341 ( 1.3A)
ALA  A 182 ( 0.0A)
GLU  A 180 ( 0.5A)
0.95A 3kw4A-1txuA:
undetectable
3kw4A-1txuA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LFA_A_1N1A361_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
5 / 8 VAL A  31
ALA A  52
LYS A  54
GLU A  69
LEU A 103
VAL  A  31 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A 103 ( 0.6A)
0.57A 3lfaA-5d7aA:
22.0
3lfaA-5d7aA:
24.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LIK_A_HAEA302_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.30A 3likA-5d7wA:
14.3
3likA-5d7wA:
26.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LIL_A_HAEA302_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.31A 3lilA-5d7wA:
14.3
3lilA-5d7wA:
26.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LJG_A_HAEA301_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.34A 3ljgA-5d7wA:
14.3
3ljgA-5d7wA:
26.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LKA_A_HAEA269_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.31A 3lkaA-5d7wA:
14.2
3lkaA-5d7wA:
26.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LP9_D_SPMD230_1
(LS-24)
3iha SALT-TOLERANT
GLUTAMINASE

(Micrococcus
luteus)
3 / 3 GLU A  94
GLU A 160
ASN A 167
None
GLU  A 500 (-3.7A)
GLU  A 500 (-3.6A)
0.91A 3lp9B-3ihaA:
undetectable
3lp9D-3ihaA:
undetectable
3lp9B-3ihaA:
18.24
3lp9D-3ihaA:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3M7R_A_VDXA425_1
(VITAMIN D3 RECEPTOR)
5ict GLUTAMATE RECEPTOR 1
(Drosophila
melanogaster)
5 / 12 LEU A  60
VAL A  61
SER A  12
SER A  94
LEU A 144
None
None
None
None
GLU  A 301 ( 3.8A)
1.22A 3m7rA-5ictA:
undetectable
3m7rA-5ictA:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MB5_A_SAMA301_1
(SAM-DEPENDENT
METHYLTRANSFERASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
4 / 4 GLY A 539
GLU A 140
ASP A 535
ASP A 540
GLY  A 539 ( 0.0A)
GLU  A 140 ( 0.6A)
ASP  A 535 ( 0.6A)
ASP  A 540 ( 0.5A)
1.26A 3mb5A-5gprA:
undetectable
3mb5A-5gprA:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MJR_A_AC2A301_1
(DEOXYCYTIDINE KINASE)
5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus)
5 / 9 ILE A 458
GLU A 472
ARG A 137
ASP A 138
LEU A 455
ILE  A 458 ( 0.6A)
GLU  A 472 ( 0.6A)
ARG  A 137 ( 0.6A)
ASP  A 138 ( 0.6A)
LEU  A 455 ( 0.6A)
1.44A 3mjrA-5cdnA:
undetectable
3mjrA-5cdnA:
19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N2R_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3n2rA-5bs1A:
undetectable
3n2rB-5bs1A:
undetectable
3n2rA-5bs1A:
14.45
3n2rB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N3I_A_ROCA201_2
(PROTEASE)
1xov PLY PROTEIN
(Listeria
virus
PSA)
4 / 6 ILE A  49
ASP A  19
GLY A  16
VAL A 142
None
None
GLU  A2001 ( 3.7A)
None
0.94A 3n3iA-1xovA:
undetectable
3n3iA-1xovA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N58_C_ADNC500_2
(ADENOSYLHOMOCYSTEINA
SE)
3rab PROTEIN (RAB3A)
(Rattus
norvegicus)
4 / 5 LEU A 131
GLN A 174
THR A 175
GLU A 160
LEU  A 131 ( 0.6A)
GLN  A 174 ( 0.6A)
THR  A 175 ( 0.8A)
GLU  A 160 ( 0.5A)
1.12A 3n58C-3rabA:
2.9
3n58C-3rabA:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Y_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 3n5yA-5bs1A:
undetectable
3n5yB-5bs1A:
undetectable
3n5yA-5bs1A:
14.45
3n5yB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Z_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3n5zA-5bs1A:
undetectable
3n5zB-5bs1A:
undetectable
3n5zA-5bs1A:
14.45
3n5zB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDI_A_SAMA601_0
(METHYLTRANSFERASE)
5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM

(Homo
sapiens)
5 / 12 PHE A 246
GLU A 226
ILE A 227
ALA A 222
ILE A 204
PHE  A 246 ( 1.3A)
GLU  A 226 ( 0.5A)
ILE  A 227 ( 0.6A)
ALA  A 222 ( 0.0A)
ILE  A 204 ( 0.7A)
1.26A 3ndiA-5jjaA:
undetectable
3ndiA-5jjaA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLJ_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 3nljA-5bs1A:
undetectable
3nljB-5bs1A:
undetectable
3nljA-5bs1A:
15.01
3nljB-5bs1A:
15.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLK_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3nlkA-5bs1A:
undetectable
3nlkB-5bs1A:
undetectable
3nlkA-5bs1A:
14.45
3nlkB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLK_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 3nlkA-5bs1A:
undetectable
3nlkB-5bs1A:
undetectable
3nlkA-5bs1A:
14.45
3nlkB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3nlmA-5bs1A:
undetectable
3nlmB-5bs1A:
undetectable
3nlmA-5bs1A:
14.45
3nlmB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 3nlnA-5bs1A:
undetectable
3nlnB-5bs1A:
undetectable
3nlnA-5bs1A:
14.45
3nlnB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3nlvA-5bs1A:
undetectable
3nlvB-5bs1A:
undetectable
3nlvA-5bs1A:
14.45
3nlvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3nlwA-5bs1A:
undetectable
3nlwB-5bs1A:
undetectable
3nlwA-5bs1A:
14.45
3nlwB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLX_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3nlxA-5bs1A:
undetectable
3nlxB-5bs1A:
undetectable
3nlxA-5bs1A:
14.45
3nlxB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLX_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 3nlxA-5bs1A:
undetectable
3nlxB-5bs1A:
undetectable
3nlxA-5bs1A:
14.45
3nlxB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLY_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 3nlyA-5bs1A:
undetectable
3nlyB-5bs1A:
undetectable
3nlyA-5bs1A:
14.45
3nlyB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NM0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3nm0A-5bs1A:
undetectable
3nm0B-5bs1A:
undetectable
3nm0A-5bs1A:
14.45
3nm0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NM0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3nm0A-5bs1A:
undetectable
3nm0B-5bs1A:
undetectable
3nm0A-5bs1A:
14.45
3nm0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNY_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 3nnyA-5bs1A:
undetectable
3nnyB-5bs1A:
undetectable
3nnyA-5bs1A:
14.45
3nnyB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNY_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3nnyA-5bs1A:
undetectable
3nnyB-5bs1A:
undetectable
3nnyA-5bs1A:
14.45
3nnyB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNZ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3nnzA-5bs1A:
undetectable
3nnzB-5bs1A:
undetectable
3nnzA-5bs1A:
14.45
3nnzB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NS1_C_PM6C1_1
(XANTHINE
DEHYDROGENASE/OXIDAS
E)
2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE

(Lactococcus
lactis)
4 / 6 GLU A 156
ARG A 148
ALA A 132
ALA A 133
GLU  A 156 ( 0.6A)
ARG  A 148 ( 0.6A)
ALA  A 132 ( 0.0A)
ALA  A 133 ( 0.0A)
1.09A 3ns1C-2vbfA:
undetectable
3ns1C-2vbfA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O94_A_NCAA192_0
(NICOTINAMIDASE)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
5 / 11 ASP A  14
GLU A  63
LEU A  18
ILE A  90
SER A  16
ASP  A  14 ( 0.6A)
GLU  A  63 ( 0.6A)
LEU  A  18 ( 0.6A)
ILE  A  90 ( 0.7A)
SER  A  16 ( 0.0A)
1.21A 3o94A-5d7aA:
undetectable
3o94A-5d7aA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O94_B_NCAB192_0
(NICOTINAMIDASE)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
5 / 11 ASP A  14
GLU A  63
LEU A  18
ILE A  90
SER A  16
ASP  A  14 ( 0.6A)
GLU  A  63 ( 0.6A)
LEU  A  18 ( 0.6A)
ILE  A  90 ( 0.7A)
SER  A  16 ( 0.0A)
1.22A 3o94B-5d7aA:
undetectable
3o94B-5d7aA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O94_C_NCAC192_0
(NICOTINAMIDASE)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
5 / 11 ASP A  14
GLU A  63
LEU A  18
ILE A  90
SER A  16
ASP  A  14 ( 0.6A)
GLU  A  63 ( 0.6A)
LEU  A  18 ( 0.6A)
ILE  A  90 ( 0.7A)
SER  A  16 ( 0.0A)
1.21A 3o94C-5d7aA:
undetectable
3o94C-5d7aA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3O94_D_NCAD192_0
(NICOTINAMIDASE)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
5 / 11 ASP A  14
GLU A  63
LEU A  18
ILE A  90
SER A  16
ASP  A  14 ( 0.6A)
GLU  A  63 ( 0.6A)
LEU  A  18 ( 0.6A)
ILE  A  90 ( 0.7A)
SER  A  16 ( 0.0A)
1.21A 3o94D-5d7aA:
undetectable
3o94D-5d7aA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_A_1N1A1000_2
(P38A)
1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE

(Escherichia
coli)
3 / 3 GLU A 236
LEU A  30
LEU A  23
GLU  A 236 ( 0.6A)
LEU  A  30 ( 0.6A)
LEU  A  23 ( 0.6A)
0.70A 3ohtA-1fxjA:
undetectable
3ohtA-1fxjA:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B1000_2
(P38A)
1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE

(Escherichia
coli)
3 / 3 GLU A 236
LEU A  30
LEU A  23
GLU  A 236 ( 0.6A)
LEU  A  30 ( 0.6A)
LEU  A  23 ( 0.6A)
0.67A 3ohtB-1fxjA:
undetectable
3ohtB-1fxjA:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OLS_B_ESTB600_1
(ESTROGEN RECEPTOR
BETA)
3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE

(Citrus
x
microcarpa)
5 / 12 LEU A 222
ALA A 113
GLU A 116
ARG A 234
LEU A 187
LEU  A 222 ( 0.6A)
ALA  A 113 ( 0.0A)
GLU  A 116 ( 0.5A)
ARG  A 234 ( 0.6A)
LEU  A 187 ( 0.5A)
1.17A 3olsB-3wd7A:
undetectable
3olsB-3wd7A:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OU6_D_SAMD300_0
(SAM-DEPENDENT
METHYLTRANSFERASE)
5hfi UNCHARACTERIZED
PROTEIN, CYTOSOLIC
DISULFIDE REDUCTASE
DSBM

(Pseudomonas
aeruginosa)
5 / 12 TYR A   8
GLU A  29
ALA A  27
LEU A 207
TRP A 203
TYR  A   8 ( 1.3A)
GLU  A  29 ( 0.6A)
ALA  A  27 ( 0.0A)
LEU  A 207 ( 0.6A)
TRP  A 203 ( 0.5A)
1.41A 3ou6D-5hfiA:
undetectable
3ou6D-5hfiA:
25.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P2K_A_SAMA6735_1
(16S RRNA METHYLASE)
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
3 / 3 ASP A 372
GLU A  69
SER A 189
ASP  A 372 ( 0.6A)
GLU  A  69 ( 0.5A)
SER  A 189 ( 0.0A)
0.70A 3p2kA-4mwtA:
undetectable
3p2kA-4mwtA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3P2K_C_SAMC6735_1
(16S RRNA METHYLASE)
5ve2 ENOYL-COA HYDRATASE
(Pseudoalteromona
s
atlantica)
4 / 5 ASN A  43
GLU A 137
THR A 109
SER A  42
ASN  A  43 ( 0.6A)
GLU  A 137 ( 0.6A)
THR  A 109 ( 0.8A)
SER  A  42 (-0.0A)
1.14A 3p2kC-5ve2A:
undetectable
3p2kC-5ve2A:
24.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PFG_A_SAMA264_1
(N-METHYLTRANSFERASE)
2ywy NEW ANTIGEN RECEPTOR
VARIABLE DOMAIN

(Orectolobus
maculatus)
3 / 3 TYR A  86
TYR A  37
GLU A 101
TYR  A  86 ( 1.3A)
TYR  A  37 ( 1.3A)
GLU  A 101 ( 0.6A)
0.85A 3pfgA-2ywyA:
undetectable
3pfgA-2ywyA:
17.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PGY_A_GLYA510_0
(SERINE
HYDROXYMETHYLTRANSFE
RASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 6 GLU A 383
ILE A 382
PHE A 373
ALA A 386
GLU  A 383 ( 0.6A)
ILE  A 382 ( 0.7A)
PHE  A 373 ( 1.3A)
ALA  A 386 ( 0.0A)
1.06A 3pgyA-3ulkA:
3.5
3pgyB-3ulkA:
3.6
3pgyA-3ulkA:
23.61
3pgyB-3ulkA:
23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNF_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3pnfA-5bs1A:
undetectable
3pnfB-5bs1A:
undetectable
3pnfA-5bs1A:
14.45
3pnfB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_A_STIA3_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
6 / 12 VAL A  39
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
0.84A 3pyyA-5d7aA:
23.9
3pyyA-5d7aA:
25.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_A_STIA3_2
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)
1t2w SORTASE
(Staphylococcus
aureus)
4 / 6 TYR A 153
VAL A  87
ILE A  83
ARG A 197
None
None
None
GLU  A 333 ( 3.8A)
0.92A 3pyyA-1t2wA:
undetectable
3pyyA-1t2wA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q99_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 3q99A-5bs1A:
undetectable
3q99B-5bs1A:
undetectable
3q99A-5bs1A:
14.45
3q99B-5bs1A:
14.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R43_A_ID8A332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
5 / 12 TYR A  53
TRP A  80
HIS A 111
ASN A 141
PHE A 276
GLU  A 301 (-4.4A)
None
GLU  A 301 (-3.8A)
GLU  A 301 (-3.7A)
None
0.63A 3r43A-4fziA:
36.9
3r43A-4fziA:
35.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R6I_A_JMSA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
5 / 12 TYR A  53
TRP A  80
HIS A 111
ASN A 141
PHE A 276
GLU  A 301 (-4.4A)
None
GLU  A 301 (-3.8A)
GLU  A 301 (-3.7A)
None
0.67A 3r6iA-4fziA:
37.1
3r6iA-4fziA:
35.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R75_A_BEZA701_0
(ANTHRANILATE/PARA-AM
INOBENZOATE
SYNTHASES COMPONENT
I)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
5 / 12 GLU A 182
SER A 119
GLY A 118
THR A 115
GLU A 134
None
GLU  A1620 (-4.7A)
None
None
None
1.48A 3r75A-2pyyA:
undetectable
3r75A-2pyyA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R75_A_BEZA701_0
(ANTHRANILATE/PARA-AM
INOBENZOATE
SYNTHASES COMPONENT
I)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
5 / 12 ILE A  69
SER A  70
GLU A 182
SER A 119
THR A 120
GLU  A1620 (-4.9A)
GLU  A1620 (-2.9A)
None
GLU  A1620 (-4.7A)
GLU  A1620 (-3.4A)
1.41A 3r75A-2pyyA:
undetectable
3r75A-2pyyA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R75_B_BEZB701_0
(ANTHRANILATE/PARA-AM
INOBENZOATE
SYNTHASES COMPONENT
I)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
5 / 12 GLU A 182
SER A 119
GLY A 118
THR A 115
GLU A 134
None
GLU  A1620 (-4.7A)
None
None
None
1.50A 3r75B-2pyyA:
undetectable
3r75B-2pyyA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R75_B_BEZB701_0
(ANTHRANILATE/PARA-AM
INOBENZOATE
SYNTHASES COMPONENT
I)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
5 / 12 ILE A  69
SER A  70
GLU A 182
SER A 119
THR A 120
GLU  A1620 (-4.9A)
GLU  A1620 (-2.9A)
None
GLU  A1620 (-4.7A)
GLU  A1620 (-3.4A)
1.41A 3r75B-2pyyA:
undetectable
3r75B-2pyyA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R76_A_BEZA701_0
(ANTHRANILATE/PARA-AM
INOBENZOATE
SYNTHASES COMPONENT
I)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
5 / 11 GLU A 182
SER A 119
GLY A 118
THR A 115
GLU A 134
None
GLU  A1620 (-4.7A)
None
None
None
1.45A 3r76A-2pyyA:
2.2
3r76A-2pyyA:
16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R76_B_BEZB701_0
(ANTHRANILATE/PARA-AM
INOBENZOATE
SYNTHASES COMPONENT
I)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
5 / 11 GLU A 182
SER A 119
GLY A 118
THR A 115
GLU A 134
None
GLU  A1620 (-4.7A)
None
None
None
1.46A 3r76B-2pyyA:
2.3
3r76B-2pyyA:
16.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R7M_A_SUZA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
5 / 10 TYR A  53
TRP A  80
HIS A 111
ASN A 141
PHE A 276
GLU  A 301 (-4.4A)
None
GLU  A 301 (-3.8A)
GLU  A 301 (-3.7A)
None
0.64A 3r7mA-4fziA:
37.0
3r7mA-4fziA:
35.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RAE_F_LFXF101_1
(DNA TOPOISOMERASE 4
SUBUNIT A
DNA TOPOISOMERASE 4
SUBUNIT B)
3icc PUTATIVE
3-OXOACYL-(ACYL
CARRIER PROTEIN)
REDUCTASE

(Bacillus
anthracis)
3 / 4 SER A 145
GLY A 101
GLU A 105
SER  A 145 (-0.0A)
GLY  A 101 ( 0.0A)
GLU  A 105 ( 0.6A)
0.49A 3raeA-3iccA:
undetectable
3raeC-3iccA:
3.0
3raeA-3iccA:
20.69
3raeC-3iccA:
24.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ROP_A_NCAA302_0
(ADP-RIBOSYL CYCLASE
1)
2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1

(Homo
sapiens)
4 / 6 LEU A  67
GLU A 251
SER A  52
THR A  75
LEU  A  67 (-0.6A)
GLU  A 251 ( 0.6A)
SER  A  52 ( 0.0A)
THR  A  75 ( 0.8A)
1.40A 3ropA-2b92A:
4.0
3ropA-2b92A:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ROZ_A_NCAA266_0
(APOLIPOPROTEIN
A-I-BINDING PROTEIN)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
4 / 6 ASP A 305
LEU A 329
ALA A 171
THR A 175
GLU  A 506 (-2.7A)
None
None
GLU  A 506 (-3.0A)
1.12A 3rozA-3lmkA:
4.8
3rozA-3lmkA:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3rqmA-5bs1A:
undetectable
3rqmB-5bs1A:
undetectable
3rqmA-5bs1A:
14.45
3rqmB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 3rqnA-5bs1A:
undetectable
3rqnB-5bs1A:
undetectable
3rqnA-5bs1A:
14.45
3rqnB-5bs1A:
14.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S3G_A_TLTA317_1
(ALDOSE REDUCTASE)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
4 / 7 TRP A  24
TYR A  53
HIS A 111
PHE A 276
GLU  A 301 (-3.5A)
GLU  A 301 (-4.4A)
GLU  A 301 (-3.8A)
None
1.22A 3s3gA-4fziA:
37.3
3s3gA-4fziA:
39.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S3G_A_TLTA317_1
(ALDOSE REDUCTASE)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
4 / 7 TRP A  24
TYR A  53
HIS A 111
TRP A 112
GLU  A 301 (-3.5A)
GLU  A 301 (-4.4A)
GLU  A 301 (-3.8A)
GLU  A 301 (-4.1A)
0.40A 3s3gA-4fziA:
37.3
3s3gA-4fziA:
39.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SI7_B_ACTB4_0
(CYSTIC FIBROSIS
TRANSMEMBRANE
CONDUCTANCE
REGULATOR)
2zns GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 1

(Homo
sapiens)
3 / 3 GLY A 475
GLY A 673
THR A 677
None
GLU  A 301 (-3.2A)
None
0.41A 3si7B-2znsA:
undetectable
3si7B-2znsA:
21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SU9_A_ACTA426_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)
4dlk PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE, ATPASE
SUBUNIT

(Bacillus
anthracis)
3 / 3 GLN A 158
GLU A 182
LYS A 147
GLN  A 158 (-0.6A)
GLU  A 182 (-0.6A)
LYS  A 147 (-0.0A)
1.18A 3su9A-4dlkA:
undetectable
3su9A-4dlkA:
22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SXJ_A_SAMA258_0
(PUTATIVE
METHYLTRANSFERASE)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
5 / 12 GLN A  78
GLY A 140
GLY A 142
ALA A  62
ASN A  65
GLU  A1313 (-3.7A)
None
GLU  A1313 (-3.5A)
None
None
1.15A 3sxjA-1us4A:
undetectable
3sxjA-1us4A:
23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SXJ_B_SAMB258_0
(PUTATIVE
METHYLTRANSFERASE)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
5 / 12 GLN A  78
GLY A 140
GLY A 142
ALA A  62
ASN A  65
GLU  A1313 (-3.7A)
None
GLU  A1313 (-3.5A)
None
None
1.15A 3sxjB-1us4A:
undetectable
3sxjB-1us4A:
23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T7S_B_SAMB300_0
(PUTATIVE
METHYLTRANSFERASE)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
5 / 12 GLN A  78
GLY A 140
GLY A 142
ALA A  62
ASN A  65
GLU  A1313 (-3.7A)
None
GLU  A1313 (-3.5A)
None
None
1.12A 3t7sB-1us4A:
undetectable
3t7sB-1us4A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T7S_D_SAMD300_0
(PUTATIVE
METHYLTRANSFERASE)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
5 / 12 GLN A  78
GLY A 140
GLY A 142
ALA A  62
ASN A  65
GLU  A1313 (-3.7A)
None
GLU  A1313 (-3.5A)
None
None
1.12A 3t7sD-1us4A:
undetectable
3t7sD-1us4A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TGV_B_BEZB160_0
(HEME-BINDING PROTEIN
HUTZ)
5gru DIABODY PROTEIN
(Homo
sapiens)
4 / 4 LEU H 149
GLY H 150
LEU H 212
GLU H 213
LEU  H 149 ( 0.6A)
GLY  H 150 ( 0.0A)
LEU  H 212 ( 0.6A)
GLU  H 213 ( 0.6A)
0.95A 3tgvB-5gruH:
undetectable
3tgvB-5gruH:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TKA_A_SAMA400_0
(RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE H)
2qvs CAMP-DEPENDENT
PROTEIN KINASE TYPE
II-ALPHA REGULATORY
SUBUNIT

(Mus
musculus)
5 / 12 GLY B 349
GLY B 300
ARG B 283
SER B 303
GLU B 289
GLY  B 349 ( 0.0A)
GLY  B 300 ( 0.0A)
ARG  B 283 ( 0.6A)
SER  B 303 ( 0.0A)
GLU  B 289 ( 0.6A)
1.38A 3tkaA-2qvsB:
undetectable
3tkaA-2qvsB:
21.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKD_A_CYZA266_2
(GLUTAMATE RECEPTOR 2)
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus
musculus;
Rattus
norvegicus)
5 / 5 ILE A 481
PRO A 494
SER A 729
LYS A 730
GLY A 731
None
CYZ  A1302 (-4.5A)
None
GLU  A1301 ( 3.7A)
None
0.61A 3tkdB-5weoA:
24.5
3tkdB-5weoA:
33.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKD_B_CYZB267_1
(GLUTAMATE RECEPTOR 2)
5weo GLUTAMATE RECEPTOR
2,VOLTAGE-DEPENDENT
CALCIUM CHANNEL
GAMMA-2 SUBUNIT
CHIMERA

(Mus
musculus;
Rattus
norvegicus)
5 / 5 ILE A 481
PRO A 494
SER A 729
LYS A 730
GLY A 731
None
CYZ  A1302 (-4.5A)
None
GLU  A1301 ( 3.7A)
None
0.59A 3tkdA-5weoA:
25.4
3tkdA-5weoA:
33.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TM4_A_SAMA401_1
(TRNA (GUANINE
N2-)-METHYLTRANSFERA
SE TRM14)
3kqg C-TYPE LECTIN DOMAIN
FAMILY 4 MEMBER K

(Homo
sapiens)
4 / 5 SER A 218
THR A 215
GLU A 220
ASP A 269
SER  A 218 ( 0.0A)
THR  A 215 ( 0.8A)
GLU  A 220 ( 0.6A)
ASP  A 269 ( 0.5A)
1.34A 3tm4A-3kqgA:
undetectable
3tm4A-3kqgA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TM4_B_SAMB401_1
(TRNA (GUANINE
N2-)-METHYLTRANSFERA
SE TRM14)
3kqg C-TYPE LECTIN DOMAIN
FAMILY 4 MEMBER K

(Homo
sapiens)
4 / 5 SER A 218
THR A 215
GLU A 220
ASP A 269
SER  A 218 ( 0.0A)
THR  A 215 ( 0.8A)
GLU  A 220 ( 0.6A)
ASP  A 269 ( 0.5A)
1.35A 3tm4B-3kqgA:
undetectable
3tm4B-3kqgA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TMZ_A_06XA504_1
(CYTOCHROME P450 2B4)
2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE

(Lactococcus
lactis)
5 / 9 LEU A 359
LEU A 526
ILE A 498
GLU A 523
PHE A 505
LEU  A 359 ( 0.5A)
LEU  A 526 ( 0.5A)
ILE  A 498 ( 0.7A)
GLU  A 523 ( 0.5A)
PHE  A 505 ( 1.3A)
1.28A 3tmzA-2vbfA:
undetectable
3tmzA-2vbfA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYL_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3tylA-5bs1A:
undetectable
3tylB-5bs1A:
undetectable
3tylA-5bs1A:
14.45
3tylB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 3tymA-5bs1A:
undetectable
3tymB-5bs1A:
undetectable
3tymA-5bs1A:
14.45
3tymB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3tynA-5bs1A:
undetectable
3tynB-5bs1A:
undetectable
3tynA-5bs1A:
14.45
3tynB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 3tyoA-5bs1A:
undetectable
3tyoB-5bs1A:
undetectable
3tyoA-5bs1A:
14.45
3tyoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TZF_B_08DB280_1
(7,8-DIHYDROPTEROATE
SYNTHASE)
5wml -
(-)
4 / 8 THR A  84
GLY A 435
PHE A 438
SER A 418
GLU  A 502 (-3.5A)
None
None
None
1.03A 3tzfB-5wmlA:
undetectable
3tzfB-5wmlA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U40_E_ADNE251_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)
5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN

(Vibrio
vulnificus)
5 / 12 ARG A4001
GLY A3903
VAL A3901
GLU A3900
GLU A3930
ARG  A4001 ( 0.6A)
GLY  A3903 ( 0.0A)
VAL  A3901 ( 0.6A)
GLU  A3900 ( 0.6A)
GLU  A3930 ( 0.6A)
1.46A 3u40D-5w6lA:
undetectable
3u40E-5w6lA:
undetectable
3u40D-5w6lA:
17.41
3u40E-5w6lA:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAW_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.90A 3uawA-4g41A:
23.9
3uawA-4g41A:
25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAW_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.95A 3uawA-4g41A:
23.9
3uawA-4g41A:
25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAW_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.80A 3uawA-4g41A:
23.9
3uawA-4g41A:
25.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UAY_A_ADNA236_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.96A 3uayA-4g41A:
24.1
3uayA-4g41A:
25.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 3ufoA-5bs1A:
undetectable
3ufoB-5bs1A:
undetectable
3ufoA-5bs1A:
14.45
3ufoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.26A 3ufpA-5bs1A:
undetectable
3ufpB-5bs1A:
undetectable
3ufpA-5bs1A:
14.45
3ufpB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.33A 3ufpA-5bs1A:
undetectable
3ufpB-5bs1A:
undetectable
3ufpA-5bs1A:
14.45
3ufpB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 3ufqA-5bs1A:
undetectable
3ufqB-5bs1A:
undetectable
3ufqA-5bs1A:
14.45
3ufqB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 3ufrA-5bs1A:
undetectable
3ufrB-5bs1A:
undetectable
3ufrA-5bs1A:
14.45
3ufrB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 3ufrA-5bs1A:
undetectable
3ufrB-5bs1A:
undetectable
3ufrA-5bs1A:
14.45
3ufrB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFS_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 3ufsA-5bs1A:
undetectable
3ufsB-5bs1A:
undetectable
3ufsA-5bs1A:
14.45
3ufsB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFS_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 3ufsA-5bs1A:
undetectable
3ufsB-5bs1A:
undetectable
3ufsA-5bs1A:
14.45
3ufsB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFU_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 3ufuA-5bs1A:
undetectable
3ufuB-5bs1A:
undetectable
3ufuA-5bs1A:
14.45
3ufuB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFV_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 3ufvA-5bs1A:
undetectable
3ufvB-5bs1A:
undetectable
3ufvA-5bs1A:
14.45
3ufvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UFW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 3ufwA-5bs1A:
undetectable
3ufwB-5bs1A:
undetectable
3ufwA-5bs1A:
14.45
3ufwB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UVV_B_9CRB501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
5 / 12 ILE A 304
ALA A 308
ALA A 311
ILE A 298
LEU A 326
None
None
None
GLU  A2471 (-4.3A)
None
1.13A 3uvvB-1tkkA:
undetectable
3uvvB-1tkkA:
21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V1N_A_BEZA288_0
(2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
5 / 8 GLY A  30
GLY A 179
SER A 199
ILE A 193
LEU A 155
None
None
None
None
GLU  A1055 (-4.1A)
1.17A 3v1nA-2dvzA:
undetectable
3v1nA-2dvzA:
22.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3V35_A_NTIA317_1
(ALDOSE REDUCTASE)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
4 / 8 TRP A  24
TRP A  80
HIS A 111
TRP A 112
GLU  A 301 (-3.5A)
None
GLU  A 301 (-3.8A)
GLU  A 301 (-4.1A)
0.50A 3v35A-4fziA:
37.8
3v35A-4fziA:
39.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_A_ACTA503_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
3 / 3 ARG A 276
GLU A 263
THR A 260
ARG  A 276 ( 0.6A)
GLU  A 263 ( 0.6A)
THR  A 260 ( 0.8A)
0.79A 3v4tA-3ulkA:
undetectable
3v4tA-3ulkA:
24.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_A_ACTA505_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)
2vha PERIPLASMIC BINDING
TRANSPORT PROTEIN

(Shigella
flexneri)
3 / 3 THR A  92
ASN A  94
GLU A 209
GLU  A1280 (-4.0A)
None
None
0.82A 3v4tA-2vhaA:
undetectable
3v4tC-2vhaA:
undetectable
3v4tA-2vhaA:
21.36
3v4tC-2vhaA:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_A_ACTA505_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)
3h7a SHORT CHAIN
DEHYDROGENASE

(Rhodopseudomonas
palustris)
3 / 3 THR A  70
ASN A  74
GLU A 122
THR  A  70 ( 0.8A)
ASN  A  74 ( 0.6A)
GLU  A 122 ( 0.6A)
0.69A 3v4tA-3h7aA:
undetectable
3v4tC-3h7aA:
0.3
3v4tA-3h7aA:
20.29
3v4tC-3h7aA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V4T_C_ACTC502_0
(UDP-N-ACETYLGLUCOSAM
INE
1-CARBOXYVINYLTRANSF
ERASE)
5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE

(Bacillus
subtilis)
3 / 3 PRO A 105
ASP A 103
GLU A  75
PRO  A 105 ( 1.1A)
ASP  A 103 ( 0.6A)
GLU  A  75 ( 0.6A)
0.83A 3v4tC-5ep8A:
undetectable
3v4tC-5ep8A:
26.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VHU_A_SNLA1001_1
(MINERALOCORTICOID
RECEPTOR)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
5 / 12 MET A 282
LEU A 247
LEU A 297
THR A 125
PHE A  18
None
None
None
ALA  A 402 (-3.5A)
GLU  A 403 (-4.6A)
1.33A 3vhuA-4gfiA:
undetectable
3vhuA-4gfiA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VLN_A_ASCA904_0
(GLUTATHIONE
S-TRANSFERASE
OMEGA-1)
3i4k MUCONATE LACTONIZING
ENZYME

(Corynebacterium
glutamicum)
4 / 6 PHE A 331
LEU A 330
PRO A 333
GLU A 306
PHE  A 331 ( 1.3A)
LEU  A 330 ( 0.6A)
PRO  A 333 ( 1.1A)
GLU  A 306 ( 0.5A)
1.39A 3vlnA-3i4kA:
undetectable
3vlnA-3i4kA:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VLN_A_ASCA904_0
(GLUTATHIONE
S-TRANSFERASE
OMEGA-1)
6ezy -
(-)
4 / 6 ARG A  15
PRO A  54
GLU A  65
SER A  66
ARG  A  15 ( 0.6A)
PRO  A  54 ( 1.1A)
GLU  A  65 ( 0.6A)
SER  A  66 ( 0.0A)
0.95A 3vlnA-6ezyA:
20.5
3vlnA-6ezyA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VYW_C_SAMC401_1
(MNMC2)
3gnr OS03G0212800 PROTEIN
(Oryza
sativa)
4 / 6 GLY A 295
ASP A 279
ASP A 344
GLU A 271
GLY  A 295 ( 0.0A)
ASP  A 279 ( 0.6A)
ASP  A 344 ( 0.6A)
GLU  A 271 ( 0.6A)
0.97A 3vywC-3gnrA:
undetectable
3vywC-3gnrA:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_B_W9TB504_1
(HEMOLYTIC LECTIN
CEL-III)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 ASP A 168
GLU A 167
GLY A 170
TYR A 230
ASP  A 168 (-0.6A)
GLU  A 167 ( 0.6A)
GLY  A 170 ( 0.0A)
TYR  A 230 (-1.3A)
1.21A 3w9tB-5d7wA:
undetectable
3w9tB-5d7wA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_B_W9TB504_1
(HEMOLYTIC LECTIN
CEL-III)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 GLU A 167
GLY A 170
TYR A 230
GLN A 172
GLU  A 167 ( 0.6A)
GLY  A 170 ( 0.0A)
TYR  A 230 (-1.3A)
GLN  A 172 ( 0.6A)
1.46A 3w9tB-5d7wA:
undetectable
3w9tB-5d7wA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_E_W9TE505_1
(HEMOLYTIC LECTIN
CEL-III)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 ASP A 168
GLU A 167
GLY A 170
TYR A 230
ASP  A 168 (-0.6A)
GLU  A 167 ( 0.6A)
GLY  A 170 ( 0.0A)
TYR  A 230 (-1.3A)
1.19A 3w9tE-5d7wA:
undetectable
3w9tE-5d7wA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_F_W9TF503_1
(HEMOLYTIC LECTIN
CEL-III)
5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN

(Vibrio
vulnificus)
4 / 6 GLU A3846
GLY A3847
LEU A3710
GLU A3854
GLU  A3846 ( 0.6A)
GLY  A3847 ( 0.0A)
LEU  A3710 ( 0.6A)
GLU  A3854 ( 0.6A)
1.16A 3w9tF-5w6lA:
undetectable
3w9tF-5w6lA:
12.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQV_A_GCSA501_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
10 / 11 PHE A 184
GLY A 267
TRP A 268
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
ARG A 439
TRP A 532
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
0.44A 3wqvA-5gprA:
43.0
3wqvA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WQW_A_GCSA501_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
10 / 11 PHE A 184
GLY A 267
TRP A 268
GLU A 308
MET A 381
TYR A 383
ASP A 384
TYR A 437
ARG A 439
TRP A 532
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
MET  A 381 ( 0.0A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
TYR  A 437 ( 1.3A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
0.47A 3wqwA-5gprA:
43.0
3wqwA-5gprA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZS3_A_ACTA1224_0
(THAUMATIN-LIKE
PROTEIN)
5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE

(Thymus
vulgaris)
4 / 5 SER A 377
GLU A 374
THR A 378
ASP A 372
SER  A 377 ( 0.0A)
GLU  A 374 ( 0.6A)
THR  A 378 ( 0.8A)
ASP  A 372 ( 0.6A)
1.49A 3zs3A-5c05A:
undetectable
3zs3A-5c05A:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A7B_A_HAEA1273_1
(COLLAGENASE 3)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 6 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.25A 4a7bA-5d7wA:
14.6
4a7bA-5d7wA:
16.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A7B_B_HAEB1270_1
(COLLAGENASE 3)
5ec3 4-HYDROXYPHENYLPYRUV
ATE DIOXYGENASE

(Homo
sapiens)
4 / 5 LEU A 323
HIS A 183
GLU A 349
HIS A 266
LEU  A 323 ( 0.6A)
HIS  A 183 (-1.0A)
GLU  A 349 (-0.6A)
HIS  A 266 (-1.0A)
1.32A 4a7bB-5ec3A:
undetectable
4a7bB-5ec3A:
18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A99_D_MIYD393_1
(TETX2 PROTEIN)
3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE

(Mycobacteroides
abscessus)
4 / 5 ILE A  46
ILE A 278
TYR A 277
GLU A 279
ILE  A  46 ( 0.7A)
ILE  A 278 ( 0.7A)
TYR  A 277 ( 1.3A)
GLU  A 279 ( 0.6A)
1.23A 4a99D-3r9rA:
undetectable
4a99D-3r9rA:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AE1_A_NCAA1536_0
(DIPHTHERIA TOXIN)
5nh2 UNCHARACTERIZED
PROTEIN

(Bartonella
henselae)
4 / 6 GLY B  49
ALA B  51
TYR B  50
GLU B  17
GLY  B  49 ( 0.0A)
ALA  B  51 ( 0.0A)
TYR  B  50 ( 1.3A)
GLU  B  17 ( 0.5A)
0.91A 4ae1A-5nh2B:
undetectable
4ae1A-5nh2B:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AE1_B_NCAB1536_0
(DIPHTHERIA TOXIN)
5c6d UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 7

(Homo
sapiens)
4 / 5 HIS A 578
GLY A 580
TYR A 584
GLU A 586
HIS  A 578 ( 1.0A)
GLY  A 580 ( 0.0A)
TYR  A 584 ( 1.3A)
GLU  A 586 ( 0.5A)
1.37A 4ae1B-5c6dA:
undetectable
4ae1B-5c6dA:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AE1_B_NCAB1536_0
(DIPHTHERIA TOXIN)
5gru DIABODY PROTEIN
(Homo
sapiens)
4 / 5 GLY H  99
TYR H 102
TYR H 100
GLU H 113
GLY  H  99 ( 0.0A)
TYR  H 102 ( 1.3A)
TYR  H 100 ( 1.3A)
GLU  H 113 ( 0.6A)
1.20A 4ae1B-5gruH:
3.9
4ae1B-5gruH:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ASD_A_BAXA1500_1
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
9 / 12 VAL A  39
ALA A  52
LYS A  54
GLU A  69
LEU A  73
PHE A 107
GLY A 111
LEU A 144
HIS A 151
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A  73 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 144 ( 0.6A)
HIS  A 151 ( 1.0A)
0.79A 4asdA-5d7aA:
10.1
4asdA-5d7aA:
26.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AX8_A_SAMA1474_1
(WBDD)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo
sapiens)
4 / 6 TYR A 223
ASP A 203
GLU A 243
LEU A 234
TYR  A 223 ( 1.3A)
ASP  A 203 ( 0.6A)
GLU  A 243 ( 0.5A)
LEU  A 234 ( 0.6A)
1.16A 4ax8A-3sl5A:
undetectable
4ax8A-3sl5A:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BVA_A_T3A1314_1
(THIOMORPHOLINE-CARBO
XYLATE DEHYDROGENASE)
5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4

(Homo
sapiens)
5 / 12 VAL A 437
PHE A 434
GLY A 436
SER A 363
GLU A 367
VAL  A 437 ( 0.6A)
PHE  A 434 ( 1.3A)
GLY  A 436 ( 0.0A)
SER  A 363 ( 0.0A)
GLU  A 367 ( 0.6A)
1.36A 4bvaA-5nksA:
1.4
4bvaA-5nksA:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C39_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 4c39A-5bs1A:
undetectable
4c39B-5bs1A:
undetectable
4c39A-5bs1A:
14.45
4c39B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_B_0LIB1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
7 / 12 ALA A  52
LYS A  54
GLU A  69
LEU A  73
ILE A  82
HIS A 151
LEU A 160
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A  73 ( 0.6A)
ILE  A  82 ( 0.7A)
HIS  A 151 ( 1.0A)
LEU  A 160 (-0.6A)
0.91A 4c8bB-5d7aA:
25.6
4c8bB-5d7aA:
25.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4camA-5bs1A:
undetectable
4camB-5bs1A:
undetectable
4camA-5bs1A:
14.45
4camB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 4camA-5bs1A:
undetectable
4camB-5bs1A:
undetectable
4camA-5bs1A:
14.45
4camB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 4canA-5bs1A:
undetectable
4canB-5bs1A:
undetectable
4canA-5bs1A:
14.45
4canB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 4caoA-5bs1A:
undetectable
4caoB-5bs1A:
undetectable
4caoA-5bs1A:
14.45
4caoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4capA-5bs1A:
undetectable
4capB-5bs1A:
undetectable
4capA-5bs1A:
14.45
4capB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CDT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.34A 4cdtA-5bs1A:
undetectable
4cdtB-5bs1A:
undetectable
4cdtA-5bs1A:
14.45
4cdtB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CDT_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.32A 4cdtA-5bs1A:
undetectable
4cdtB-5bs1A:
undetectable
4cdtA-5bs1A:
14.45
4cdtB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4ctpA-5bs1A:
undetectable
4ctpB-5bs1A:
undetectable
4ctpA-5bs1A:
14.45
4ctpB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTQ_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4ctqA-5bs1A:
undetectable
4ctqB-5bs1A:
undetectable
4ctqA-5bs1A:
14.45
4ctqB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 4ctqA-5bs1A:
undetectable
4ctqB-5bs1A:
undetectable
4ctqA-5bs1A:
14.45
4ctqB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 4ctrA-5bs1A:
undetectable
4ctrB-5bs1A:
undetectable
4ctrA-5bs1A:
14.45
4ctrB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3r6y ASPARTASE
(Bacillus
sp.
YM55-1)
4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
1.43A 4cttA-3r6yA:
undetectable
4cttB-3r6yA:
undetectable
4cttA-3r6yA:
22.39
4cttB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.33A 4cttA-5bs1A:
undetectable
4cttB-5bs1A:
undetectable
4cttA-5bs1A:
14.45
4cttB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTU_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 4ctuA-5bs1A:
undetectable
4ctuB-5bs1A:
undetectable
4ctuA-5bs1A:
14.45
4ctuB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTV_A_H4BA1718_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4ctvA-5bs1A:
undetectable
4ctvB-5bs1A:
undetectable
4ctvA-5bs1A:
14.45
4ctvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTV_B_H4BB1720_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 4ctvA-5bs1A:
undetectable
4ctvB-5bs1A:
undetectable
4ctvA-5bs1A:
14.45
4ctvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTW_A_H4BA1718_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 4ctwA-5bs1A:
undetectable
4ctwB-5bs1A:
undetectable
4ctwA-5bs1A:
14.45
4ctwB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4cx5A-5bs1A:
undetectable
4cx5B-5bs1A:
undetectable
4cx5A-5bs1A:
14.45
4cx5B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1N_D_H4BD760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.27A 4d1nC-5bs1A:
undetectable
4d1nD-5bs1A:
undetectable
4d1nC-5bs1A:
16.01
4d1nD-5bs1A:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Z_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.33A 4d2zA-5bs1A:
undetectable
4d2zB-5bs1A:
undetectable
4d2zA-5bs1A:
14.45
4d2zB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D31_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4d31A-5bs1A:
undetectable
4d31B-5bs1A:
undetectable
4d31A-5bs1A:
14.45
4d31B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D9H_A_ADNA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.72A 4d9hA-4g41A:
23.9
4d9hA-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DA7_A_AC2A301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.77A 4da7A-4g41A:
23.8
4da7A-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_A_2FAA301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.78A 4danA-4g41A:
23.4
4danA-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAN_B_2FAB301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 12 GLY A  78
GLU A 172
MET A 173
GLU A 174
SER A 196
GLY  A  78 ( 0.0A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.83A 4danA-4g41A:
23.4
4danB-4g41A:
23.4
4danA-4g41A:
25.86
4danB-4g41A:
25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DF3_A_SAMA301_1
(FIBRILLARIN-LIKE
RRNA/TRNA
2'-O-METHYLTRANSFERA
SE)
2pk2 CYCLIN-T1, PROTEIN
TAT

(Homo
sapiens;
Equine
infectious
anemia
virus)
3 / 3 TYR A  13
THR A 192
GLU A 147
TYR  A  13 ( 1.3A)
THR  A 192 ( 0.8A)
GLU  A 147 ( 0.6A)
0.83A 4df3A-2pk2A:
undetectable
4df3A-2pk2A:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FEU_B_KANB301_1
(AMINOGLYCOSIDE
3'-PHOSPHOTRANSFERAS
E APHA1-IAB)
5wpi HSVA
(Erwinia
amylovora)
4 / 7 ASP A 251
ASP A 203
GLU A 244
ASP A 123
ASP  A 251 ( 0.6A)
ASP  A 203 ( 0.5A)
GLU  A 244 ( 0.6A)
ASP  A 123 ( 0.6A)
1.19A 4feuB-5wpiA:
undetectable
4feuB-5wpiA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGL_B_CLQB303_0
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])
4bwi PHYTOCHROME-LIKE
PROTEIN CPH2

(Synechocystis
sp.)
5 / 11 HIS A 130
PHE A  49
GLY A  89
MET A 148
GLU A  87
CYC  A1422 (-3.5A)
None
GLU  A1427 (-3.2A)
None
None
1.26A 4fglA-4bwiA:
undetectable
4fglB-4bwiA:
undetectable
4fglA-4bwiA:
20.59
4fglB-4bwiA:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGZ_A_CQAA301_0
(PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE)
1ryn PROTEIN CRS2
(Zea
mays)
5 / 8 GLY A  52
GLY A  55
GLU A  36
LEU A 178
VAL A 177
GLY  A  52 ( 0.0A)
GLY  A  55 ( 0.0A)
GLU  A  36 ( 0.5A)
LEU  A 178 ( 0.6A)
VAL  A 177 ( 0.5A)
1.38A 4fgzA-1rynA:
undetectable
4fgzA-1rynA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGZ_B_CQAB302_0
(PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 8 GLU A 304
GLU A 305
GLY A 266
ARG A 307
GLU  A 304 ( 0.6A)
GLU  A 305 ( 0.6A)
GLY  A 266 ( 0.0A)
ARG  A 307 ( 0.6A)
1.03A 4fgzA-3c3nA:
undetectable
4fgzB-3c3nA:
undetectable
4fgzA-3c3nA:
22.15
4fgzB-3c3nA:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FIM_A_CELA711_1
(LACTOTRANSFERRIN)
1vho ENDOGLUCANASE
(Thermotoga
maritima)
5 / 9 GLY A 148
VAL A  73
GLU A  68
TYR A  21
GLY A  70
GLY  A 148 ( 0.0A)
VAL  A  73 ( 0.6A)
GLU  A  68 ( 0.6A)
TYR  A  21 ( 1.3A)
GLY  A  70 ( 0.0A)
1.24A 4fimA-1vhoA:
undetectable
4fimA-1vhoA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVQ_A_ACTA904_0
(TYROSINE-PROTEIN
KINASE JAK2)
2grx PROTEIN TONB
(Escherichia
coli)
3 / 3 PHE C 230
VAL C 176
GLU C 203
PHE  C 230 ( 1.3A)
VAL  C 176 ( 0.6A)
GLU  C 203 ( 0.6A)
0.58A 4fvqA-2grxC:
undetectable
4fvqA-2grxC:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4fvwA-5bs1A:
undetectable
4fvwB-5bs1A:
undetectable
4fvwA-5bs1A:
14.45
4fvwB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 4fvwA-5bs1A:
undetectable
4fvwB-5bs1A:
undetectable
4fvwA-5bs1A:
14.45
4fvwB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4fvxA-5bs1A:
undetectable
4fvxB-5bs1A:
undetectable
4fvxA-5bs1A:
14.45
4fvxB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.27A 4fvxA-5bs1A:
undetectable
4fvxB-5bs1A:
undetectable
4fvxA-5bs1A:
14.45
4fvxB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G24_A_ACAA1004_1
(PENTATRICOPEPTIDE
REPEAT-CONTAINING
PROTEIN AT2G32230,
MITOCHONDRIAL)
1wqa PHOSPHO-SUGAR MUTASE
(Pyrococcus
horikoshii)
4 / 6 LEU A 234
VAL A 231
ASP A 237
GLU A 254
LEU  A 234 ( 0.6A)
VAL  A 231 ( 0.6A)
ASP  A 237 ( 0.5A)
GLU  A 254 ( 0.6A)
0.83A 4g24A-1wqaA:
undetectable
4g24A-1wqaA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GQE_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4gqeA-5bs1A:
undetectable
4gqeB-5bs1A:
undetectable
4gqeA-5bs1A:
14.45
4gqeB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GQE_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 4gqeA-5bs1A:
undetectable
4gqeB-5bs1A:
undetectable
4gqeA-5bs1A:
14.45
4gqeB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HB8_A_DXCA75_0
(PPCA)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
4 / 8 ILE A  23
LEU A  76
ILE A 278
GLY A  30
None
None
None
GLU  A1313 ( 4.0A)
0.78A 4hb8A-1us4A:
undetectable
4hb8A-1us4A:
12.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HFP_D_15UD402_1
(PROTHROMBIN)
3h7a SHORT CHAIN
DEHYDROGENASE

(Rhodopseudomonas
palustris)
5 / 12 ASP A  62
ALA A  63
GLU A 110
ALA A 112
VAL A  89
ASP  A  62 ( 0.6A)
ALA  A  63 ( 0.0A)
GLU  A 110 ( 0.6A)
ALA  A 112 ( 0.0A)
VAL  A  89 ( 0.6A)
1.01A 4hfpD-3h7aA:
undetectable
4hfpD-3h7aA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HOJ_A_ACTA303_0
(REGF PROTEIN)
4c9g ADP, ATP CARRIER
PROTEIN 2

(Saccharomyces
cerevisiae)
4 / 5 VAL A 251
ARG A 254
MET A 255
GLU A  56
VAL  A 251 ( 0.6A)
ARG  A 254 ( 0.6A)
MET  A 255 (-0.0A)
GLU  A  56 ( 0.6A)
0.82A 4hojA-4c9gA:
undetectable
4hojA-4c9gA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HVC_B_HFGB1602_0
(BIFUNCTIONAL
GLUTAMATE/PROLINE--T
RNA LIGASE)
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A   6
GLU A 306
VAL A 304
THR A  92
GLY A  93
LEU  A   6 ( 0.6A)
GLU  A 306 ( 0.6A)
VAL  A 304 ( 0.6A)
THR  A  92 ( 0.8A)
GLY  A  93 ( 0.0A)
1.19A 4hvcB-1omoA:
undetectable
4hvcB-1omoA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HVR_A_SALA203_1
(3-HYDROXYANTHRANILAT
E 3,4-DIOXYGENASE)
1wly 2-HALOACRYLATE
REDUCTASE

(Burkholderia
sp.
WS)
4 / 7 GLU A  19
HIS A   8
PRO A  61
VAL A  21
GLU  A  19 ( 0.6A)
HIS  A   8 ( 1.0A)
PRO  A  61 ( 1.1A)
VAL  A  21 ( 0.6A)
1.03A 4hvrA-1wlyA:
undetectable
4hvrA-1wlyA:
16.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4I41_A_MIXA500_2
(SERINE/THREONINE-PRO
TEIN KINASE PIM-1)
1ted PKS18
(Mycobacterium
tuberculosis)
4 / 4 LEU A 352
LEU A 182
GLN A 336
GLU A 357
LEU  A 352 ( 0.6A)
LEU  A 182 ( 0.6A)
GLN  A 336 ( 0.6A)
GLU  A 357 ( 0.6A)
1.21A 4i41A-1tedA:
undetectable
4i41A-1tedA:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4II8_A_010A210_0
(LYSOZYME C)
3cb7 LYS-RICH LYSOZYME 2
(Musca
domestica)
6 / 7 GLU A  36
ASP A  54
GLN A  59
ASN A  61
TRP A  65
TRP A 109
GLU  A  36 (-0.6A)
ASP  A  54 (-0.5A)
GLN  A  59 (-0.6A)
ASN  A  61 (-0.6A)
TRP  A  65 (-0.5A)
TRP  A 109 ( 0.5A)
0.32A 4ii8A-3cb7A:
19.0
4ii8A-3cb7A:
37.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IPM_A_ACTA503_0
(GH7 FAMILY PROTEIN)
5w0a GLUCANASE
(Trichoderma
harzianum)
9 / 9 ASN A 142
ALA A 144
TYR A 146
TYR A 170
ASP A 172
GLU A 196
ASP A 198
GLU A 201
TRP A 320
ASN  A 142 ( 0.6A)
ALA  A 144 ( 0.0A)
TYR  A 146 ( 1.3A)
TYR  A 170 ( 1.3A)
ASP  A 172 ( 0.5A)
GLU  A 196 ( 0.6A)
ASP  A 198 (-0.6A)
GLU  A 201 (-0.5A)
TRP  A 320 ( 0.5A)
0.55A 4ipmA-5w0aA:
48.2
4ipmA-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JDS_C_SAMC401_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD7)
5nqf APICAL MEMBRANE
ANTIGEN 1

(Plasmodium
falciparum)
5 / 11 ILE A 127
ALA A 346
GLY A 394
GLU A 120
ASN A 398
ILE  A 127 ( 0.7A)
ALA  A 346 ( 0.0A)
GLY  A 394 ( 0.0A)
GLU  A 120 ( 0.5A)
ASN  A 398 ( 0.6A)
1.13A 4jdsC-5nqfA:
undetectable
4jdsC-5nqfA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSG_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4jsgA-5bs1A:
undetectable
4jsgB-5bs1A:
undetectable
4jsgA-5bs1A:
14.45
4jsgB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 4jsiA-5bs1A:
undetectable
4jsiB-5bs1A:
undetectable
4jsiA-5bs1A:
14.45
4jsiB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSJ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4jsjA-5bs1A:
undetectable
4jsjB-5bs1A:
undetectable
4jsjA-5bs1A:
14.45
4jsjB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JUO_F_LFXF101_1
(DNA TOPOISOMERASE 4
SUBUNIT A
DNA TOPOISOMERASE 4
SUBUNIT B
E-SITE DNA)
3icc PUTATIVE
3-OXOACYL-(ACYL
CARRIER PROTEIN)
REDUCTASE

(Bacillus
anthracis)
3 / 4 SER A 145
GLY A 101
GLU A 105
SER  A 145 (-0.0A)
GLY  A 101 ( 0.0A)
GLU  A 105 ( 0.6A)
0.52A 4juoA-3iccA:
undetectable
4juoC-3iccA:
2.8
4juoA-3iccA:
20.69
4juoC-3iccA:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K17_B_OHBB701_0
(LEUCINE-RICH
REPEAT-CONTAINING
PROTEIN 16A)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
4 / 5 GLU A 185
ARG A 212
PRO A 289
SER A 241
GLU  A 185 ( 0.5A)
ARG  A 212 ( 0.6A)
PRO  A 289 ( 1.1A)
SER  A 241 ( 0.0A)
1.38A 4k17B-4kqnA:
undetectable
4k17B-4kqnA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5E_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4k5eA-5bs1A:
undetectable
4k5eB-5bs1A:
undetectable
4k5eA-5bs1A:
14.45
4k5eB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5G_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 4k5gA-5bs1A:
undetectable
4k5gB-5bs1A:
undetectable
4k5gA-5bs1A:
14.45
4k5gB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCK_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4kckA-5bs1A:
undetectable
4kckB-5bs1A:
undetectable
4kckA-5bs1A:
14.45
4kckB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCK_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.33A 4kckA-5bs1A:
undetectable
4kckB-5bs1A:
undetectable
4kckA-5bs1A:
14.45
4kckB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCL_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 4kclA-5bs1A:
undetectable
4kclB-5bs1A:
undetectable
4kclA-5bs1A:
14.45
4kclB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCM_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4kcmA-5bs1A:
undetectable
4kcmB-5bs1A:
undetectable
4kcmA-5bs1A:
14.45
4kcmB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4kcnA-5bs1A:
undetectable
4kcnB-5bs1A:
undetectable
4kcnA-5bs1A:
14.45
4kcnB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCN_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 4kcnA-5bs1A:
undetectable
4kcnB-5bs1A:
undetectable
4kcnA-5bs1A:
14.45
4kcnB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCO_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4kcoA-5bs1A:
undetectable
4kcoB-5bs1A:
undetectable
4kcoA-5bs1A:
14.45
4kcoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCO_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 4kcoA-5bs1A:
undetectable
4kcoB-5bs1A:
undetectable
4kcoA-5bs1A:
14.45
4kcoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOE_H_TR6H101_1
(DNA TOPOISOMERASE 4
SUBUNIT A
DNA TOPOISOMERASE 4
SUBUNIT B
E-SITE DNA4)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 7 GLY A  84
ASP A  83
GLY A  58
GLU A  78
GLY  A  84 ( 0.0A)
ASP  A  83 ( 0.6A)
GLY  A  58 ( 0.0A)
GLU  A  78 ( 0.6A)
0.96A 4koeA-2ogsA:
undetectable
4koeB-2ogsA:
undetectable
4koeD-2ogsA:
2.5
4koeA-2ogsA:
23.33
4koeB-2ogsA:
23.33
4koeD-2ogsA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KOU_A_C04A207_1
(UNCHARACTERIZED
PROTEIN)
1joy PROTEIN (ENVZ_ECOLI)
(Escherichia
coli)
3 / 3 GLY A 264
GLU A 257
THR A 256
GLY  A 264 ( 0.0A)
GLU  A 257 ( 0.5A)
THR  A 256 ( 0.8A)
0.56A 4kouA-1joyA:
undetectable
4kouA-1joyA:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KSZ_A_CYSA620_0
(LACTOPEROXIDASE)
2j5b TYROSYL-TRNA
SYNTHETASE

(Acanthamoeba
polyphaga
mimivirus)
3 / 3 ARG A  92
GLU A  96
PHE A 318
ARG  A  92 ( 0.6A)
GLU  A  96 ( 0.6A)
PHE  A 318 ( 1.3A)
0.96A 4kszA-2j5bA:
undetectable
4kszA-2j5bA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KSZ_A_CYSA620_0
(LACTOPEROXIDASE)
5l5n PLEXIN-A4
(Mus
musculus)
3 / 3 ARG A  69
GLU A  45
PHE A  42
ARG  A  69 ( 0.6A)
GLU  A  45 ( 0.5A)
PHE  A  42 ( 1.3A)
0.78A 4kszA-5l5nA:
undetectable
4kszA-5l5nA:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KTT_A_SAMA405_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4ikn AP-3 COMPLEX SUBUNIT
MU-1

(Rattus
norvegicus)
4 / 8 GLU A 185
ASP A 188
ILE A 187
ILE A 272
GLU  A 185 ( 0.6A)
ASP  A 188 ( 0.6A)
ILE  A 187 ( 0.6A)
ILE  A 272 ( 0.7A)
0.90A 4kttB-4iknA:
undetectable
4kttB-4iknA:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KTT_C_SAMC404_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4ikn AP-3 COMPLEX SUBUNIT
MU-1

(Rattus
norvegicus)
4 / 8 GLU A 185
ASP A 188
ILE A 187
ILE A 272
GLU  A 185 ( 0.6A)
ASP  A 188 ( 0.6A)
ILE  A 187 ( 0.6A)
ILE  A 272 ( 0.7A)
0.83A 4kttD-4iknA:
undetectable
4kttD-4iknA:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L7I_B_SAMB501_0
(S-ADENOSYLMETHIONINE
SYNTHASE)
4bwi PHYTOCHROME-LIKE
PROTEIN CPH2

(Synechocystis
sp.)
4 / 8 ASN A  90
ARG A  92
LEU A 153
ILE A  80
GLU  A1427 (-3.2A)
None
GLU  A1427 ( 4.9A)
CYC  A1422 (-4.0A)
1.09A 4l7iA-4bwiA:
undetectable
4l7iA-4bwiA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LB2_A_DM5A601_1
(SERUM ALBUMIN)
4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB

(Caldanaerobacter
subterraneus)
4 / 7 LEU A 125
VAL A 127
GLU A  53
TYR A  59
LEU  A 125 ( 0.6A)
VAL  A 127 ( 0.6A)
GLU  A  53 ( 0.6A)
TYR  A  59 ( 1.3A)
1.06A 4lb2A-4egsA:
undetectable
4lb2A-4egsA:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LB2_A_DM5A601_1
(SERUM ALBUMIN)
4egs RIBOSE 5-PHOSPHATE
ISOMERASE RPIB

(Caldanaerobacter
subterraneus)
4 / 7 LEU A 125
VAL A 127
PRO A 120
GLU A  53
LEU  A 125 ( 0.6A)
VAL  A 127 ( 0.6A)
PRO  A 120 ( 1.1A)
GLU  A  53 ( 0.6A)
1.03A 4lb2A-4egsA:
undetectable
4lb2A-4egsA:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LG1_B_SAMB301_0
(PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21D)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
5 / 12 GLY A 153
GLY A 150
LEU A 155
ALA A  63
TYR A 243
None
None
GLU  A1055 (-4.1A)
None
GLU  A1055 (-4.2A)
1.15A 4lg1B-2dvzA:
undetectable
4lg1B-2dvzA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUF_A_ACTA605_0
(SERUM ALBUMIN)
3g9k CAPSULE BIOSYNTHESIS
PROTEIN CAPD
CAPSULE BIOSYNTHESIS
PROTEIN CAPD

(Bacillus
anthracis;
Bacillus
anthracis)
4 / 4 ALA S 495
HIS L  89
PHE S 374
LEU L 175
None
None
GLU  S   2 (-4.2A)
None
1.35A 4lufA-3g9kS:
undetectable
4lufA-3g9kS:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4luxA-5bs1A:
undetectable
4luxB-5bs1A:
undetectable
4luxA-5bs1A:
14.45
4luxB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LUX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 4luxA-5bs1A:
undetectable
4luxB-5bs1A:
undetectable
4luxA-5bs1A:
14.45
4luxB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M93_B_ACTB303_0
(S25-26 FAB (IGG1K)
HEAVY CHAIN
S25-26 FAB (IGG1K)
LIGHT CHAIN)
3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE

(Corynebacterium
glutamicum)
4 / 5 SER A 233
ALA A 258
PHE A 234
GLU A 260
SER  A 233 ( 0.0A)
ALA  A 258 ( 0.0A)
PHE  A 234 ( 1.3A)
GLU  A 260 ( 0.6A)
1.04A 4m93B-3r64A:
undetectable
4m93C-3r64A:
undetectable
4m93B-3r64A:
16.27
4m93C-3r64A:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MJ8_A_SPMA202_1
(SPERMIDINE
N1-ACETYLTRANSFERASE)
1txu RAB5 GDP/GTP
EXCHANGE FACTOR

(Homo
sapiens)
4 / 8 GLU A 232
GLN A 239
ILE A 242
LEU A 331
GLU  A 232 ( 0.5A)
GLN  A 239 ( 0.6A)
ILE  A 242 ( 0.7A)
LEU  A 331 ( 0.6A)
0.76A 4mj8A-1txuA:
undetectable
4mj8A-1txuA:
19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MK4_B_CHDB502_0
(FERROCHELATASE,
MITOCHONDRIAL)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
4 / 6 PHE A  81
ILE A  71
ARG A  75
VAL A  50
None
None
GLU  A1620 (-2.9A)
GLU  A1620 (-4.9A)
1.32A 4mk4B-2pyyA:
undetectable
4mk4B-2pyyA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWZ_B_CQAB303_0
(PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE,
PUTATIVE)
5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE

(Bacillus
subtilis)
4 / 8 GLY A  88
LEU A 251
GLU A 252
LYS A 254
GLY  A  88 ( 0.0A)
LEU  A 251 ( 0.6A)
GLU  A 252 ( 0.6A)
LYS  A 254 ( 0.0A)
0.62A 4mwzB-5ep8A:
undetectable
4mwzB-5ep8A:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MWZ_B_CQAB303_0
(PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE,
PUTATIVE)
5l5n PLEXIN-A4
(Mus
musculus)
4 / 8 GLY A 804
GLU A 808
LEU A 812
LYS A 815
GLY  A 804 ( 0.0A)
GLU  A 808 ( 0.5A)
LEU  A 812 ( 0.5A)
LYS  A 815 ( 0.0A)
0.78A 4mwzB-5l5nA:
undetectable
4mwzB-5l5nA:
12.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NDN_A_SAMA407_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4ikn AP-3 COMPLEX SUBUNIT
MU-1

(Rattus
norvegicus)
4 / 8 GLU A 185
ASP A 188
ILE A 187
ILE A 272
GLU  A 185 ( 0.6A)
ASP  A 188 ( 0.6A)
ILE  A 187 ( 0.6A)
ILE  A 272 ( 0.7A)
0.91A 4ndnB-4iknA:
undetectable
4ndnB-4iknA:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NDN_C_SAMC405_1
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4ikn AP-3 COMPLEX SUBUNIT
MU-1

(Rattus
norvegicus)
4 / 8 GLU A 185
ASP A 188
ILE A 187
ILE A 272
GLU  A 185 ( 0.6A)
ASP  A 188 ( 0.6A)
ILE  A 187 ( 0.6A)
ILE  A 272 ( 0.7A)
0.85A 4ndnD-4iknA:
undetectable
4ndnD-4iknA:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_B_STRB601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus)
4 / 5 ILE A 452
LEU A 371
GLU A 454
VAL A 464
ILE  A 452 ( 0.6A)
LEU  A 371 ( 0.6A)
GLU  A 454 ( 0.6A)
VAL  A 464 ( 0.6A)
1.00A 4nkxB-5cdnA:
undetectable
4nkxB-5cdnA:
22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O4D_A_ACTA406_0
(INOSITOL
HEXAKISPHOSPHATE
KINASE)
2vha PERIPLASMIC BINDING
TRANSPORT PROTEIN

(Shigella
flexneri)
4 / 7 THR A  91
ARG A  24
PHE A  30
SER A  27
GLU  A1280 (-4.4A)
GLU  A1280 (-3.0A)
None
GLU  A1280 ( 4.0A)
1.39A 4o4dA-2vhaA:
undetectable
4o4dA-2vhaA:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O5F_B_PAUB302_0
(TYPE III
PANTOTHENATE KINASE)
4pe5 GLUTAMATE RECEPTOR
IONOTROPIC, NMDA 2B

(Rattus
norvegicus)
5 / 12 LEU B 465
VAL B 417
LEU B 513
GLY B 511
ILE B 408
None
None
GLU  B 921 (-4.5A)
None
None
1.03A 4o5fA-4pe5B:
undetectable
4o5fB-4pe5B:
2.2
4o5fA-4pe5B:
16.26
4o5fB-4pe5B:
16.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4O8F_B_BRLB501_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
3t7b ACETYLGLUTAMATE
KINASE

(Yersinia
pestis)
5 / 12 SER A 146
LEU A 167
VAL A 132
LEU A  13
LEU A  79
GLU  A 258 ( 4.0A)
None
None
None
None
1.44A 4o8fB-3t7bA:
undetectable
4o8fB-3t7bA:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OU1_A_BEZA302_0
(RETRO-ALDOLASE,
DESIGN RA114)
3t7b ACETYLGLUTAMATE
KINASE

(Yersinia
pestis)
4 / 8 ILE A   6
LYS A   7
ILE A 176
ALA A 234
None
GLU  A 258 (-2.7A)
None
None
0.93A 4ou1A-3t7bA:
undetectable
4ou1A-3t7bA:
23.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PB1_A_RBVA501_1
(NUPC FAMILY PROTEIN)
3ghg FIBRINOGEN GAMMA
CHAIN

(Homo
sapiens)
5 / 12 GLY C 200
GLU C 225
ASN C 365
SER C 378
ILE C 367
GLY  C 200 ( 0.0A)
GLU  C 225 ( 0.5A)
ASN  C 365 ( 0.6A)
SER  C 378 ( 0.0A)
ILE  C 367 ( 0.5A)
1.26A 4pb1A-3ghgC:
undetectable
4pb1A-3ghgC:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PFJ_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)
3i4k MUCONATE LACTONIZING
ENZYME

(Corynebacterium
glutamicum)
4 / 7 GLU A  52
THR A 311
HIS A  24
LEU A  20
GLU  A  52 ( 0.6A)
THR  A 311 ( 0.8A)
HIS  A  24 ( 1.0A)
LEU  A  20 ( 0.6A)
1.13A 4pfjA-3i4kA:
undetectable
4pfjA-3i4kA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
5 / 12 ASP A 244
GLU A 219
LYS A 160
LEU A  23
GLY A 164
MG  A1601 ( 3.2A)
MG  A1601 (-2.9A)
GLU  A2471 (-2.6A)
None
None
1.34A 4pgfA-1tkkA:
undetectable
4pgfA-1tkkA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_A_ADNA502_1
(ADENOSYLHOMOCYSTEINA
SE)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
5 / 12 ASP A 244
GLU A 219
LYS A 160
LEU A  23
GLY A 195
MG  A1601 ( 3.2A)
MG  A1601 (-2.9A)
GLU  A2471 (-2.6A)
None
None
1.46A 4pgfA-1tkkA:
undetectable
4pgfA-1tkkA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PL1_A_SAMA401_0
(DUAL-SPECIFICITY RNA
METHYLTRANSFERASE
RLMN)
2e4u METABOTROPIC
GLUTAMATE RECEPTOR 3

(Rattus
norvegicus)
5 / 11 PHE A 187
PRO A  46
SER A 173
ILE A 155
ASN A 159
None
None
GLU  A 701 (-4.5A)
None
None
1.39A 4pl1A-2e4uA:
1.4
4pl1A-2e4uA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q15_A_HFGA803_1
(PROLINE--TRNA LIGASE)
5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4

(Homo
sapiens)
3 / 3 GLU A 360
THR A 335
HIS A 333
GLU  A 360 ( 0.6A)
THR  A 335 ( 0.8A)
HIS  A 333 ( 1.0A)
0.51A 4q15A-5nksA:
undetectable
4q15A-5nksA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q15_B_HFGB803_1
(PROLINE--TRNA LIGASE)
5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4

(Homo
sapiens)
3 / 3 GLU A 359
THR A 335
HIS A 333
GLU  A 359 ( 0.6A)
THR  A 335 ( 0.8A)
HIS  A 333 ( 1.0A)
0.87A 4q15B-5nksA:
undetectable
4q15B-5nksA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q15_B_HFGB803_1
(PROLINE--TRNA LIGASE)
5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4

(Homo
sapiens)
3 / 3 GLU A 360
THR A 335
HIS A 333
GLU  A 360 ( 0.6A)
THR  A 335 ( 0.8A)
HIS  A 333 ( 1.0A)
0.50A 4q15B-5nksA:
undetectable
4q15B-5nksA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QB9_D_PARD500_1
(ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
4 / 8 PHE A 283
THR A 319
GLU A 143
ASP A 141
PHE  A 283 ( 1.3A)
THR  A 319 ( 0.8A)
GLU  A 143 (-0.6A)
ASP  A 141 (-0.5A)
0.94A 4qb9D-4flxA:
undetectable
4qb9D-4flxA:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QB9_F_PARF500_1
(ENHANCED
INTRACELLULAR
SURVIVAL PROTEIN)
5lmx DNA-DIRECTED RNA
POLYMERASE I SUBUNIT
RPA49

(Saccharomyces
cerevisiae)
5 / 11 PHE M  30
GLU M  50
ASP M  39
TYR M  65
GLY M  64
PHE  M  30 ( 1.3A)
GLU  M  50 ( 0.6A)
ASP  M  39 ( 0.5A)
TYR  M  65 ( 1.3A)
GLY  M  64 ( 0.0A)
1.31A 4qb9F-5lmxM:
undetectable
4qb9F-5lmxM:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QGI_A_ROCA101_1
(PROTEASE)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
5 / 11 GLY A 224
ASP A 195
ILE A 327
GLY A 306
VAL A 274
None
None
None
GLU  A 506 ( 3.7A)
None
0.97A 4qgiA-3lmkA:
undetectable
4qgiA-3lmkA:
11.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R3A_A_RBFA402_2
(BLUE-LIGHT-ACTIVATED
HISTIDINE KINASE 2)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 THR A 135
GLU A 193
VAL A 425
GLY A 115
THR  A 135 ( 0.8A)
GLU  A 193 ( 0.6A)
VAL  A 425 ( 0.6A)
GLY  A 115 ( 0.0A)
0.71A 4r3aA-2ogsA:
undetectable
4r3aA-2ogsA:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R82_A_ACTA205_0
(OXIDOREDUCTASE)
1ryn PROTEIN CRS2
(Zea
mays)
4 / 5 GLY A 138
ARG A  21
GLU A 158
PHE A 154
GLY  A 138 ( 0.0A)
ARG  A  21 ( 0.6A)
GLU  A 158 ( 0.6A)
PHE  A 154 ( 1.3A)
1.02A 4r82A-1rynA:
undetectable
4r82B-1rynA:
undetectable
4r82A-1rynA:
24.19
4r82B-1rynA:
24.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_A_DGXA1107_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)
2jfn GLUTAMATE RACEMASE
(Escherichia
coli)
4 / 4 ASN A  93
VAL A 201
THR A 144
ILE A 148
GLU  A1287 (-4.0A)
None
None
None
1.37A 4retA-2jfnA:
2.1
4retA-2jfnA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RET_C_DGXC2005_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)
2jfn GLUTAMATE RACEMASE
(Escherichia
coli)
4 / 4 ASN A  93
VAL A 201
THR A 144
ILE A 148
GLU  A1287 (-4.0A)
None
None
None
1.37A 4retC-2jfnA:
2.3
4retC-2jfnA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RP8_C_ASCC501_1
(ASCORBATE-SPECIFIC
PERMEASE IIC
COMPONENT ULAA)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
3 / 3 SER A  60
TYR A  32
ASP A  80
GLU  A1313 (-2.6A)
GLU  A1313 (-3.7A)
None
0.73A 4rp8C-1us4A:
undetectable
4rp8C-1us4A:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RTB_A_SAMA501_1
(HYDG PROTEIN)
4xm4 MEX67
(Chaetomium
thermophilum)
3 / 3 GLU A 511
ARG A 522
GLN A 516
GLU  A 511 ( 0.5A)
ARG  A 522 ( 0.6A)
GLN  A 516 ( 0.6A)
0.93A 4rtbA-4xm4A:
undetectable
4rtbA-4xm4A:
22.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RYA_A_MTLA501_1
(ABC TRANSPORTER
SUBSTRATE BINDING
PROTEIN (SORBITOL))
3kbb PHOSPHORYLATED
CARBOHYDRATES
PHOSPHATASE TM_1254

(Thermotoga
maritima)
3 / 3 GLU A 113
TYR A  19
GLU A  47
GLU  A 113 ( 0.6A)
TYR  A  19 ( 1.3A)
GLU  A  47 (-0.6A)
0.82A 4ryaA-3kbbA:
undetectable
4ryaA-3kbbA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_G_377G401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN

(Porphyromonas
gingivalis)
4 / 6 TYR A 114
ARG A 150
GLU A 334
LEU A 177
TYR  A 114 ( 1.3A)
ARG  A 150 ( 0.6A)
GLU  A 334 ( 0.6A)
LEU  A 177 ( 0.6A)
1.37A 4twdF-2nvvA:
undetectable
4twdG-2nvvA:
undetectable
4twdF-2nvvA:
21.66
4twdG-2nvvA:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UAC_A_ACRA501_2
(CARBOHYDRATE ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN, CUT1 FAMILY
(TC 3.A.1.1.-))
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
4 / 7 SER A 414
GLU A 221
TRP A 320
ASP A 319
SER  A 414 ( 0.0A)
GLU  A 221 (-0.6A)
TRP  A 320 ( 0.5A)
ASP  A 319 ( 0.6A)
1.18A 4uacA-3ulkA:
undetectable
4uacA-3ulkA:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UAC_A_ACRA501_2
(CARBOHYDRATE ABC
TRANSPORTER
SUBSTRATE-BINDING
PROTEIN, CUT1 FAMILY
(TC 3.A.1.1.-))
4mwt LYSOSOMAL PROTECTIVE
PROTEIN

(Homo
sapiens)
4 / 7 PRO A 432
GLU A 149
ASP A  78
THR A 311
PRO  A 432 ( 1.1A)
GLU  A 149 ( 0.5A)
ASP  A  78 ( 0.6A)
THR  A 311 ( 0.8A)
1.26A 4uacA-4mwtA:
undetectable
4uacA-4mwtA:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UCH_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN

(Mycolicibacteriu
m
fortuitum)
4 / 8 TRP A 151
GLU A 168
VAL A 197
TRP A 169
TRP  A 151 (-0.5A)
GLU  A 168 (-0.5A)
VAL  A 197 ( 0.6A)
TRP  A 169 ( 0.5A)
1.08A 4uchA-4w65A:
undetectable
4uchB-4w65A:
undetectable
4uchA-4w65A:
19.68
4uchB-4w65A:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UGZ_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 4ugzA-5bs1A:
undetectable
4ugzB-5bs1A:
undetectable
4ugzA-5bs1A:
14.45
4ugzB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 4uh0A-5bs1A:
undetectable
4uh0B-5bs1A:
undetectable
4uh0A-5bs1A:
14.45
4uh0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 4uh0A-5bs1A:
undetectable
4uh0B-5bs1A:
undetectable
4uh0A-5bs1A:
14.45
4uh0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH2_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4uh2A-5bs1A:
undetectable
4uh2B-5bs1A:
undetectable
4uh2A-5bs1A:
14.45
4uh2B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH2_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 4uh2A-5bs1A:
undetectable
4uh2B-5bs1A:
undetectable
4uh2A-5bs1A:
14.45
4uh2B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UH5_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 4uh5A-5bs1A:
undetectable
4uh5B-5bs1A:
undetectable
4uh5A-5bs1A:
15.97
4uh5B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)
2e4u METABOTROPIC
GLUTAMATE RECEPTOR 3

(Rattus
norvegicus)
5 / 12 ALA A 172
SER A 149
GLU A 324
GLY A 304
GLN A  67
GLU  A 701 (-3.9A)
GLU  A 701 (-4.0A)
None
None
None
1.19A 4uilH-2e4uA:
undetectable
4uilL-2e4uA:
undetectable
4uilH-2e4uA:
15.81
4uilL-2e4uA:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPM_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 4upmA-5bs1A:
undetectable
4upmB-5bs1A:
undetectable
4upmA-5bs1A:
14.45
4upmB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPM_B_H4BB760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 4upmA-5bs1A:
undetectable
4upmB-5bs1A:
undetectable
4upmA-5bs1A:
14.45
4upmB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPN_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)
3r6y ASPARTASE
(Bacillus
sp.
YM55-1)
4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
1.39A 4upnA-3r6yA:
undetectable
4upnB-3r6yA:
1.3
4upnA-3r6yA:
22.39
4upnB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPN_A_H4BA760_1
(NEURONAL NITRIC
OXIDE SYNTHASE)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 4upnA-5bs1A:
undetectable
4upnB-5bs1A:
undetectable
4upnA-5bs1A:
14.45
4upnB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4upoA-5bs1A:
undetectable
4upoB-5bs1A:
undetectable
4upoA-5bs1A:
14.45
4upoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UPP_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 4uppA-5bs1A:
undetectable
4uppB-5bs1A:
undetectable
4uppA-5bs1A:
14.45
4uppB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4URO_B_NOVB2000_1
(DNA GYRASE SUBUNIT B)
4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE

(Saccharomyces
cerevisiae)
5 / 12 SER A  83
GLU A 128
PRO A 345
ILE A 347
SER A 174
SER  A  83 (-0.0A)
GLU  A 128 (-0.5A)
PRO  A 345 ( 1.1A)
ILE  A 347 ( 0.7A)
SER  A 174 ( 0.0A)
1.31A 4uroB-4g9kA:
undetectable
4uroB-4g9kA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V1F_A_BQ1A1087_0
(F0F1 ATP SYNTHASE
SUBUNIT C)
5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE

(Thymus
vulgaris)
3 / 3 GLU A 255
ALA A 256
PHE A 259
GLU  A 255 ( 0.5A)
ALA  A 256 ( 0.0A)
PHE  A 259 (-1.3A)
0.54A 4v1fA-5c05A:
undetectable
4v1fA-5c05A:
9.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V1F_C_BQ1C1087_0
(F0F1 ATP SYNTHASE
SUBUNIT C)
5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE

(Thymus
vulgaris)
3 / 3 GLU A 255
ALA A 256
PHE A 259
GLU  A 255 ( 0.5A)
ALA  A 256 ( 0.0A)
PHE  A 259 (-1.3A)
0.58A 4v1fC-5c05A:
undetectable
4v1fC-5c05A:
9.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V20_A_ACTA1444_0
(CELLOBIOHYDROLASE)
5w0a GLUCANASE
(Trichoderma
harzianum)
4 / 5 GLY A   4
THR A   5
HIS A  42
GLU A  73
GLY  A   4 ( 0.0A)
THR  A   5 ( 0.8A)
HIS  A  42 ( 1.0A)
GLU  A  73 ( 0.6A)
0.44A 4v20A-5w0aA:
50.4
4v20A-5w0aA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3U_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 4v3uA-5bs1A:
undetectable
4v3uB-5bs1A:
undetectable
4v3uA-5bs1A:
16.01
4v3uB-5bs1A:
16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3V_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4v3vA-5bs1A:
undetectable
4v3vB-5bs1A:
undetectable
4v3vA-5bs1A:
14.45
4v3vB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3V_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 4v3vA-5bs1A:
undetectable
4v3vB-5bs1A:
undetectable
4v3vA-5bs1A:
14.45
4v3vB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3Y_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 4v3yA-5bs1A:
undetectable
4v3yB-5bs1A:
undetectable
4v3yA-5bs1A:
14.45
4v3yB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4W5N_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5c05 PUTATIVE
GAMMA-TERPINENE
SYNTHASE

(Thymus
vulgaris)
4 / 6 LEU A 115
ILE A 112
LEU A  99
GLU A 127
LEU  A 115 ( 0.6A)
ILE  A 112 ( 0.7A)
LEU  A  99 ( 0.6A)
GLU  A 127 ( 0.6A)
0.85A 4w5nA-5c05A:
undetectable
4w5nA-5c05A:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WG0_H_CHDH103_0
(NUCLEAR RECEPTOR
COACTIVATOR 2)
5w6l RTX
REPEAT-CONTAINING
CYTOTOXIN

(Vibrio
vulnificus)
5 / 11 LEU A4048
LEU A3897
GLU A4011
LEU A4013
ALA A4005
LEU  A4048 ( 0.6A)
LEU  A3897 ( 0.6A)
GLU  A4011 ( 0.6A)
LEU  A4013 ( 0.5A)
ALA  A4005 ( 0.0A)
1.17A 4wg0H-5w6lA:
undetectable
4wg0I-5w6lA:
undetectable
4wg0J-5w6lA:
undetectable
4wg0H-5w6lA:
undetectable
4wg0I-5w6lA:
undetectable
4wg0J-5w6lA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WG0_J_CHDJ103_0
(NUCLEAR RECEPTOR
COACTIVATOR 2)
2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1

(Homo
sapiens)
5 / 11 LEU A 280
LEU A 236
GLU A 230
ALA A 229
LEU A 232
LEU  A 280 ( 0.6A)
LEU  A 236 ( 0.6A)
GLU  A 230 ( 0.6A)
ALA  A 229 ( 0.0A)
LEU  A 232 ( 0.6A)
0.75A 4wg0J-2qv2A:
undetectable
4wg0K-2qv2A:
undetectable
4wg0L-2qv2A:
undetectable
4wg0J-2qv2A:
3.69
4wg0K-2qv2A:
3.69
4wg0L-2qv2A:
3.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)
2qv2 INOSITOL
POLYPHOSPHATE
5-PHOSPHATASE OCRL-1

(Homo
sapiens)
5 / 9 LEU A 173
LEU A 213
GLU A 178
VAL A 183
PHE A 235
LEU  A 173 ( 0.6A)
LEU  A 213 ( 0.6A)
GLU  A 178 ( 0.5A)
VAL  A 183 ( 0.6A)
PHE  A 235 ( 1.3A)
1.44A 4wnvB-2qv2A:
undetectable
4wnvB-2qv2A:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X5I_A_FOLA201_1
(DIHYDROFOLATE
REDUCTASE)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
3 / 3 ASP A 296
ARG A  22
ARG A  25
ALA  A 402 (-2.5A)
None
GLU  A 403 (-3.5A)
0.87A 4x5iA-4gfiA:
undetectable
4x5iA-4gfiA:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XJ7_D_ADND303_1
(5'/3'-NUCLEOTIDASE
SURE)
5dtb CG3822
(Drosophila
melanogaster)
5 / 10 LEU A 142
GLY A 144
ASN A  76
SER A  67
ALA A  92
GLU  A 301 ( 3.6A)
GOL  A 302 (-3.8A)
None
GOL  A 302 (-4.1A)
None
1.12A 4xj7C-5dtbA:
undetectable
4xj7D-5dtbA:
undetectable
4xj7C-5dtbA:
22.30
4xj7D-5dtbA:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XJ7_D_ADND303_1
(5'/3'-NUCLEOTIDASE
SURE)
5dtb CG3822
(Drosophila
melanogaster)
5 / 10 LEU A 142
GLY A 145
ASN A  76
SER A  67
ALA A  92
GLU  A 301 ( 3.6A)
GOL  A 302 ( 3.4A)
None
GOL  A 302 (-4.1A)
None
1.05A 4xj7C-5dtbA:
undetectable
4xj7D-5dtbA:
undetectable
4xj7C-5dtbA:
22.30
4xj7D-5dtbA:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XP9_C_1WEC706_1
(TRANSPORTER)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
4 / 4 PHE A 290
ASP A 318
GLY A 240
SER A 317
None
GLU  A 701 (-3.0A)
None
None
1.33A 4xp9C-1ewkA:
0.0
4xp9C-1ewkA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XP9_C_1WEC706_1
(TRANSPORTER)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
4 / 4 PHE A 277
ASP A 305
GLY A 227
SER A 304
None
GLU  A 506 (-2.7A)
None
None
1.39A 4xp9C-3lmkA:
undetectable
4xp9C-3lmkA:
22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YDQ_B_HFGB802_1
(PROLINE--TRNA LIGASE)
5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4

(Homo
sapiens)
3 / 3 GLU A 360
THR A 335
HIS A 333
GLU  A 360 ( 0.6A)
THR  A 335 ( 0.8A)
HIS  A 333 ( 1.0A)
0.52A 4ydqB-5nksA:
undetectable
4ydqB-5nksA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YMG_B_SAMB1001_1
(PUTATIVE
SAM-DEPENDENT
O-METHYLTRANFERASE)
1v0f ENDO-ALPHA-SIALIDASE
(Enterobacteria
phage
K1F)
3 / 3 SER A 605
GLU A 651
GLU A 721
SER  A 605 ( 0.0A)
GLU  A 651 ( 0.6A)
GLU  A 721 ( 0.6A)
0.87A 4ymgB-1v0fA:
undetectable
4ymgB-1v0fA:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z2E_F_TR6F101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
SYMMETRIZED E-SITE
DNA)
5nh2 UNCHARACTERIZED
PROTEIN

(Bartonella
henselae)
4 / 5 GLY B  53
ARG B  52
GLY B  49
GLU B  48
GLY  B  53 ( 0.0A)
ARG  B  52 ( 0.6A)
GLY  B  49 ( 0.0A)
GLU  B  48 ( 0.6A)
1.17A 4z2eB-5nh2B:
undetectable
4z2eC-5nh2B:
undetectable
4z2eB-5nh2B:
10.20
4z2eC-5nh2B:
15.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z2E_H_TR6H101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
SYMMETRIZED E-SITE
DNA)
5l5n PLEXIN-A4
(Mus
musculus)
3 / 5 GLY A 867
GLY A 871
GLU A 870
GLY  A 867 ( 0.0A)
GLY  A 871 ( 0.0A)
GLU  A 870 ( 0.6A)
0.52A 4z2eA-5l5nA:
undetectable
4z2eD-5l5nA:
undetectable
4z2eA-5l5nA:
18.05
4z2eD-5l5nA:
11.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z53_H_TR6H101_1
(DNA TOPOISOMERASE 4
SUBUNIT B,DNA
TOPOISOMERASE 4
SUBUNIT A
E-SITE DNA)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 7 GLY A  84
ASP A  83
GLY A  58
GLU A  78
GLY  A  84 ( 0.0A)
ASP  A  83 ( 0.6A)
GLY  A  58 ( 0.0A)
GLU  A  78 ( 0.6A)
0.94A 4z53A-2ogsA:
2.2
4z53B-2ogsA:
1.7
4z53A-2ogsA:
21.16
4z53B-2ogsA:
21.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZBQ_A_ACTA605_0
(SERUM ALBUMIN)
3gwm HOLO-[ACYL-CARRIER-P
ROTEIN] SYNTHASE

(Mycolicibacteriu
m
smegmatis)
4 / 6 HIS A  80
GLY A  78
GLU A  29
ARG A  81
HIS  A  80 (-1.0A)
GLY  A  78 (-0.0A)
GLU  A  29 (-0.5A)
ARG  A  81 (-0.6A)
1.30A 4zbqA-3gwmA:
undetectable
4zbqA-3gwmA:
14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZBQ_A_ACTA605_0
(SERUM ALBUMIN)
4wxj GLUTAMATE RECEPTOR
IIB,GLUTAMATE
RECEPTOR IIB

(Drosophila
melanogaster)
4 / 6 TYR A  68
GLY A  18
GLU A 182
ASN A 181
GLU  A 301 (-2.8A)
None
None
GLU  A 301 ( 3.5A)
1.26A 4zbqA-4wxjA:
undetectable
4zbqA-4wxjA:
16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZBQ_A_DIFA602_1
(SERUM ALBUMIN)
2hk0 D-PSICOSE
3-EPIMERASE

(Agrobacterium
tumefaciens)
4 / 8 ASP A 275
ASN A 278
ALA A 279
GLU A 212
ASP  A 275 ( 0.6A)
ASN  A 278 ( 0.6A)
ALA  A 279 ( 0.0A)
GLU  A 212 ( 0.6A)
0.90A 4zbqA-2hk0A:
undetectable
4zbqA-2hk0A:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZJL_A_ERYA1101_0
(MULTIDRUG EFFLUX
PUMP SUBUNIT ACRB)
5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE

(Bacillus
subtilis)
5 / 12 SER A 347
GLU A 348
GLU A 211
THR A 202
GLY A 203
SER  A 347 ( 0.0A)
GLU  A 348 ( 0.6A)
GLU  A 211 ( 0.6A)
THR  A 202 ( 0.8A)
GLY  A 203 ( 0.0A)
1.45A 4zjlA-5ep8A:
undetectable
4zjlA-5ep8A:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZN7_A_DESA601_1
(ESTROGEN RECEPTOR)
5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE

(Bacillus
subtilis)
5 / 12 LEU A 289
ALA A 292
GLU A 291
MET A 233
LEU A 296
LEU  A 289 ( 0.6A)
ALA  A 292 ( 0.0A)
GLU  A 291 ( 0.6A)
MET  A 233 ( 0.0A)
LEU  A 296 ( 0.5A)
1.02A 4zn7A-5ep8A:
undetectable
4zn7A-5ep8A:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZVM_A_DM2A303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
5 / 12 GLY A  84
GLY A  85
THR A  86
GLU A 343
ILE A 342
GLY  A  84 ( 0.0A)
GLY  A  85 ( 0.0A)
THR  A  86 ( 0.8A)
GLU  A 343 ( 0.6A)
ILE  A 342 ( 0.6A)
1.19A 4zvmA-4kqnA:
undetectable
4zvmB-4kqnA:
undetectable
4zvmA-4kqnA:
20.17
4zvmB-4kqnA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZVM_A_DM2A303_1
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])
5nks DIHYDROPYRIMIDINASE-
RELATED PROTEIN 4

(Homo
sapiens)
5 / 12 GLY A  99
GLY A 100
THR A 101
GLU A 359
ILE A 358
GLY  A  99 ( 0.0A)
GLY  A 100 ( 0.0A)
THR  A 101 ( 0.8A)
GLU  A 359 ( 0.6A)
ILE  A 358 ( 0.7A)
1.24A 4zvmA-5nksA:
undetectable
4zvmB-5nksA:
undetectable
4zvmA-5nksA:
18.43
4zvmB-5nksA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZB_C_ACTC401_0
(PROTON-GATED ION
CHANNEL)
5gpr CHITINASE
(Ostrinia
furnacalis)
4 / 7 ILE A 506
ARG A 499
VAL A 497
GLU A 478
ILE  A 506 ( 0.7A)
ARG  A 499 ( 0.6A)
VAL  A 497 ( 0.6A)
GLU  A 478 ( 0.6A)
0.93A 4zzbC-5gprA:
undetectable
4zzbD-5gprA:
undetectable
4zzbC-5gprA:
20.43
4zzbD-5gprA:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZC_A_ACTA401_0
(PROTON-GATED ION
CHANNEL)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
4 / 6 ILE A  69
PHE A  81
ARG A  75
ILE A  54
GLU  A1620 (-4.9A)
None
GLU  A1620 (-2.9A)
None
1.18A 4zzcA-2pyyA:
undetectable
4zzcB-2pyyA:
undetectable
4zzcA-2pyyA:
23.29
4zzcB-2pyyA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZC_B_ACTB401_0
(PROTON-GATED ION
CHANNEL)
2pyy IONOTROPIC GLUTAMATE
RECEPTOR BACTERIAL
HOMOLOGUE

(Nostoc
punctiforme)
4 / 6 ILE A  69
PHE A  81
ARG A  75
ILE A  54
GLU  A1620 (-4.9A)
None
GLU  A1620 (-2.9A)
None
1.20A 4zzcB-2pyyA:
undetectable
4zzcC-2pyyA:
undetectable
4zzcB-2pyyA:
23.29
4zzcC-2pyyA:
23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_D_SORD1343_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)
4dlk PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE, ATPASE
SUBUNIT

(Bacillus
anthracis)
4 / 5 ARG A 107
HIS A 274
ALA A 270
GLU A 268
ARG  A 107 (-0.6A)
HIS  A 274 (-1.0A)
ALA  A 270 ( 0.0A)
GLU  A 268 (-0.6A)
1.41A 5a06C-4dlkA:
undetectable
5a06D-4dlkA:
undetectable
5a06C-4dlkA:
21.81
5a06D-4dlkA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_F_SORF1342_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)
3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE

(Mycobacteroides
abscessus)
4 / 4 ARG A  34
HIS A  10
ALA A  12
GLU A  18
ARG  A  34 ( 0.6A)
HIS  A  10 ( 1.0A)
ALA  A  12 ( 0.0A)
GLU  A  18 ( 0.5A)
1.34A 5a06A-3r9rA:
0.0
5a06F-3r9rA:
0.0
5a06A-3r9rA:
22.82
5a06F-3r9rA:
22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_F_SORF1342_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)
4dlk PHOSPHORIBOSYLAMINOI
MIDAZOLE
CARBOXYLASE, ATPASE
SUBUNIT

(Bacillus
anthracis)
4 / 4 ARG A 107
HIS A 274
ALA A 270
GLU A 268
ARG  A 107 (-0.6A)
HIS  A 274 (-1.0A)
ALA  A 270 ( 0.0A)
GLU  A 268 (-0.6A)
1.34A 5a06A-4dlkA:
undetectable
5a06F-4dlkA:
1.2
5a06A-4dlkA:
21.81
5a06F-4dlkA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.33A 5ad4A-5bs1A:
undetectable
5ad4B-5bs1A:
undetectable
5ad4A-5bs1A:
14.45
5ad4B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 5ad4A-5bs1A:
undetectable
5ad4B-5bs1A:
undetectable
5ad4A-5bs1A:
14.45
5ad4B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD6_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.33A 5ad6A-5bs1A:
undetectable
5ad6B-5bs1A:
undetectable
5ad6A-5bs1A:
14.45
5ad6B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AD9_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.35A 5ad9A-5bs1A:
undetectable
5ad9B-5bs1A:
undetectable
5ad9A-5bs1A:
14.45
5ad9B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5adaA-5bs1A:
undetectable
5adaB-5bs1A:
undetectable
5adaA-5bs1A:
14.45
5adaB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADA_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.32A 5adaA-5bs1A:
undetectable
5adaB-5bs1A:
undetectable
5adaA-5bs1A:
14.45
5adaB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADC_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5adcA-5bs1A:
undetectable
5adcB-5bs1A:
undetectable
5adcA-5bs1A:
14.45
5adcB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADF_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5adfA-5bs1A:
undetectable
5adfB-5bs1A:
undetectable
5adfA-5bs1A:
15.97
5adfB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADG_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 5adgA-5bs1A:
undetectable
5adgB-5bs1A:
undetectable
5adgA-5bs1A:
15.97
5adgB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADG_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 5adgA-5bs1A:
undetectable
5adgB-5bs1A:
undetectable
5adgA-5bs1A:
15.97
5adgB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ADI_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5adiA-5bs1A:
undetectable
5adiB-5bs1A:
undetectable
5adiA-5bs1A:
15.97
5adiB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGK_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 5agkA-5bs1A:
undetectable
5agkB-5bs1A:
undetectable
5agkA-5bs1A:
14.45
5agkB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGL_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 5aglA-5bs1A:
undetectable
5aglB-5bs1A:
undetectable
5aglA-5bs1A:
14.45
5aglB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGL_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 5aglA-5bs1A:
undetectable
5aglB-5bs1A:
undetectable
5aglA-5bs1A:
14.45
5aglB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5agmA-5bs1A:
undetectable
5agmB-5bs1A:
undetectable
5agmA-5bs1A:
14.45
5agmB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5agoA-5bs1A:
undetectable
5agoB-5bs1A:
undetectable
5agoA-5bs1A:
14.45
5agoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AGO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 5agoA-5bs1A:
undetectable
5agoB-5bs1A:
undetectable
5agoA-5bs1A:
14.45
5agoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AJQ_B_DB8B800_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
5 / 10 ALA A  28
PHE A  27
GLY A 150
ALA A 181
ASP A 184
None
GLU  A1055 (-3.7A)
None
None
None
1.28A 5ajqB-2dvzA:
undetectable
5ajqB-2dvzA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AOX_C_ACTC1001_0
(ALU JO CONSENSUS RNA
SIGNAL RECOGNITION
PARTICLE 14 KDA
PROTEIN)
2vha PERIPLASMIC BINDING
TRANSPORT PROTEIN

(Shigella
flexneri)
3 / 3 TYR A 211
THR A 106
THR A  92
GLU  A1280 (-4.7A)
None
GLU  A1280 (-4.0A)
0.70A 5aoxB-2vhaA:
undetectable
5aoxB-2vhaA:
17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5AOX_F_ACTF1001_0
(ALU JO CONSENSUS RNA
SIGNAL RECOGNITION
PARTICLE 14 KDA
PROTEIN)
2vha PERIPLASMIC BINDING
TRANSPORT PROTEIN

(Shigella
flexneri)
3 / 3 TYR A 211
THR A 106
THR A  92
GLU  A1280 (-4.7A)
None
GLU  A1280 (-4.0A)
0.74A 5aoxE-2vhaA:
undetectable
5aoxE-2vhaA:
17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BPH_C_ACTC403_0
(D-ALANINE--D-ALANINE
LIGASE)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
4 / 4 TYR A 109
GLY A  26
SER A  25
LEU A  76
None
GLU  A1313 ( 3.8A)
None
None
1.37A 5bphC-1us4A:
2.9
5bphC-1us4A:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BS8_G_MFXG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 7 ALA A  14
ARG A 286
GLY A 282
GLU A 279
ALA  A  14 ( 0.0A)
ARG  A 286 ( 0.6A)
GLY  A 282 ( 0.0A)
GLU  A 279 ( 0.5A)
0.86A 5bs8A-3c3nA:
undetectable
5bs8C-3c3nA:
undetectable
5bs8D-3c3nA:
undetectable
5bs8A-3c3nA:
20.95
5bs8C-3c3nA:
20.95
5bs8D-3c3nA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BS8_H_MFXH101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 7 ALA A  14
ARG A 286
GLY A 282
GLU A 279
ALA  A  14 ( 0.0A)
ARG  A 286 ( 0.6A)
GLY  A 282 ( 0.0A)
GLU  A 279 ( 0.5A)
0.85A 5bs8A-3c3nA:
undetectable
5bs8B-3c3nA:
undetectable
5bs8C-3c3nA:
undetectable
5bs8A-3c3nA:
20.95
5bs8B-3c3nA:
21.00
5bs8C-3c3nA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BS8_H_MFXH101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)
4oud TYROSYL-TRNA
SYNTHETASE

(Escherichia
coli)
4 / 7 ALA B  49
ARG B 309
GLY B 313
GLU B 314
ALA  B  49 ( 0.0A)
ARG  B 309 ( 0.6A)
GLY  B 313 ( 0.0A)
GLU  B 314 ( 0.5A)
0.96A 5bs8A-4oudB:
undetectable
5bs8B-4oudB:
2.9
5bs8C-4oudB:
undetectable
5bs8A-4oudB:
22.39
5bs8B-4oudB:
22.14
5bs8C-4oudB:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTD_E_GFNE101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 7 ALA A  14
ARG A 286
GLY A 282
GLU A 279
ALA  A  14 ( 0.0A)
ARG  A 286 ( 0.6A)
GLY  A 282 ( 0.0A)
GLU  A 279 ( 0.5A)
0.88A 5btdA-3c3nA:
undetectable
5btdB-3c3nA:
undetectable
5btdC-3c3nA:
undetectable
5btdA-3c3nA:
20.95
5btdB-3c3nA:
21.00
5btdC-3c3nA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTD_E_GFNE101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)
4oud TYROSYL-TRNA
SYNTHETASE

(Escherichia
coli)
4 / 7 ALA B  49
ARG B 309
GLY B 313
GLU B 314
ALA  B  49 ( 0.0A)
ARG  B 309 ( 0.6A)
GLY  B 313 ( 0.0A)
GLU  B 314 ( 0.5A)
0.96A 5btdA-4oudB:
undetectable
5btdB-4oudB:
3.0
5btdC-4oudB:
undetectable
5btdA-4oudB:
22.39
5btdB-4oudB:
22.14
5btdC-4oudB:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTD_G_GFNG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)
1rrv GLYCOSYLTRANSFERASE
GTFD

(Amycolatopsis
orientalis)
4 / 7 ALA A 388
ASP A 221
ARG A 223
GLU A  45
ALA  A 388 ( 0.0A)
ASP  A 221 ( 0.6A)
ARG  A 223 (-0.6A)
GLU  A  45 ( 0.6A)
0.93A 5btdA-1rrvA:
0.0
5btdC-1rrvA:
undetectable
5btdD-1rrvA:
2.3
5btdA-1rrvA:
25.98
5btdC-1rrvA:
25.98
5btdD-1rrvA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTD_G_GFNG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 7 ALA A  14
ARG A 286
GLY A 282
GLU A 279
ALA  A  14 ( 0.0A)
ARG  A 286 ( 0.6A)
GLY  A 282 ( 0.0A)
GLU  A 279 ( 0.5A)
0.89A 5btdA-3c3nA:
undetectable
5btdC-3c3nA:
undetectable
5btdD-3c3nA:
undetectable
5btdA-3c3nA:
20.95
5btdC-3c3nA:
20.95
5btdD-3c3nA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTD_G_GFNG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)
4oud TYROSYL-TRNA
SYNTHETASE

(Escherichia
coli)
4 / 7 ALA B  49
ARG B 309
GLY B 313
GLU B 314
ALA  B  49 ( 0.0A)
ARG  B 309 ( 0.6A)
GLY  B 313 ( 0.0A)
GLU  B 314 ( 0.5A)
0.98A 5btdA-4oudB:
undetectable
5btdC-4oudB:
undetectable
5btdD-4oudB:
2.8
5btdA-4oudB:
22.39
5btdC-4oudB:
22.39
5btdD-4oudB:
22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTF_G_GFNG101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
4 / 7 SER A 233
ASP A 163
ARG A 223
GLU A 219
SER  A 233 ( 0.0A)
ASP  A 163 ( 0.6A)
ARG  A 223 ( 0.6A)
GLU  A 219 ( 0.6A)
1.11A 5btfA-4kqnA:
undetectable
5btfC-4kqnA:
undetectable
5btfD-4kqnA:
undetectable
5btfA-4kqnA:
22.00
5btfC-4kqnA:
22.00
5btfD-4kqnA:
20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTG_E_LFXE101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
GGTCATGAATGACTATGCAC
GTAA)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 6 ALA A  14
ARG A 286
GLY A 282
GLU A 279
ALA  A  14 ( 0.0A)
ARG  A 286 ( 0.6A)
GLY  A 282 ( 0.0A)
GLU  A 279 ( 0.5A)
0.89A 5btgA-3c3nA:
undetectable
5btgB-3c3nA:
undetectable
5btgC-3c3nA:
undetectable
5btgA-3c3nA:
20.95
5btgB-3c3nA:
21.00
5btgC-3c3nA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BTG_F_LFXF101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT B
DNA SUBSTRATE 24-MER
TTACGTGCATAGTCATTCAT
GACC)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 7 ALA A  14
ARG A 286
GLY A 282
GLU A 279
ALA  A  14 ( 0.0A)
ARG  A 286 ( 0.6A)
GLY  A 282 ( 0.0A)
GLU  A 279 ( 0.5A)
0.92A 5btgA-3c3nA:
undetectable
5btgC-3c3nA:
undetectable
5btgD-3c3nA:
undetectable
5btgA-3c3nA:
20.95
5btgC-3c3nA:
20.95
5btgD-3c3nA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BW4_B_SAMB301_1
(16S RRNA
(ADENINE(1408)-N(1))
-METHYLTRANSFERASE)
5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM

(Homo
sapiens)
3 / 3 ASP A 278
GLU A 241
SER A 318
ASP  A 278 ( 0.6A)
GLU  A 241 ( 0.6A)
SER  A 318 ( 0.0A)
0.64A 5bw4B-5jjaA:
undetectable
5bw4B-5jjaA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_G_EVPG2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)
2hk0 D-PSICOSE
3-EPIMERASE

(Agrobacterium
tumefaciens)
4 / 6 SER A   8
GLU A  11
GLY A 106
GLY A  67
SER  A   8 ( 0.0A)
GLU  A  11 ( 0.6A)
GLY  A 106 ( 0.0A)
GLY  A  67 ( 0.0A)
0.82A 5cdnA-2hk0A:
undetectable
5cdnB-2hk0A:
undetectable
5cdnA-2hk0A:
23.31
5cdnB-2hk0A:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_G_EVPG2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)
4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE

(Saccharomyces
cerevisiae)
5 / 6 SER A  83
GLU A 126
GLY A 382
ASP A 383
GLY A  64
SER  A  83 (-0.0A)
GLU  A 126 ( 0.5A)
GLY  A 382 (-0.0A)
ASP  A 383 (-0.5A)
GLY  A  64 (-0.0A)
1.05A 5cdnA-4g9kA:
undetectable
5cdnB-4g9kA:
2.2
5cdnA-4g9kA:
22.75
5cdnB-4g9kA:
16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_N_EVPN2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)
2hk0 D-PSICOSE
3-EPIMERASE

(Agrobacterium
tumefaciens)
4 / 6 SER A   8
GLU A  11
GLY A 106
GLY A  67
SER  A   8 ( 0.0A)
GLU  A  11 ( 0.6A)
GLY  A 106 ( 0.0A)
GLY  A  67 ( 0.0A)
0.81A 5cdnR-2hk0A:
undetectable
5cdnS-2hk0A:
undetectable
5cdnR-2hk0A:
23.31
5cdnS-2hk0A:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_O_EVPO2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)
4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE

(Saccharomyces
cerevisiae)
4 / 6 GLU A 126
GLY A 382
ASP A 383
GLY A  64
GLU  A 126 ( 0.5A)
GLY  A 382 (-0.0A)
ASP  A 383 (-0.5A)
GLY  A  64 (-0.0A)
0.74A 5cdnC-4g9kA:
undetectable
5cdnD-4g9kA:
undetectable
5cdnC-4g9kA:
22.75
5cdnD-4g9kA:
16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CDN_P_EVPP2101_1
(DNA GYRASE SUBUNIT A
DNA GYRASE SUBUNIT
B,DNA GYRASE SUBUNIT
B)
4g9k ROTENONE-INSENSITIVE
NADH-UBIQUINONE
OXIDOREDUCTASE

(Saccharomyces
cerevisiae)
4 / 6 GLU A 126
GLY A 382
ASP A 383
GLY A  64
GLU  A 126 ( 0.5A)
GLY  A 382 (-0.0A)
ASP  A 383 (-0.5A)
GLY  A  64 (-0.0A)
0.78A 5cdnT-4g9kA:
undetectable
5cdnU-4g9kA:
undetectable
5cdnT-4g9kA:
22.75
5cdnU-4g9kA:
16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CPR_B_SAMB402_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SUV420H1)
5d7w SERRALYSIN
(Serratia
marcescens)
5 / 12 GLY A  36
ALA A  35
SER A 215
TYR A 190
GLU A  42
GLY  A  36 ( 0.0A)
ALA  A  35 ( 0.0A)
SER  A 215 ( 0.0A)
TYR  A 190 ( 1.3A)
GLU  A  42 ( 0.6A)
1.31A 5cprB-5d7wA:
undetectable
5cprB-5d7wA:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CYM_A_T27A601_1
(HIV-1 REVERSE
TRANSCRIPTASE, P66
SUBUNIT)
3iha SALT-TOLERANT
GLUTAMINASE

(Micrococcus
luteus)
5 / 12 PRO A 108
LEU A 174
VAL A 188
TYR A 191
LEU A 170
None
None
None
GLU  A 500 (-4.1A)
None
1.17A 5cymA-3ihaA:
undetectable
5cymA-3ihaA:
21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D4U_A_SAMA301_0
(UNCHARACTERIZED
PROTEIN MJ0489)
3t7b ACETYLGLUTAMATE
KINASE

(Yersinia
pestis)
5 / 12 LEU A 178
TRP A 236
ILE A 184
LEU A 185
GLY A   9
None
None
None
None
GLU  A 258 ( 4.0A)
1.11A 5d4uA-3t7bA:
undetectable
5d4uA-3t7bA:
23.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D4U_B_SAMB301_0
(UNCHARACTERIZED
PROTEIN MJ0489)
3t7b ACETYLGLUTAMATE
KINASE

(Yersinia
pestis)
5 / 12 LEU A 178
TRP A 236
ILE A 184
LEU A 185
GLY A   9
None
None
None
None
GLU  A 258 ( 4.0A)
1.13A 5d4uB-3t7bA:
undetectable
5d4uB-3t7bA:
23.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DXB_A_ESTA1000_1
(ESTROGEN RECEPTOR)
3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE

(Citrus
x
microcarpa)
5 / 10 LEU A 222
ALA A 113
GLU A 116
ARG A 234
LEU A 187
LEU  A 222 ( 0.6A)
ALA  A 113 ( 0.0A)
GLU  A 116 ( 0.5A)
ARG  A 234 ( 0.6A)
LEU  A 187 ( 0.5A)
1.23A 5dxbA-3wd7A:
undetectable
5dxbA-3wd7A:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DXE_A_ESTA1000_1
(ESTROGEN RECEPTOR)
5hxk ZINC-DEPENDENT
PEPTIDASE

(Thermus
thermophilus)
4 / 8 LEU A 138
GLU A 153
LEU A 129
LEU A 397
LEU  A 138 ( 0.6A)
GLU  A 153 ( 0.6A)
LEU  A 129 ( 0.5A)
LEU  A 397 ( 0.6A)
1.25A 5dxeA-5hxkA:
undetectable
5dxeA-5hxkA:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ECM_D_LEUD602_0
(JASMONIC ACID-AMIDO
SYNTHETASE JAR1)
5ihl 3H56-5 DOMAIN
ANTIBODY (DAB)

(Homo
sapiens)
4 / 7 ALA B  88
THR B  87
VAL B 109
GLU B  85
ALA  B  88 ( 0.0A)
THR  B  87 ( 0.8A)
VAL  B 109 ( 0.5A)
GLU  B  85 ( 0.6A)
0.75A 5ecmD-5ihlB:
undetectable
5ecmD-5ihlB:
12.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EQB_A_1YNA602_2
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
3iha SALT-TOLERANT
GLUTAMINASE

(Micrococcus
luteus)
4 / 4 TYR A 243
TYR A 191
PRO A  68
THR A  61
None
GLU  A 500 (-4.1A)
None
None
1.22A 5eqbA-3ihaA:
0.0
5eqbA-3ihaA:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo
sapiens)
5 / 8 GLU A 339
VAL A 157
HIS A 160
ASP A 201
HIS A 233
GLU  A 339 ( 0.5A)
VAL  A 157 ( 0.6A)
HIS  A 160 ( 1.0A)
ASP  A 201 ( 0.5A)
HIS  A 233 ( 1.0A)
1.31A 5f8yA-3sl5A:
undetectable
5f8yA-3sl5A:
16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo
sapiens)
5 / 8 GLU A 339
VAL A 157
HIS A 160
ASP A 201
HIS A 233
GLU  A 339 ( 0.5A)
VAL  A 157 ( 0.6A)
HIS  A 160 ( 1.0A)
ASP  A 201 ( 0.5A)
HIS  A 233 ( 1.0A)
1.34A 5f8yB-3sl5A:
undetectable
5f8yB-3sl5A:
16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F9Z_B_HFGB703_0
(AMINOACYL-TRNA
SYNTHETASE)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
5 / 12 LEU A  73
SER A  99
GLU A 127
SER A  67
GLY A 224
LEU  A  73 (-0.6A)
SER  A  99 ( 0.0A)
GLU  A 127 ( 0.5A)
SER  A  67 ( 0.0A)
GLY  A 224 (-0.0A)
1.34A 5f9zB-3c3nA:
undetectable
5f9zB-3c3nA:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVR_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5fvrA-5bs1A:
undetectable
5fvrB-5bs1A:
undetectable
5fvrA-5bs1A:
14.45
5fvrB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.26A 5fvrA-5bs1A:
undetectable
5fvrB-5bs1A:
undetectable
5fvrA-5bs1A:
14.45
5fvrB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5fvwA-5bs1A:
undetectable
5fvwB-5bs1A:
undetectable
5fvwA-5bs1A:
15.97
5fvwB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVW_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 5fvwA-5bs1A:
undetectable
5fvwB-5bs1A:
undetectable
5fvwA-5bs1A:
15.97
5fvwB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FW0_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5fw0A-5bs1A:
undetectable
5fw0B-5bs1A:
undetectable
5fw0A-5bs1A:
14.45
5fw0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FW0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 5fw0A-5bs1A:
undetectable
5fw0B-5bs1A:
undetectable
5fw0A-5bs1A:
14.45
5fw0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0O_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.27A 5g0oA-5bs1A:
undetectable
5g0oB-5bs1A:
undetectable
5g0oA-5bs1A:
14.45
5g0oB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GQB_A_GCSA602_1
(CHITINASE)
4zke SUPERKILLER PROTEIN
7

(Saccharomyces
cerevisiae)
3 / 3 TRP A 498
GLU A 440
ASP A 435
TRP  A 498 ( 0.5A)
GLU  A 440 ( 0.6A)
ASP  A 435 ( 0.6A)
1.01A 5gqbA-4zkeA:
undetectable
5gqbA-4zkeA:
21.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5GQB_A_GCSA602_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
3 / 3 TRP A 268
GLU A 308
ASP A 384
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
ASP  A 384 ( 0.5A)
0.28A 5gqbA-5gprA:
67.9
5gqbA-5gprA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5GQB_A_GCSA603_1
(CHITINASE)
5gpr CHITINASE
(Ostrinia
furnacalis)
8 / 8 PHE A 184
GLY A 267
TRP A 268
GLU A 308
TYR A 383
ASP A 384
ARG A 439
TRP A 532
PHE  A 184 ( 1.3A)
GLY  A 267 ( 0.0A)
TRP  A 268 ( 0.5A)
GLU  A 308 ( 0.6A)
TYR  A 383 ( 1.3A)
ASP  A 384 ( 0.5A)
ARG  A 439 ( 0.6A)
TRP  A 532 ( 0.5A)
0.27A 5gqbA-5gprA:
67.9
5gqbA-5gprA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GWZ_D_010D6_0
(N-[(5-METHYLISOXAZOL
-3-YL)CARBONYL]ALANY
L-L-VALYL-N~1~-((1R,
2Z)-4-(BENZYLOXY)-4-
OXO-1-{[(3R)-2-OXOPY
RROLIDIN-3-YL]METHYL
}BUT-2-ENYL)-L-LEUCI
NAMIDE
PEDV MAIN PROTEASE)
2qm6 GAMMA-GLUTAMYLTRANSP
EPTIDASE

(Helicobacter
pylori)
3 / 3 MET B 540
HIS B 504
GLY B 473
None
None
GLU  B   1 (-3.6A)
0.80A 5gwzB-2qm6B:
undetectable
5gwzB-2qm6B:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5H5F_A_SAMA301_1
(PROTEIN ARGININE
N-METHYLTRANSFERASE
SFM1)
4otu GAMMA-GLUTAMYLTRANSP
EPTIDASE

(Bacillus
licheniformis)
4 / 5 GLY B 481
PRO B 464
THR B 399
THR B 484
GLU  B 602 ( 4.2A)
None
GLU  B 602 (-2.7A)
None
1.07A 5h5fA-4otuB:
undetectable
5h5fA-4otuB:
24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HHJ_A_GLYA403_0
(RETRON-TYPE REVERSE
TRANSCRIPTASE)
2bzt PROTEIN ISCX
(Escherichia
coli)
4 / 4 LEU A   3
LEU A  15
GLY A  12
GLU A  13
LEU  A   3 ( 0.6A)
LEU  A  15 ( 0.6A)
GLY  A  12 ( 0.0A)
GLU  A  13 ( 0.6A)
1.25A 5hhjA-2bztA:
undetectable
5hhjA-2bztA:
17.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HI2_A_BAXA801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
6 / 12 ALA A  52
LYS A  54
GLU A  69
LEU A  73
LEU A 144
HIS A 151
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
GLU  A  69 ( 0.6A)
LEU  A  73 ( 0.6A)
LEU  A 144 ( 0.6A)
HIS  A 151 ( 1.0A)
0.92A 5hi2A-5d7aA:
24.7
5hi2A-5d7aA:
31.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3C_B_AC2B301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 10 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.79A 5i3cB-4g41A:
24.9
5i3cB-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3C_C_AC2C301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
ILE A 158
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
ILE  A 158 ( 0.7A)
0.79A 5i3cC-4g41A:
24.8
5i3cC-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I3C_C_AC2C301_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE)
4g41 MTA/SAH NUCLEOSIDASE
(Streptococcus
pyogenes)
5 / 11 VAL A 171
GLU A 172
MET A 173
GLU A 174
SER A 196
VAL  A 171 ( 0.6A)
GLU  A 172 ( 0.5A)
MET  A 173 ( 0.0A)
GLU  A 174 ( 0.6A)
SER  A 196 ( 0.0A)
0.69A 5i3cC-4g41A:
24.8
5i3cC-4g41A:
25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQB_D_KAND600_1
(BIFUNCTIONAL AAC/APH)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 12 ASP A 315
ASP A 141
TYR A 311
GLU A 294
TYR A 291
ASP  A 315 (-0.5A)
ASP  A 141 (-0.5A)
TYR  A 311 ( 1.3A)
GLU  A 294 ( 0.6A)
TYR  A 291 ( 1.3A)
1.29A 5iqbD-4flxA:
1.3
5iqbD-4flxA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQE_B_NMYB600_1
(BIFUNCTIONAL AAC/APH)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 10 ASP A 315
ASP A 141
TYR A 311
GLU A 294
TYR A 291
ASP  A 315 (-0.5A)
ASP  A 141 (-0.5A)
TYR  A 311 ( 1.3A)
GLU  A 294 ( 0.6A)
TYR  A 291 ( 1.3A)
1.46A 5iqeB-4flxA:
2.5
5iqeB-4flxA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQE_D_NMYD600_1
(BIFUNCTIONAL AAC/APH)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 12 ASP A 315
ASP A 141
TYR A 311
GLU A 294
TYR A 291
ASP  A 315 (-0.5A)
ASP  A 141 (-0.5A)
TYR  A 311 ( 1.3A)
GLU  A 294 ( 0.6A)
TYR  A 291 ( 1.3A)
1.32A 5iqeD-4flxA:
2.5
5iqeD-4flxA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQG_B_51GB600_1
(BIFUNCTIONAL AAC/APH)
4flx DNA POLYMERASE 1
(Pyrococcus
abyssi)
5 / 10 ASP A 315
ASP A 141
TYR A 311
GLU A 294
TYR A 291
ASP  A 315 (-0.5A)
ASP  A 141 (-0.5A)
TYR  A 311 ( 1.3A)
GLU  A 294 ( 0.6A)
TYR  A 291 ( 1.3A)
1.47A 5iqgB-4flxA:
0.0
5iqgB-4flxA:
17.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JHD_E_EDTE301_0
(BETA-2-MICROGLOBULIN
TCRBETA CHAIN)
2zns GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 1

(Homo
sapiens)
4 / 8 SER A 674
THR A 503
THR A 505
ILE A 523
GLU  A 301 (-3.2A)
GLU  A 301 (-3.9A)
None
None
0.92A 5jhdE-2znsA:
undetectable
5jhdG-2znsA:
undetectable
5jhdE-2znsA:
20.30
5jhdG-2znsA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JHD_E_EDTE301_0
(BETA-2-MICROGLOBULIN
TCRBETA CHAIN)
3h6t GLUTAMATE RECEPTOR 2
(Rattus
norvegicus)
4 / 8 SER A 142
THR A  91
THR A  93
ILE A 111
GLU  A 264 (-3.2A)
GLU  A 264 (-4.2A)
None
None
1.04A 5jhdE-3h6tA:
undetectable
5jhdG-3h6tA:
undetectable
5jhdE-3h6tA:
21.55
5jhdG-3h6tA:
16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JSD_B_1GNB603_1
(PHIAB6 TAILSPIKE)
5hfi UNCHARACTERIZED
PROTEIN, CYTOSOLIC
DISULFIDE REDUCTASE
DSBM

(Pseudomonas
aeruginosa)
3 / 3 VAL A 122
GLU A 135
GLU A 139
VAL  A 122 ( 0.6A)
GLU  A 135 ( 0.6A)
GLU  A 139 ( 0.6A)
0.82A 5jsdB-5hfiA:
undetectable
5jsdC-5hfiA:
undetectable
5jsdB-5hfiA:
15.74
5jsdC-5hfiA:
15.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KBW_A_RBFA201_1
(RIBOFLAVIN
TRANSPORTER RIBU)
1i7q TRPG
(Serratia
marcescens)
5 / 12 GLU B 174
LEU B  86
GLY B  83
LEU B   7
ASN B  33
None
GLU  B1401 (-4.0A)
None
None
None
1.23A 5kbwA-1i7qB:
undetectable
5kbwA-1i7qB:
23.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L6E_B_ACTB401_0
(N6-ADENOSINE-METHYLT
RANSFERASE 70 KDA
SUBUNIT
N6-ADENOSINE-METHYLT
RANSFERASE SUBUNIT
METTL14)
6ezy -
(-)
4 / 6 GLU A  96
ARG A  92
LEU A 163
ARG A  67
GLU  A  96 ( 0.6A)
ARG  A  92 ( 0.6A)
LEU  A 163 ( 0.6A)
ARG  A  67 ( 0.6A)
0.87A 5l6eA-6ezyA:
undetectable
5l6eB-6ezyA:
undetectable
5l6eA-6ezyA:
undetectable
5l6eB-6ezyA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L8D_A_EDTA609_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
4 / 8 TYR A  74
ARG A  71
TYR A 236
THR A 188
GLU  A 701 (-4.6A)
None
GLU  A 701 (-3.4A)
GLU  A 701 (-3.1A)
1.46A 5l8dA-1ewkA:
1.7
5l8dA-1ewkA:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L8D_A_EDTA609_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
4 / 8 TYR A  64
ARG A  61
TYR A 223
THR A 175
GLU  A 506 (-4.6A)
None
GLU  A 506 (-3.4A)
GLU  A 506 (-3.0A)
1.47A 5l8dA-3lmkA:
1.7
5l8dA-3lmkA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LJC_A_RTLA201_1
(RETINOL-BINDING
PROTEIN 1)
3h6t GLUTAMATE RECEPTOR 2
(Rattus
norvegicus)
4 / 7 LEU A 127
THR A 143
TRP A 159
MET A 162
None
GLU  A 264 (-3.6A)
None
None
1.42A 5ljcA-3h6tA:
undetectable
5ljcA-3h6tA:
19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LJC_A_RTLA201_1
(RETINOL-BINDING
PROTEIN 1)
5ict GLUTAMATE RECEPTOR 1
(Drosophila
melanogaster)
4 / 7 LEU A 133
THR A 149
TRP A 165
MET A 168
None
GLU  A 301 (-3.4A)
None
None
1.43A 5ljcA-5ictA:
undetectable
5ljcA-5ictA:
20.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LRB_A_ACRA1003_1
(ALPHA-1,4 GLUCAN
PHOSPHORYLASE)
5xlu GAMMA GLUTAMYL
TRANSPEPTIDASE

(Bacillus
licheniformis)
4 / 6 GLU A 151
PHE A 225
THR A 224
TYR A 237
GLU  A 151 ( 0.6A)
PHE  A 225 ( 1.3A)
THR  A 224 ( 0.8A)
TYR  A 237 ( 1.3A)
1.29A 5lrbA-5xluA:
undetectable
5lrbA-5xluA:
6.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M45_A_ACTA803_0
(ACETONE CARBOXYLASE
ALPHA SUBUNIT)
1zlm OSTEOCLAST
STIMULATING FACTOR 1

(Homo
sapiens)
4 / 4 GLU A  30
PRO A  62
ILE A  61
LEU A  60
GLU  A  30 ( 0.6A)
PRO  A  62 ( 1.1A)
ILE  A  61 ( 0.5A)
LEU  A  60 ( 0.6A)
1.17A 5m45A-1zlmA:
undetectable
5m45A-1zlmA:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M45_D_ACTD803_0
(ACETONE CARBOXYLASE
ALPHA SUBUNIT)
1zlm OSTEOCLAST
STIMULATING FACTOR 1

(Homo
sapiens)
4 / 4 GLU A  30
PRO A  62
ILE A  61
LEU A  60
GLU  A  30 ( 0.6A)
PRO  A  62 ( 1.1A)
ILE  A  61 ( 0.5A)
LEU  A  60 ( 0.6A)
1.21A 5m45D-1zlmA:
undetectable
5m45D-1zlmA:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M45_G_ACTG803_0
(ACETONE CARBOXYLASE
ALPHA SUBUNIT)
1zlm OSTEOCLAST
STIMULATING FACTOR 1

(Homo
sapiens)
4 / 4 GLU A  30
PRO A  62
ILE A  61
LEU A  60
GLU  A  30 ( 0.6A)
PRO  A  62 ( 1.1A)
ILE  A  61 ( 0.5A)
LEU  A  60 ( 0.6A)
1.15A 5m45G-1zlmA:
undetectable
5m45G-1zlmA:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M45_J_ACTJ803_0
(ACETONE CARBOXYLASE
ALPHA SUBUNIT)
1zlm OSTEOCLAST
STIMULATING FACTOR 1

(Homo
sapiens)
4 / 4 GLU A  30
PRO A  62
ILE A  61
LEU A  60
GLU  A  30 ( 0.6A)
PRO  A  62 ( 1.1A)
ILE  A  61 ( 0.5A)
LEU  A  60 ( 0.6A)
1.20A 5m45J-1zlmA:
undetectable
5m45J-1zlmA:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MRA_B_DM2B204_1
(SORCIN)
2e4u METABOTROPIC
GLUTAMATE RECEPTOR 3

(Rattus
norvegicus)
4 / 6 TYR A 222
THR A 174
ASP A 221
GLY A 220
GLU  A 701 (-3.8A)
GLU  A 701 (-2.9A)
None
None
1.17A 5mraA-2e4uA:
undetectable
5mraB-2e4uA:
undetectable
5mraA-2e4uA:
13.64
5mraB-2e4uA:
13.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_A_ADNA401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
1vho ENDOGLUCANASE
(Thermotoga
maritima)
4 / 7 GLY A  17
GLU A  68
ALA A 168
ASN A  24
GLY  A  17 ( 0.0A)
GLU  A  68 ( 0.6A)
ALA  A 168 ( 0.0A)
ASN  A  24 ( 0.6A)
0.97A 5mvsA-1vhoA:
undetectable
5mvsA-1vhoA:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_B_ADNB401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
1vho ENDOGLUCANASE
(Thermotoga
maritima)
4 / 8 GLY A  17
GLU A  68
ALA A 168
ASN A  24
GLY  A  17 ( 0.0A)
GLU  A  68 ( 0.6A)
ALA  A 168 ( 0.0A)
ASN  A  24 ( 0.6A)
0.96A 5mvsB-1vhoA:
undetectable
5mvsB-1vhoA:
24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MWU_A_EDTA609_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
4 / 8 TYR A  74
ARG A  71
TYR A 236
THR A 188
GLU  A 701 (-4.6A)
None
GLU  A 701 (-3.4A)
GLU  A 701 (-3.1A)
1.46A 5mwuA-1ewkA:
1.7
5mwuA-1ewkA:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MWU_A_EDTA609_0
(NICKEL-BINDING
PERIPLASMIC PROTEIN)
3lmk METABOTROPIC
GLUTAMATE RECEPTOR 5

(Homo
sapiens)
4 / 8 TYR A  64
ARG A  61
TYR A 223
THR A 175
GLU  A 506 (-4.6A)
None
GLU  A 506 (-3.4A)
GLU  A 506 (-3.0A)
1.47A 5mwuA-3lmkA:
1.7
5mwuA-3lmkA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MZJ_A_TEPA2401_1
(ADENOSINE RECEPTOR
A2A,SOLUBLE
CYTOCHROME
B562,ADENOSINE
RECEPTOR A2A)
3o96 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo
sapiens)
4 / 8 LEU A 335
GLU A 256
LEU A 280
ILE A 290
LEU  A 335 ( 0.6A)
GLU  A 256 ( 0.6A)
LEU  A 280 ( 0.6A)
ILE  A 290 (-0.7A)
0.99A 5mzjA-3o96A:
2.3
5mzjA-3o96A:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N5J_A_HAEA306_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.31A 5n5jA-5d7wA:
14.2
5n5jA-5d7wA:
26.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5N5K_A_HAEA306_1
(MACROPHAGE
METALLOELASTASE)
5d7w SERRALYSIN
(Serratia
marcescens)
4 / 5 HIS A 176
GLU A 177
HIS A 180
HIS A 186
HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
0.27A 5n5kA-5d7wA:
13.8
5n5kA-5d7wA:
26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NVP_A_ACAA18_1
(ENVELOPE
GLYCOPROTEIN,GP41)
3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE

(Corynebacterium
glutamicum)
5 / 12 SER A 327
ASN A  34
GLU A  99
GLU A  94
LEU A  96
SER  A 327 ( 0.0A)
ASN  A  34 ( 0.6A)
GLU  A  99 ( 0.6A)
GLU  A  94 ( 0.6A)
LEU  A  96 ( 0.6A)
1.11A 5nvpA-3r64A:
0.0
5nvpA-3r64A:
5.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NWU_A_ACAA18_1
(WTFP-TAG,GP41)
2b92 INTERFERON-INDUCED
GUANYLATE-BINDING
PROTEIN 1

(Homo
sapiens)
5 / 12 ALA A  59
GLY A  60
GLN A 254
GLU A 257
GLU A 256
ALA  A  59 ( 0.0A)
GLY  A  60 ( 0.0A)
GLN  A 254 ( 0.6A)
GLU  A 257 ( 0.6A)
GLU  A 256 ( 0.6A)
1.13A 5nwuA-2b92A:
undetectable
5nwuA-2b92A:
7.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NWU_A_ACAA18_1
(WTFP-TAG,GP41)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
5 / 12 ALA A 231
GLY A 232
SER A 233
GLU A 243
LEU A 444
ALA  A 231 ( 0.0A)
GLY  A 232 ( 0.0A)
SER  A 233 ( 0.0A)
GLU  A 243 ( 0.6A)
LEU  A 444 ( 0.6A)
0.94A 5nwuA-3ulkA:
undetectable
5nwuA-3ulkA:
6.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NWV_A_ACAA18_1
(SCRFP-TAG,GP41)
5wml -
(-)
5 / 12 LEU A 315
GLY A 167
LYS A 169
LEU A 163
LEU A 318
None
PMP  A 501 (-3.4A)
GLU  A 502 ( 2.3A)
None
None
1.26A 5nwvA-5wmlA:
undetectable
5nwvA-5wmlA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NWW_A_ACAA18_1
(SCRFP-TAG,GP41)
5hfi UNCHARACTERIZED
PROTEIN, CYTOSOLIC
DISULFIDE REDUCTASE
DSBM

(Pseudomonas
aeruginosa)
5 / 12 GLY A 124
LEU A 133
LEU A 134
GLU A 135
LEU A 136
GLY  A 124 ( 0.0A)
LEU  A 133 ( 0.6A)
LEU  A 134 ( 0.6A)
GLU  A 135 ( 0.6A)
LEU  A 136 ( 0.6A)
0.72A 5nwwA-5hfiA:
undetectable
5nwwA-5hfiA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5O96_A_SAMA501_0
(RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE E)
4zke SUPERKILLER PROTEIN
7

(Saccharomyces
cerevisiae)
5 / 11 GLU A 329
GLY A 331
SER A 316
LEU A 302
THR A 324
GLU  A 329 ( 0.6A)
GLY  A 331 (-0.0A)
SER  A 316 ( 0.0A)
LEU  A 302 ( 0.6A)
THR  A 324 ( 0.8A)
1.02A 5o96A-4zkeA:
2.4
5o96B-4zkeA:
undetectable
5o96A-4zkeA:
20.56
5o96B-4zkeA:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ONL_A_010A302_0
(YNDL)
2bzt PROTEIN ISCX
(Escherichia
coli)
4 / 5 GLU A  55
LYS A  52
GLU A  51
PHE A  29
GLU  A  55 ( 0.6A)
LYS  A  52 ( 0.0A)
GLU  A  51 ( 0.6A)
PHE  A  29 ( 1.3A)
1.37A 5onlA-2bztA:
undetectable
5onlA-2bztA:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5SXQ_A_NIZA808_1
(CATALASE-PEROXIDASE)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 GLU A 261
VAL A 142
GLY A 245
LEU A 241
GLU  A 261 ( 0.6A)
VAL  A 142 ( 0.4A)
GLY  A 245 ( 0.0A)
LEU  A 241 ( 0.6A)
0.99A 5sxqA-2ogsA:
undetectable
5sxqA-2ogsA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5SXT_B_NIZB808_1
(CATALASE-PEROXIDASE)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 GLU A 261
VAL A 142
GLY A 245
LEU A 241
GLU  A 261 ( 0.6A)
VAL  A 142 ( 0.4A)
GLY  A 245 ( 0.0A)
LEU  A 241 ( 0.6A)
1.00A 5sxtB-2ogsA:
undetectable
5sxtB-2ogsA:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5SYJ_B_NIZB809_1
(CATALASE-PEROXIDASE)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 8 GLU A 261
VAL A 142
GLY A 245
LEU A 241
GLU  A 261 ( 0.6A)
VAL  A 142 ( 0.4A)
GLY  A 245 ( 0.0A)
LEU  A 241 ( 0.6A)
1.00A 5syjB-2ogsA:
undetectable
5syjB-2ogsA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5T8S_B_SAMB402_0
(S-ADENOSYLMETHIONINE
SYNTHASE)
4ikn AP-3 COMPLEX SUBUNIT
MU-1

(Rattus
norvegicus)
4 / 8 GLU A 185
ASP A 188
ILE A 187
ILE A 272
GLU  A 185 ( 0.6A)
ASP  A 188 ( 0.6A)
ILE  A 187 ( 0.6A)
ILE  A 272 ( 0.7A)
0.87A 5t8sA-4iknA:
undetectable
5t8sA-4iknA:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TE0_A_XINA401_1
(AP2-ASSOCIATED
PROTEIN KINASE 1)
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo
sapiens)
6 / 12 GLU A  29
ALA A  52
GLU A  69
PHE A 107
GLY A 111
LEU A 160
GLU  A  29 ( 0.6A)
ALA  A  52 (-0.0A)
GLU  A  69 ( 0.6A)
PHE  A 107 ( 1.3A)
GLY  A 111 (-0.0A)
LEU  A 160 (-0.6A)
0.65A 5te0A-5d7aA:
24.8
5te0A-5d7aA:
26.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TRQ_B_ACTB307_0
(WELO5)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
3 / 3 GLU A 141
HIS A 111
VAL A 115
GLU  A 141 ( 0.6A)
HIS  A 111 (-1.0A)
VAL  A 115 ( 0.6A)
0.81A 5trqB-3ulkA:
undetectable
5trqB-3ulkA:
21.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TUD_D_ERMD1201_2
(5-HYDROXYTRYPTAMINE
RECEPTOR 2B,SOLUBLE
CYTOCHROME B562
CHIMERA)
2ixq PROTEIN AFAD
(Escherichia
coli)
4 / 6 LEU A  16
THR A 142
LEU A   6
GLU A  42
LEU  A  16 ( 0.4A)
THR  A 142 ( 0.2A)
LEU  A   6 ( 0.5A)
GLU  A  42 ( 0.5A)
0.96A 5tudD-2ixqA:
undetectable
5tudD-2ixqA:
14.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UL4_A_SAMA803_0
(OXSB PROTEIN)
2jfn GLUTAMATE RACEMASE
(Escherichia
coli)
5 / 12 ALA A 134
GLY A 137
GLY A  61
ILE A  68
LEU A 100
None
None
GLU  A1287 (-3.5A)
None
UMA  A1286 (-4.4A)
1.02A 5ul4A-2jfnA:
2.7
5ul4A-2jfnA:
17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 5unrA-5bs1A:
undetectable
5unrB-5bs1A:
undetectable
5unrA-5bs1A:
14.45
5unrB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.34A 5unuA-5bs1A:
undetectable
5unuB-5bs1A:
undetectable
5unuA-5bs1A:
14.45
5unuB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.37A 5unuA-5bs1A:
undetectable
5unuB-5bs1A:
undetectable
5unuA-5bs1A:
14.45
5unuB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNV_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.34A 5unvA-5bs1A:
undetectable
5unvB-5bs1A:
undetectable
5unvA-5bs1A:
14.45
5unvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.33A 5unvA-5bs1A:
undetectable
5unvB-5bs1A:
undetectable
5unvA-5bs1A:
14.45
5unvB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 5unwA-5bs1A:
undetectable
5unwB-5bs1A:
undetectable
5unwA-5bs1A:
14.45
5unwB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.36A 5unwA-5bs1A:
undetectable
5unwB-5bs1A:
undetectable
5unwA-5bs1A:
14.45
5unwB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5unyA-5bs1A:
undetectable
5unyB-5bs1A:
undetectable
5unyA-5bs1A:
14.45
5unyB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UNY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.33A 5unyA-5bs1A:
undetectable
5unyB-5bs1A:
undetectable
5unyA-5bs1A:
14.45
5unyB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO0_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.38A 5uo0A-5bs1A:
undetectable
5uo0B-5bs1A:
undetectable
5uo0A-5bs1A:
14.45
5uo0B-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 5uo1A-5bs1A:
undetectable
5uo1B-5bs1A:
undetectable
5uo1A-5bs1A:
15.97
5uo1B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.27A 5uo1A-5bs1A:
undetectable
5uo1B-5bs1A:
undetectable
5uo1A-5bs1A:
15.97
5uo1B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 5uo3A-5bs1A:
undetectable
5uo3B-5bs1A:
undetectable
5uo3A-5bs1A:
15.97
5uo3B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO4_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 5uo4A-5bs1A:
undetectable
5uo4B-5bs1A:
undetectable
5uo4A-5bs1A:
15.97
5uo4B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5uo5A-5bs1A:
undetectable
5uo5B-5bs1A:
undetectable
5uo5A-5bs1A:
15.97
5uo5B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO5_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 5uo5A-5bs1A:
undetectable
5uo5B-5bs1A:
undetectable
5uo5A-5bs1A:
15.97
5uo5B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO6_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.33A 5uo6A-5bs1A:
undetectable
5uo6B-5bs1A:
undetectable
5uo6A-5bs1A:
15.97
5uo6B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UO7_B_H4BB803_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.32A 5uo7A-5bs1A:
undetectable
5uo7B-5bs1A:
undetectable
5uo7A-5bs1A:
15.97
5uo7B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UTU_H_ADNH503_2
(ADENOSYLHOMOCYSTEINA
SE)
5ict GLUTAMATE RECEPTOR 1
(Drosophila
melanogaster)
4 / 5 THR A  99
GLU A 151
HIS A 177
LEU A 144
None
None
None
GLU  A 301 ( 3.8A)
1.33A 5utuH-5ictA:
undetectable
5utuH-5ictA:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UUN_A_ACTA310_0
(GLUTATHIONE
S-TRANSFERASE-LIKE
PROTEIN)
1rrv GLYCOSYLTRANSFERASE
GTFD

(Amycolatopsis
orientalis)
3 / 3 GLU A 315
HIS A 316
ARG A 320
GLU  A 315 ( 0.6A)
HIS  A 316 ( 1.0A)
ARG  A 320 ( 0.6A)
0.91A 5uunA-1rrvA:
0.6
5uunA-1rrvA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXC_A_ZITA307_1
(PREDICTED
AMINOGLYCOSIDE
PHOSPHOTRANSFERASE)
1i7q ANTHRANILATE
SYNTHASE
TRPG

(Serratia
marcescens)
4 / 5 ASP B  19
PRO B  57
ARG A 375
THR B  14
None
GLU  B1401 (-3.8A)
None
None
1.02A 5uxcA-1i7qB:
0.0
5uxcA-1i7qB:
24.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXD_A_ZITA501_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E MPHH)
2ogs THERMOSTABLE
CARBOXYLESTERASE
EST50

(Geobacillus
stearothermophil
us)
4 / 7 GLU A 310
PHE A 314
ALA A 109
GLY A 107
GLU  A 310 ( 0.6A)
PHE  A 314 ( 1.3A)
ALA  A 109 ( 0.0A)
GLY  A 107 ( 0.0A)
1.05A 5uxdA-2ogsA:
undetectable
5uxdA-2ogsA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UXD_A_ZITA501_1
(MACROLIDE
2'-PHOSPHOTRANSFERAS
E MPHH)
2vbf BRANCHED-CHAIN
ALPHA-KETOACID
DECARBOXYLASE

(Lactococcus
lactis)
4 / 7 GLU A  89
ALA A  60
GLY A  58
TYR A  54
GLU  A  89 ( 0.5A)
ALA  A  60 ( 0.0A)
GLY  A  58 ( 0.0A)
TYR  A  54 ( 1.3A)
1.02A 5uxdA-2vbfA:
undetectable
5uxdA-2vbfA:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V02_R_657R201_0
(CALMODULIN-1
SMALL CONDUCTANCE
CALCIUM-ACTIVATED
POTASSIUM CHANNEL
PROTEIN 2)
4gow CALMODULIN
(Homo
sapiens)
6 / 10 LEU D  32
MET D  51
GLU D  54
VAL D  55
ILE D  63
MET D  72
LEU  D  32 ( 0.6A)
MET  D  51 ( 0.0A)
GLU  D  54 ( 0.5A)
VAL  D  55 ( 0.6A)
ILE  D  63 ( 0.7A)
MET  D  72 ( 0.0A)
0.71A 5v02B-4gowD:
undetectable
5v02R-4gowD:
14.5
5v02B-4gowD:
19.86
5v02R-4gowD:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)
5cdn DNA GYRASE SUBUNIT A
(Staphylococcus
aureus)
5 / 12 GLU A 156
LEU A 136
LEU A 160
LEU A  42
ILE A  49
GLU  A 156 (-0.5A)
LEU  A 136 ( 0.5A)
LEU  A 160 ( 0.6A)
LEU  A  42 ( 0.6A)
ILE  A  49 ( 0.6A)
1.18A 5v0vA-5cdnA:
undetectable
5v0vA-5cdnA:
20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VIM_B_SAMB301_0
(METHYLTRANSFERASE)
5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE

(Bacillus
subtilis)
6 / 12 GLY A 115
GLY A 248
GLY A 364
GLU A 252
VAL A 395
ILE A 354
GLY  A 115 ( 0.0A)
GLY  A 248 ( 0.0A)
GLY  A 364 ( 0.0A)
GLU  A 252 ( 0.6A)
VAL  A 395 ( 0.5A)
ILE  A 354 ( 0.7A)
1.31A 5vimB-5ep8A:
undetectable
5vimB-5ep8A:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_A_CVIA301_0
(REGULATORY PROTEIN
TETR)
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
5 / 12 ALA A 182
SER A 186
GLU A 208
LEU A 191
ILE A 213
ALA  A 182 ( 0.0A)
SER  A 186 ( 0.0A)
GLU  A 208 ( 0.6A)
LEU  A 191 ( 0.6A)
ILE  A 213 ( 0.7A)
1.50A 5vlmA-1omoA:
0.0
5vlmA-1omoA:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_A_CVIA301_0
(REGULATORY PROTEIN
TETR)
2zns GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 1

(Homo
sapiens)
5 / 12 GLN A 739
SER A 524
GLU A 723
LEU A 743
PHE A 678
None
None
GLU  A 301 ( 2.8A)
None
None
1.50A 5vlmA-2znsA:
undetectable
5vlmA-2znsA:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VLM_C_CVIC301_1
(REGULATORY PROTEIN
TETR)
4fzi PROSTAGLANDIN F
SYNTHASE

(Trypanosoma
cruzi)
4 / 7 GLN A  84
GLY A 114
GLN A 171
TRP A 112
None
None
None
GLU  A 301 (-4.1A)
1.11A 5vlmC-4fziA:
undetectable
5vlmC-4fziA:
21.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOP_A_C2FA3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
3 / 3 ASP A 244
ASN A 266
ASP A 321
MG  A1601 ( 3.2A)
GLU  A2471 ( 4.7A)
ALA  A2470 (-2.7A)
0.78A 5vopA-1tkkA:
6.7
5vopA-1tkkA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOP_A_C2FA3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
3 / 3 ASP A 224
ASN A 244
ASP A 296
NA  A 401 ( 3.3A)
GLU  A 403 ( 4.4A)
ALA  A 402 (-2.5A)
0.85A 5vopA-4gfiA:
6.8
5vopA-4gfiA:
24.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOP_B_C2FB3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)
1tkk SIMILAR TO
CHLOROMUCONATE
CYCLOISOMERASE

(Bacillus
subtilis)
3 / 3 ASP A 244
ASN A 266
ASP A 321
MG  A1601 ( 3.2A)
GLU  A2471 ( 4.7A)
ALA  A2470 (-2.7A)
0.73A 5vopB-1tkkA:
3.7
5vopB-1tkkA:
23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOP_B_C2FB3001_1
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)
4gfi MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN

(Agrobacterium
fabrum)
3 / 3 ASP A 224
ASN A 244
ASP A 296
NA  A 401 ( 3.3A)
GLU  A 403 ( 4.4A)
ALA  A 402 (-2.5A)
0.82A 5vopB-4gfiA:
4.3
5vopB-4gfiA:
24.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5vuiA-5bs1A:
undetectable
5vuiB-5bs1A:
undetectable
5vuiA-5bs1A:
14.45
5vuiB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 5vuiA-5bs1A:
undetectable
5vuiB-5bs1A:
undetectable
5vuiA-5bs1A:
14.45
5vuiB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUJ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.33A 5vujA-5bs1A:
undetectable
5vujB-5bs1A:
undetectable
5vujA-5bs1A:
14.45
5vujB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUJ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.34A 5vujA-5bs1A:
undetectable
5vujB-5bs1A:
undetectable
5vujA-5bs1A:
14.45
5vujB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUK_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5vukA-5bs1A:
undetectable
5vukB-5bs1A:
undetectable
5vukA-5bs1A:
14.45
5vukB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUK_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 5vukA-5bs1A:
undetectable
5vukB-5bs1A:
undetectable
5vukA-5bs1A:
14.45
5vukB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUL_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5vulA-5bs1A:
undetectable
5vulB-5bs1A:
undetectable
5vulA-5bs1A:
14.45
5vulB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUL_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 5vulA-5bs1A:
undetectable
5vulB-5bs1A:
undetectable
5vulA-5bs1A:
14.45
5vulB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUM_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5vumA-5bs1A:
undetectable
5vumB-5bs1A:
undetectable
5vumA-5bs1A:
14.45
5vumB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUM_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 5vumA-5bs1A:
undetectable
5vumB-5bs1A:
undetectable
5vumA-5bs1A:
14.45
5vumB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUO_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.31A 5vuoA-5bs1A:
undetectable
5vuoB-5bs1A:
undetectable
5vuoA-5bs1A:
14.45
5vuoB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUP_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 5vupA-5bs1A:
undetectable
5vupB-5bs1A:
undetectable
5vupA-5bs1A:
14.45
5vupB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUQ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 5vuqA-5bs1A:
undetectable
5vuqB-5bs1A:
undetectable
5vuqA-5bs1A:
14.45
5vuqB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUQ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 5vuqA-5bs1A:
undetectable
5vuqB-5bs1A:
undetectable
5vuqA-5bs1A:
14.45
5vuqB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUR_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.32A 5vurA-5bs1A:
undetectable
5vurB-5bs1A:
undetectable
5vurA-5bs1A:
14.45
5vurB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3r6y ASPARTASE
(Bacillus
sp.
YM55-1)
4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
1.40A 5vusA-3r6yA:
undetectable
5vusB-3r6yA:
undetectable
5vusA-3r6yA:
22.39
5vusB-3r6yA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.31A 5vusA-5bs1A:
undetectable
5vusB-5bs1A:
undetectable
5vusA-5bs1A:
14.45
5vusB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUS_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.32A 5vusA-5bs1A:
undetectable
5vusB-5bs1A:
undetectable
5vusA-5bs1A:
14.45
5vusB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 5vuuA-5bs1A:
undetectable
5vuuB-5bs1A:
undetectable
5vuuA-5bs1A:
14.45
5vuuB-5bs1A:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUV_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5vuvA-5bs1A:
undetectable
5vuvB-5bs1A:
undetectable
5vuvA-5bs1A:
15.97
5vuvB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUV_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 5vuvA-5bs1A:
undetectable
5vuvB-5bs1A:
undetectable
5vuvA-5bs1A:
15.97
5vuvB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUW_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.25A 5vuwA-5bs1A:
undetectable
5vuwB-5bs1A:
undetectable
5vuwA-5bs1A:
15.97
5vuwB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUX_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 5vuxA-5bs1A:
undetectable
5vuxB-5bs1A:
undetectable
5vuxA-5bs1A:
15.97
5vuxB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUY_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 5vuyA-5bs1A:
undetectable
5vuyB-5bs1A:
undetectable
5vuyA-5bs1A:
15.97
5vuyB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUY_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.25A 5vuyA-5bs1A:
undetectable
5vuyB-5bs1A:
undetectable
5vuyA-5bs1A:
15.97
5vuyB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUZ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5vuzA-5bs1A:
undetectable
5vuzB-5bs1A:
undetectable
5vuzA-5bs1A:
15.97
5vuzB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 5vuzA-5bs1A:
undetectable
5vuzB-5bs1A:
undetectable
5vuzA-5bs1A:
15.97
5vuzB-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV0_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.28A 5vv0A-5bs1A:
undetectable
5vv0B-5bs1A:
undetectable
5vv0A-5bs1A:
15.97
5vv0B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV0_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.29A 5vv0A-5bs1A:
undetectable
5vv0B-5bs1A:
undetectable
5vv0A-5bs1A:
15.97
5vv0B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 5vv1A-5bs1A:
undetectable
5vv1B-5bs1A:
undetectable
5vv1A-5bs1A:
15.97
5vv1B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV2_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 5vv2A-5bs1A:
undetectable
5vv2B-5bs1A:
undetectable
5vv2A-5bs1A:
15.97
5vv2B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 5vv3A-5bs1A:
undetectable
5vv3B-5bs1A:
undetectable
5vv3A-5bs1A:
15.97
5vv3B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV3_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 5vv3A-5bs1A:
undetectable
5vv3B-5bs1A:
undetectable
5vv3A-5bs1A:
15.97
5vv3B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV4_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.28A 5vv4A-5bs1A:
undetectable
5vv4B-5bs1A:
undetectable
5vv4A-5bs1A:
15.97
5vv4B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV5_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 5vv5A-5bs1A:
undetectable
5vv5B-5bs1A:
undetectable
5vv5A-5bs1A:
15.97
5vv5B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VV5_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.32A 5vv5A-5bs1A:
undetectable
5vv5B-5bs1A:
undetectable
5vv5A-5bs1A:
15.97
5vv5B-5bs1A:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_A_SAMA601_0
(NS5
METHYLTRANSFERASE)
5l5n PLEXIN-A4
(Mus
musculus)
5 / 12 GLY A 420
GLY A 298
GLU A 416
VAL A 293
ILE A 366
GLY  A 420 ( 0.0A)
GLY  A 298 ( 0.0A)
GLU  A 416 ( 0.5A)
VAL  A 293 ( 0.6A)
ILE  A 366 ( 0.6A)
0.98A 5wz1A-5l5nA:
undetectable
5wz1A-5l5nA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_C_SAMC601_0
(NS5
METHYLTRANSFERASE)
5l5n PLEXIN-A4
(Mus
musculus)
5 / 12 GLY A 420
GLY A 298
GLU A 416
VAL A 293
ILE A 366
GLY  A 420 ( 0.0A)
GLY  A 298 ( 0.0A)
GLU  A 416 ( 0.5A)
VAL  A 293 ( 0.6A)
ILE  A 366 ( 0.6A)
1.00A 5wz1C-5l5nA:
undetectable
5wz1C-5l5nA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_D_SAMD601_0
(NS5
METHYLTRANSFERASE)
5l5n PLEXIN-A4
(Mus
musculus)
5 / 12 GLY A 420
GLY A 298
GLU A 416
VAL A 293
ILE A 366
GLY  A 420 ( 0.0A)
GLY  A 298 ( 0.0A)
GLU  A 416 ( 0.5A)
VAL  A 293 ( 0.6A)
ILE  A 366 ( 0.6A)
0.97A 5wz1D-5l5nA:
undetectable
5wz1D-5l5nA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_E_SAME601_0
(NS5
METHYLTRANSFERASE)
5l5n PLEXIN-A4
(Mus
musculus)
5 / 12 GLY A 420
GLY A 298
GLU A 416
VAL A 293
ILE A 366
GLY  A 420 ( 0.0A)
GLY  A 298 ( 0.0A)
GLU  A 416 ( 0.5A)
VAL  A 293 ( 0.6A)
ILE  A 366 ( 0.6A)
1.00A 5wz1E-5l5nA:
undetectable
5wz1E-5l5nA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_F_SAMF601_0
(NS5
METHYLTRANSFERASE)
5l5n PLEXIN-A4
(Mus
musculus)
5 / 12 GLY A 420
GLY A 298
GLU A 416
VAL A 293
ILE A 366
GLY  A 420 ( 0.0A)
GLY  A 298 ( 0.0A)
GLU  A 416 ( 0.5A)
VAL  A 293 ( 0.6A)
ILE  A 366 ( 0.6A)
0.97A 5wz1F-5l5nA:
undetectable
5wz1F-5l5nA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_G_SAMG601_0
(NS5
METHYLTRANSFERASE)
5l5n PLEXIN-A4
(Mus
musculus)
5 / 12 GLY A 420
GLY A 298
GLU A 416
VAL A 293
ILE A 366
GLY  A 420 ( 0.0A)
GLY  A 298 ( 0.0A)
GLU  A 416 ( 0.5A)
VAL  A 293 ( 0.6A)
ILE  A 366 ( 0.6A)
0.97A 5wz1G-5l5nA:
undetectable
5wz1G-5l5nA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ1_H_SAMH601_0
(NS5
METHYLTRANSFERASE)
5l5n PLEXIN-A4
(Mus
musculus)
5 / 12 GLY A 420
GLY A 298
GLU A 416
VAL A 293
ILE A 366
GLY  A 420 ( 0.0A)
GLY  A 298 ( 0.0A)
GLU  A 416 ( 0.5A)
VAL  A 293 ( 0.6A)
ILE  A 366 ( 0.6A)
0.96A 5wz1H-5l5nA:
undetectable
5wz1H-5l5nA:
13.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5WZ2_C_SAMC601_0
(NS5 MTASE)
5ep8 PYRIMIDINE-NUCLEOSID
E PHOSPHORYLASE

(Bacillus
subtilis)
6 / 12 GLY A 115
GLY A 248
GLY A 364
GLU A 252
VAL A 395
ILE A 354
GLY  A 115 ( 0.0A)
GLY  A 248 ( 0.0A)
GLY  A 364 ( 0.0A)
GLU  A 252 ( 0.6A)
VAL  A 395 ( 0.5A)
ILE  A 354 ( 0.7A)
1.31A 5wz2C-5ep8A:
undetectable
5wz2C-5ep8A:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X7F_A_SAMA301_0
(PUTATIVE
O-METHYLTRANSFERASE
RV1220C)
1us4 PUTATIVE GLUR0
LIGAND BINDING CORE

(Thermus
thermophilus)
5 / 12 VAL A  35
VAL A  31
ILE A  64
ALA A  66
ALA A  75
None
GLU  A1313 (-3.8A)
None
None
None
1.19A 5x7fA-1us4A:
undetectable
5x7fA-1us4A:
25.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X7P_B_ACRB1421_1
(GLYCOSIDE HYDROLASE
FAMILY 31
ALPHA-GLUCOSIDASE)
3c3n DIHYDROOROTATE
DEHYDROGENASE

(Trypanosoma
cruzi)
4 / 6 TYR A 254
GLU A 257
GLY A 252
GLY A 224
TYR  A 254 ( 1.3A)
GLU  A 257 ( 0.5A)
GLY  A 252 (-0.0A)
GLY  A 224 (-0.0A)
0.94A 5x7pB-3c3nA:
undetectable
5x7pB-3c3nA:
13.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X80_C_SALC201_1
(UNCHARACTERIZED
HTH-TYPE
TRANSCRIPTIONAL
REGULATOR RV2887)
2dvz PUTATIVE EXPORTED
PROTEIN

(Bordetella
pertussis)
4 / 7 VAL A  40
VAL A  23
GLY A 244
TYR A 243
None
None
None
GLU  A1055 (-4.2A)
0.89A 5x80C-2dvzA:
undetectable
5x80D-2dvzA:
undetectable
5x80C-2dvzA:
21.38
5x80D-2dvzA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIP_A_HFGA1003_0
(PROLYL-TRNA
SYNTHETASE, PUTATIVE)
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A   6
GLU A 306
VAL A 304
THR A  92
GLY A  93
LEU  A   6 ( 0.6A)
GLU  A 306 ( 0.6A)
VAL  A 304 ( 0.6A)
THR  A  92 ( 0.8A)
GLY  A  93 ( 0.0A)
1.22A 5xipA-1omoA:
undetectable
5xipA-1omoA:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIP_A_HFGA1003_1
(PROLYL-TRNA
SYNTHETASE, PUTATIVE)
4w65 GLYCOSYL HYDROLASE
FAMILY PROTEIN

(Mycolicibacteriu
m
fortuitum)
3 / 3 GLU A 168
TRP A 175
HIS A 182
GLU  A 168 (-0.5A)
TRP  A 175 ( 0.5A)
HIS  A 182 ( 1.0A)
1.03A 5xipA-4w65A:
undetectable
5xipA-4w65A:
17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIP_C_HFGC1003_0
(PROLYL-TRNA
SYNTHETASE, PUTATIVE)
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A   6
GLU A 306
VAL A 304
THR A  92
GLY A  93
LEU  A   6 ( 0.6A)
GLU  A 306 ( 0.6A)
VAL  A 304 ( 0.6A)
THR  A  92 ( 0.8A)
GLY  A  93 ( 0.0A)
1.29A 5xipC-1omoA:
undetectable
5xipC-1omoA:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIP_D_HFGD1003_0
(PROLYL-TRNA
SYNTHETASE, PUTATIVE)
2nvv ACETYL-COA
HYDROLASE/TRANSFERAS
E FAMILY PROTEIN

(Porphyromonas
gingivalis)
5 / 12 LEU A 145
VAL A 199
PRO A 138
THR A 139
GLU A 126
LEU  A 145 ( 0.6A)
VAL  A 199 ( 0.6A)
PRO  A 138 ( 1.1A)
THR  A 139 ( 0.8A)
GLU  A 126 ( 0.5A)
1.39A 5xipD-2nvvA:
undetectable
5xipD-2nvvA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIQ_A_HFGA1002_0
(PROLYL-TRNA
SYNTHETASE (PRORS))
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A   6
GLU A 306
VAL A 304
THR A  92
GLY A  93
LEU  A   6 ( 0.6A)
GLU  A 306 ( 0.6A)
VAL  A 304 ( 0.6A)
THR  A  92 ( 0.8A)
GLY  A  93 ( 0.0A)
1.20A 5xiqA-1omoA:
undetectable
5xiqA-1omoA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIQ_D_HFGD1002_0
(PROLYL-TRNA
SYNTHETASE (PRORS))
1omo ALANINE
DEHYDROGENASE

(Archaeoglobus
fulgidus)
5 / 12 LEU A   6
GLU A 306
VAL A 304
THR A  92
GLY A  93
LEU  A   6 ( 0.6A)
GLU  A 306 ( 0.6A)
VAL  A 304 ( 0.6A)
THR  A  92 ( 0.8A)
GLY  A  93 ( 0.0A)
1.16A 5xiqD-1omoA:
undetectable
5xiqD-1omoA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XOO_A_ADNA506_1
(GLYCOSAMINOGLYCAN
XYLOSYLKINASE)
4kqn D-HYDANTOINASE
(Bacillus
sp.
AR9)
4 / 6 LEU A 124
LYS A  97
GLU A  99
LEU A 101
LEU  A 124 ( 0.5A)
LYS  A  97 ( 0.0A)
GLU  A  99 ( 0.6A)
LEU  A 101 ( 0.6A)
1.33A 5xooA-4kqnA:
undetectable
5xooA-4kqnA:
10.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XOO_B_ADNB503_1
(GLYCOSAMINOGLYCAN
XYLOSYLKINASE)
3r9r PHOSPHORIBOSYLAMINOI
MIDAZOLE-SUCCINOCARB
OXAMIDE SYNTHASE

(Mycobacteroides
abscessus)
4 / 5 LEU A  28
VAL A  83
GLU A  82
LEU A   5
LEU  A  28 ( 0.6A)
VAL  A  83 ( 0.6A)
GLU  A  82 ( 0.5A)
LEU  A   5 ( 0.6A)
0.93A 5xooB-3r9rA:
3.0
5xooB-3r9rA:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AGG_Z_AG2Z503_0
(TRNA(ILE2)
2-AGMATINYLCYTIDINE
SYNTHETASE TIAS)
4g6z GLUTAMATE-TRNA
LIGASE

(Burkholderia
thailandensis)
4 / 5 GLU A  44
VAL A 193
CYH A 190
ARG A  42
GLU  A 501 (-3.7A)
None
None
None
1.08A 6aggZ-4g6zA:
undetectable
6aggZ-4g6zA:
10.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AN0_A_HISA520_0
(HISTIDINOL
DEHYDROGENASE)
3ik5 PROTEIN NEF
(Simian
immunodeficiency
virus)
4 / 6 GLU A 150
LYS A 148
ARG A 109
GLU A 147
GLU  A 150 ( 0.6A)
LYS  A 148 ( 0.0A)
ARG  A 109 ( 0.6A)
GLU  A 147 ( 0.6A)
1.06A 6an0A-3ik5A:
undetectable
6an0A-3ik5A:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AN0_A_HISA520_0
(HISTIDINOL
DEHYDROGENASE)
3kbb PHOSPHORYLATED
CARBOHYDRATES
PHOSPHATASE TM_1254

(Thermotoga
maritima)
5 / 6 GLU A 164
LYS A 167
GLU A 171
ALA A 172
LYS A 140
GLU  A 164 ( 0.6A)
LYS  A 167 (-0.0A)
GLU  A 171 ( 0.6A)
ALA  A 172 ( 0.0A)
LYS  A 140 (-0.0A)
1.48A 6an0A-3kbbA:
4.2
6an0A-3kbbA:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUQ_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 6 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 6auqA-5bs1A:
undetectable
6auqB-5bs1A:
undetectable
6auqA-5bs1A:
18.18
6auqB-5bs1A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUT_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.30A 6autA-5bs1A:
undetectable
6autB-5bs1A:
undetectable
6autA-5bs1A:
18.18
6autB-5bs1A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUU_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.32A 6auuA-5bs1A:
undetectable
6auuB-5bs1A:
undetectable
6auuA-5bs1A:
18.18
6auuB-5bs1A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUW_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.30A 6auwA-5bs1A:
undetectable
6auwB-5bs1A:
undetectable
6auwA-5bs1A:
18.18
6auwB-5bs1A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3r6y ASPARTASE
(Bacillus
sp.
YM55-1)
4 / 7 MET A 298
VAL A 310
PHE A 178
GLU A 308
MET  A 298 ( 0.0A)
VAL  A 310 ( 0.6A)
PHE  A 178 ( 1.3A)
GLU  A 308 ( 0.6A)
1.43A 6av1A-3r6yA:
undetectable
6av1B-3r6yA:
undetectable
6av1A-3r6yA:
12.98
6av1B-3r6yA:
12.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.32A 6av1A-5bs1A:
undetectable
6av1B-5bs1A:
undetectable
6av1A-5bs1A:
20.49
6av1B-5bs1A:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV1_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 TRP A 104
GLU A 103
ARG A 123
VAL A 108
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
1.33A 6av1A-5bs1A:
undetectable
6av1B-5bs1A:
undetectable
6av1A-5bs1A:
20.49
6av1B-5bs1A:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AV3_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
5bs1 CRRBCX-IIA
(Chlamydomonas
reinhardtii)
4 / 7 ARG A 123
VAL A 108
TRP A 104
GLU A 103
ARG  A 123 ( 0.6A)
VAL  A 108 ( 0.6A)
TRP  A 104 ( 0.5A)
GLU  A 103 ( 0.6A)
1.29A 6av3A-5bs1A:
undetectable
6av3B-5bs1A:
undetectable
6av3A-5bs1A:
20.49
6av3B-5bs1A:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BER_A_DVAA2_0
(E(DVA)DP(DGL)(DHI)(D
PR)N(DAL)(DPR))
3wd7 TYPE III POLYKETIDE
SYNTHASES ACRIDONE
SYNTHASE

(Citrus
x
microcarpa)
3 / 3 GLU A 179
ASP A 227
PRO A 228
GLU  A 179 ( 0.6A)
ASP  A 227 ( 0.6A)
PRO  A 228 ( 1.1A)
0.31A 6berA-3wd7A:
undetectable
6berA-3wd7A:
3.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BER_A_DVAA2_0
(E(DVA)DP(DGL)(DHI)(D
PR)N(DAL)(DPR))
3whl PROTEASOME-ACTIVATIN
G NUCLEOTIDASE, 26S
PROTEASE REGULATORY
SUBUNIT 6A

(Pyrococcus
furiosus;
Saccharomyces
cerevisiae)
3 / 3 GLU A 208
ASP A 213
PRO A 214
GLU  A 208 ( 0.6A)
ASP  A 213 ( 0.6A)
PRO  A 214 ( 1.1A)
0.50A 6berA-3whlA:
undetectable
6berA-3whlA:
6.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BZO_C_FI8C1201_0
(DNA-DIRECTED RNA
POLYMERASE SUBUNIT
BETA)
1vho ENDOGLUCANASE
(Thermotoga
maritima)
5 / 12 THR A  42
VAL A 194
SER A 199
VAL A  66
GLU A  22
THR  A  42 ( 0.8A)
VAL  A 194 ( 0.6A)
SER  A 199 (-0.0A)
VAL  A  66 ( 0.5A)
GLU  A  22 ( 0.6A)
1.35A 6bzoC-1vhoA:
0.0
6bzoC-1vhoA:
16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CDU_H_EY4H500_0
(CHIMERIC ALPHA1GABAA
RECEPTOR)
5vaw MALTOSE-BINDING
PERIPLASMIC
PROTEIN,TYPE IV
PILIN PILA

(Acinetobacter
baumannii;
Escherichia
coli)
4 / 7 VAL A1033
ALA A1029
THR A1026
TYR A1027
None
None
None
GLU  A1203 (-4.0A)
0.95A 6cduH-5vawA:
undetectable
6cduI-5vawA:
undetectable
6cduH-5vawA:
undetectable
6cduI-5vawA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)
2hk0 D-PSICOSE
3-EPIMERASE

(Agrobacterium
tumefaciens)
4 / 7 ASP A 275
ASN A 278
ALA A 279
GLU A 212
ASP  A 275 ( 0.6A)
ASN  A 278 ( 0.6A)
ALA  A 279 ( 0.0A)
GLU  A 212 ( 0.6A)
0.84A 6ci6A-2hk0A:
undetectable
6ci6A-2hk0A:
11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6D8F_A_ACTA803_0
(UNCHARACTERIZED
PROTEIN)
3ab7 PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA0350

(Thermus
thermophilus)
3 / 3 GLU A 101
LEU A 104
ARG A 108
GLU  A 101 ( 0.6A)
LEU  A 104 ( 0.6A)
ARG  A 108 ( 0.6A)
0.66A 6d8fA-3ab7A:
2.7
6d8fA-3ab7A:
17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6D8P_A_ACTA810_0
(UNCHARACTERIZED
PROTEIN)
1fxj UDP-N-ACETYLGLUCOSAM
INE
PYROPHOSPHORYLASE

(Escherichia
coli)
4 / 6 TYR A 239
GLU A 242
GLN A 243
LYS A 246
TYR  A 239 ( 1.3A)
GLU  A 242 ( 0.6A)
GLN  A 243 ( 0.6A)
LYS  A 246 ( 0.0A)
1.02A 6d8pA-1fxjA:
0.0
6d8pA-1fxjA:
18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJZ_B_GMJB301_1
(SIGMA NON-OPIOID
INTRACELLULAR
RECEPTOR 1)
2rci TYPE-2BA CYTOLYTIC
DELTA-ENDOTOXIN

(Bacillus
thuringiensis)
4 / 6 TYR A  48
ASP A 179
VAL A 125
GLU A 178
TYR  A  48 ( 1.3A)
ASP  A 179 ( 0.6A)
VAL  A 125 ( 0.5A)
GLU  A 178 ( 0.5A)
1.25A 6djzB-2rciA:
undetectable
6djzB-2rciA:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DRZ_A_H8JA1206_0
(5HT2B RECEPTOR, BRIL
CHIMERA)
2jfn GLUTAMATE RACEMASE
(Escherichia
coli)
5 / 12 VAL A 166
SER A 162
THR A 135
PHE A  58
GLY A  61
None
None
GLU  A1287 ( 4.2A)
GLU  A1287 (-4.5A)
GLU  A1287 (-3.5A)
1.02A 6drzA-2jfnA:
undetectable
6drzA-2jfnA:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ELI_A_T27A701_1
(REVERSE
TRANSCRIPTASE)
3iha SALT-TOLERANT
GLUTAMINASE

(Micrococcus
luteus)
5 / 12 PRO A 108
LEU A 174
VAL A 188
TYR A 191
LEU A 170
None
None
None
GLU  A 500 (-4.1A)
None
1.22A 6eliA-3ihaA:
undetectable
6eliA-3ihaA:
9.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F6J_D_ACTD404_0
(L-LYSINE
3-HYDROXYLASE)
1k5d RAN-SPECIFIC
GTPASE-ACTIVATING
PROTEIN

(Homo
sapiens)
4 / 6 GLU B 136
TRP B 122
HIS B 102
ALA B 100
GLU  B 136 ( 0.5A)
TRP  B 122 ( 0.5A)
HIS  B 102 ( 1.0A)
ALA  B 100 ( 0.0A)
1.39A 6f6jC-1k5dB:
0.0
6f6jD-1k5dB:
0.0
6f6jC-1k5dB:
19.34
6f6jD-1k5dB:
19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FBN_B_SAMB401_0
(S-ADENOSYLMETHIONINE
SYNTHASE ISOFORM
TYPE-2)
4ikn AP-3 COMPLEX SUBUNIT
MU-1

(Rattus
norvegicus)
4 / 7 GLU A 185
ASP A 188
ILE A 187
ILE A 272
GLU  A 185 ( 0.6A)
ASP  A 188 ( 0.6A)
ILE  A 187 ( 0.6A)
ILE  A 272 ( 0.7A)
0.84A 6fbnA-4iknA:
undetectable
6fbnA-4iknA:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FHW_A_ACRA801_2
(GLUCOAMYLASE P)
3r64 NAD DEPENDENT
BENZALDEHYDE
DEHYDROGENASE

(Corynebacterium
glutamicum)
3 / 3 TRP A  66
GLU A  65
GLU A  73
TRP  A  66 ( 0.5A)
GLU  A  65 ( 0.6A)
GLU  A  73 ( 0.6A)
0.68A 6fhwA-3r64A:
undetectable
6fhwA-3r64A:
9.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNE_A_ACRA602_2
(-)
2hk0 D-PSICOSE
3-EPIMERASE

(Agrobacterium
tumefaciens)
4 / 6 TRP A 112
HIS A 186
ASN A 157
GLU A 165
TRP  A 112 ( 0.5A)
HIS  A 186 ( 1.0A)
ASN  A 157 ( 0.6A)
GLU  A 165 ( 0.6A)
1.42A 6gneA-2hk0A:
undetectable
6gneA-2hk0A:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNG_A_QPSA601_2
(-)
3ulk KETOL-ACID
REDUCTOISOMERASE

(Escherichia
coli)
5 / 12 GLY A 204
TRP A 194
HIS A 201
GLU A  27
GLY A  24
GLY  A 204 ( 0.0A)
TRP  A 194 ( 0.5A)
HIS  A 201 (-1.0A)
GLU  A  27 ( 0.6A)
GLY  A  24 ( 0.0A)
1.18A 6gngA-3ulkA:
3.8
6gngA-3ulkA:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HRJ_A_010A302_0
(YNDL)
2bzt PROTEIN ISCX
(Escherichia
coli)
4 / 5 GLU A  55
LYS A  52
GLU A  51
PHE A  29
GLU  A  55 ( 0.6A)
LYS  A  52 ( 0.0A)
GLU  A  51 ( 0.6A)
PHE  A  29 ( 1.3A)
1.38A 6hrjA-2bztA:
undetectable
6hrjA-2bztA:
15.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HZP_A_FVTA501_0
(PEPTIDE ABC
TRANSPORTER PERMEASE)
2qc5 STREPTOGRAMIN B
LACTONASE

(Staphylococcus
cohnii)
4 / 8 ASN A 204
GLN A 247
ILE A 220
GLU A 259
ASN  A 204 ( 0.6A)
GLN  A 247 ( 0.6A)
ILE  A 220 ( 0.7A)
GLU  A 259 ( 0.6A)
1.08A 6hzpA-2qc5A:
undetectable
6hzpA-2qc5A:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HZP_A_FVTA501_0
(PEPTIDE ABC
TRANSPORTER PERMEASE)
4wxj GLUTAMATE RECEPTOR
IIB,GLUTAMATE
RECEPTOR IIB

(Drosophila
melanogaster)
4 / 8 TYR A  68
ASN A  66
ASN A 180
GLU A 182
GLU  A 301 (-2.8A)
None
None
None
1.11A 6hzpA-4wxjA:
undetectable
6hzpA-4wxjA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_D_NMYD302_0
(AAC(3)-IIIB PROTEIN)
1ewk METABOTROPIC
GLUTAMATE RECEPTOR
SUBTYPE 1

(Rattus
norvegicus)
5 / 10 ASP A 318
THR A 232
GLY A 240
ASP A 242
GLU A 238
GLU  A 701 (-3.0A)
None
None
None
None
1.41A 6mb9D-1ewkA:
0.0
6mb9D-1ewkA:
9.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6PAH_A_DAHA600_1
(PHENYLALANINE
4-MONOOXYGENASE)
2hk0 D-PSICOSE
3-EPIMERASE

(Agrobacterium
tumefaciens)
4 / 6 LEU A 108
HIS A 207
HIS A 209
GLU A  34
LEU  A 108 ( 0.6A)
HIS  A 207 ( 1.0A)
HIS  A 209 ( 1.0A)
GLU  A  34 ( 0.6A)
0.90A 6pahA-2hk0A:
undetectable
6pahA-2hk0A:
22.41